
<html lang="en"     class="pb-page"  data-request-id="794f6d69-b15d-4f40-b5a2-620d03877dab"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2017.60.issue-1;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.6b01451"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Aminomethyl-Derived Beta Secretase (BACE1) Inhibitors: Engaging Gly230 without an Anilide Functionality" /></meta><meta name="dc.Creator" content="Christopher R.  Butler" /></meta><meta name="dc.Creator" content="Kevin  Ogilvie" /></meta><meta name="dc.Creator" content="Luis  Martinez-Alsina" /></meta><meta name="dc.Creator" content="Gabriela  Barreiro" /></meta><meta name="dc.Creator" content="Elizabeth M.  Beck" /></meta><meta name="dc.Creator" content="Charles E.  Nolan" /></meta><meta name="dc.Creator" content="Kevin  Atchison" /></meta><meta name="dc.Creator" content="Eric  Benvenuti" /></meta><meta name="dc.Creator" content="Leanne  Buzon" /></meta><meta name="dc.Creator" content="Shawn  Doran" /></meta><meta name="dc.Creator" content="Cathleen  Gonzales" /></meta><meta name="dc.Creator" content="Christopher J.  Helal" /></meta><meta name="dc.Creator" content="Xinjun  Hou" /></meta><meta name="dc.Creator" content="Mei-Hui  Hsu" /></meta><meta name="dc.Creator" content="Eric F.  Johnson" /></meta><meta name="dc.Creator" content="Kimberly  Lapham" /></meta><meta name="dc.Creator" content="Lorraine  Lanyon" /></meta><meta name="dc.Creator" content="Kevin  Parris" /></meta><meta name="dc.Creator" content="Brian T.  O’Neill" /></meta><meta name="dc.Creator" content="David  Riddell" /></meta><meta name="dc.Creator" content="Ashley  Robshaw" /></meta><meta name="dc.Creator" content="Felix  Vajdos" /></meta><meta name="dc.Creator" content="Michael A.  Brodney" /></meta><meta name="dc.Description" content="A growing subset of β-secretase (BACE1) inhibitors for the treatment of Alzheimer’s disease (AD) utilizes an anilide chemotype that engages a key residue (Gly230) in the BACE1 binding site. Althoug..." /></meta><meta name="Description" content="A growing subset of β-secretase (BACE1) inhibitors for the treatment of Alzheimer’s disease (AD) utilizes an anilide chemotype that engages a key residue (Gly230) in the BACE1 binding site. Althoug..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 20, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01451" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01451" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01451" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01451" /></link>
        
    
    

<title>Aminomethyl-Derived Beta Secretase (BACE1) Inhibitors: Engaging Gly230 without an Anilide Functionality | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01451" /></meta><meta property="og:title" content="Aminomethyl-Derived Beta Secretase (BACE1) Inhibitors: Engaging Gly230 without an Anilide Functionality" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0017.jpeg" /></meta><meta property="og:description" content="A growing subset of β-secretase (BACE1) inhibitors for the treatment of Alzheimer’s disease (AD) utilizes an anilide chemotype that engages a key residue (Gly230) in the BACE1 binding site. Although the anilide moiety affords excellent potency, it simultaneously introduces a third hydrogen bond donor that limits brain availability and provides a potential metabolic site leading to the formation of an aniline, a structural motif of prospective safety concern. We report herein an alternative aminomethyl linker that delivers similar potency and improved brain penetration relative to the amide moiety. Optimization of this series identified analogues with an excellent balance of ADME properties and potency; however, potential drug–drug interactions (DDI) were predicted based on CYP 2D6 affinities. Generation and analysis of key BACE1 and CYP 2D6 crystal structures identified strategies to obviate the DDI liability, leading to compound 16, which exhibits robust in vivo efficacy as a BACE1 inhibitor." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01451"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01451">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01451&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01451&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01451&amp;href=/doi/10.1021/acs.jmedchem.6b01451" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 386-402</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01432" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b01420" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Aminomethyl-Derived Beta Secretase (BACE1) Inhibitors: Engaging Gly230 without an Anilide Functionality</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+R.++Butler">Christopher R. Butler</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-9387-5011" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin++Ogilvie">Kevin Ogilvie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luis++Martinez-Alsina">Luis Martinez-Alsina</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gabriela++Barreiro">Gabriela Barreiro</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elizabeth+M.++Beck">Elizabeth M. Beck</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Charles+E.++Nolan">Charles E. Nolan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin++Atchison">Kevin Atchison</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric++Benvenuti">Eric Benvenuti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Leanne++Buzon">Leanne Buzon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shawn++Doran">Shawn Doran</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cathleen++Gonzales">Cathleen Gonzales</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+J.++Helal">Christopher J. Helal</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xinjun++Hou">Xinjun Hou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mei-Hui++Hsu">Mei-Hui Hsu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric+F.++Johnson">Eric F. Johnson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kimberly++Lapham">Kimberly Lapham</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lorraine++Lanyon">Lorraine Lanyon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin++Parris">Kevin Parris</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian+T.++O%E2%80%99Neill">Brian T. O’Neill</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Riddell">David Riddell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ashley++Robshaw">Ashley Robshaw</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Felix++Vajdos">Felix Vajdos</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+A.++Brodney">Michael A. Brodney</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Neuroscience & Pain Medicinal Chemistry, <sup>‡</sup>Neuroscience & Pain Research Unit, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span></div><div class="aff-info" id="aff2"><span class="aff-text"><sup>§</sup>Neuroscience & Pain Medicinal Chemistry, <sup>∥</sup>Center of Chemistry Innovation and Excellence, <sup>⊥</sup>Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">#</span> <span class="aff-text">Molecular and Experimental Medicine, The Scripps Research Institute, 10550 Torrey Pines Road, La Jolla, California 92024, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 617 395 0670. E-mail: <a href="/cdn-cgi/l/email-protection#6c0f041e051f18031c04091e421e420e191800091e2c1c0a0516091e420f0301"><span class="__cf_email__" data-cfemail="214249534852554e514944530f530f4354554d4453615147485b44530f424e4c">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01451&amp;href=/doi/10.1021%2Facs.jmedchem.6b01451" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 386–402</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 6, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 October 2016</li><li><span class="item_label"><b>Published</b> online</span>20 December 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 January 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01451" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01451</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01451"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2501</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">22</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01451" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Aminomethyl-Derived Beta Secretase (BACE1) Inhibitors: Engaging Gly230 without an Anilide Functionality&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;R. Butler&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;Ogilvie&quot;},{&quot;first_name&quot;:&quot;Luis&quot;,&quot;last_name&quot;:&quot;Martinez-Alsina&quot;},{&quot;first_name&quot;:&quot;Gabriela&quot;,&quot;last_name&quot;:&quot;Barreiro&quot;},{&quot;first_name&quot;:&quot;Elizabeth&quot;,&quot;last_name&quot;:&quot;M. Beck&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;E. Nolan&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;Atchison&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;Benvenuti&quot;},{&quot;first_name&quot;:&quot;Leanne&quot;,&quot;last_name&quot;:&quot;Buzon&quot;},{&quot;first_name&quot;:&quot;Shawn&quot;,&quot;last_name&quot;:&quot;Doran&quot;},{&quot;first_name&quot;:&quot;Cathleen&quot;,&quot;last_name&quot;:&quot;Gonzales&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;J. Helal&quot;},{&quot;first_name&quot;:&quot;Xinjun&quot;,&quot;last_name&quot;:&quot;Hou&quot;},{&quot;first_name&quot;:&quot;Mei-Hui&quot;,&quot;last_name&quot;:&quot;Hsu&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;F. Johnson&quot;},{&quot;first_name&quot;:&quot;Kimberly&quot;,&quot;last_name&quot;:&quot;Lapham&quot;},{&quot;first_name&quot;:&quot;Lorraine&quot;,&quot;last_name&quot;:&quot;Lanyon&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;Parris&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;T. O’Neill&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Riddell&quot;},{&quot;first_name&quot;:&quot;Ashley&quot;,&quot;last_name&quot;:&quot;Robshaw&quot;},{&quot;first_name&quot;:&quot;Felix&quot;,&quot;last_name&quot;:&quot;Vajdos&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;A. Brodney&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;20&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;386-402&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01451&quot;},&quot;abstract&quot;:&quot;A growing subset of β-secretase (BACE1) inhibitors for the treatment of Alzheimer’s disease (AD) utilizes an anilide chemotype that engages a key residue (Gly230) in the BACE1 binding site. Although the anilide moiety affords excellent potency, it simultaneously introduces a third hydrogen bond donor that limits brain availability and provides a potential metabolic site leading to the formation of an aniline, a structural motif of prospective safety concern. We report herein an alternative aminomethyl linker that delivers similar potency and improved brain penetration relative to the amide moiety. Optimization of this series identified analogues with an excellent balance of ADME properties and potency; however, potential drug–drug interactions (DDI) were predicted based on CYP 2D6 affinities. Generation and analysis of key BACE1 and CYP 2D6 crystal structures identified strategies to obviate the DDI liability, leading to compound 16, which exhibits robust in vivo efficacy as a BACE1 inhibitor.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01451&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01451" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01451&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01451" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01451&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01451" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01451&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01451&amp;href=/doi/10.1021/acs.jmedchem.6b01451" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01451" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01451" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01451%26sid%3Dliteratum%253Aachs%26pmid%3D27997172%26genre%3Darticle%26aulast%3DButler%26date%3D2017%26atitle%3DAminomethyl-Derived%2BBeta%2BSecretase%2B%2528BACE1%2529%2BInhibitors%253A%2BEngaging%2BGly230%2Bwithout%2Ban%2BAnilide%2BFunctionality%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D1%26spage%3D386%26epage%3D402%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/jmcmar.2017.60.issue-1/20170112/jmcmar.2017.60.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/medium/jm-2016-01451z_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01451&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A growing subset of β-secretase (BACE1) inhibitors for the treatment of Alzheimer’s disease (AD) utilizes an anilide chemotype that engages a key residue (Gly230) in the BACE1 binding site. Although the anilide moiety affords excellent potency, it simultaneously introduces a third hydrogen bond donor that limits brain availability and provides a potential metabolic site leading to the formation of an aniline, a structural motif of prospective safety concern. We report herein an alternative aminomethyl linker that delivers similar potency and improved brain penetration relative to the amide moiety. Optimization of this series identified analogues with an excellent balance of ADME properties and potency; however, potential drug–drug interactions (DDI) were predicted based on CYP 2D6 affinities. Generation and analysis of key BACE1 and CYP 2D6 crystal structures identified strategies to obviate the DDI liability, leading to compound <b>16</b>, which exhibits robust in vivo efficacy as a BACE1 inhibitor.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21677" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21677" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD), a neurological disorder that imparts a slow progression of cognitive decline, dementia, and ultimately death, has yet to yield to a significant enhancement in treatment or prevention. Disease progression is marked by the deposition of amyloid β (Aβ)-derived plaques in the hippocampal and cortical regions of the brain. The amyloid hypothesis proposes that increased Aβ production or its decreased clearance is responsible for the molecular cascade that eventually leads to neurodegeneration and AD.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Aβ production is initiated by the proteolytic cleavage of amyloid precursor protein (APP) by β-site APP cleaving enzyme (BACE1) within the endosome<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> to afford a soluble N-terminal ectodomain of APP (sAPPβ) and the C-terminal fragment C99.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The membrane-bound C99 is then cleaved by γ-secretase to release Aβ, including Aβx-40 and Aβx-42 isoforms.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Recently, an APP “loss of function” mutation, with protective effects against AD, has been reported to be cleaved more slowly by BACE1.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Modulation of the Aβ cascade via safe and effective inhibition of BACE1 has remained a target of great interest for a number of years.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p">Considering the chronic dosing regimen required for a successful AD treatment, an exquisitely selective and safe profile for a BACE1 inhibitor is paramount. Of particular concern for this target is inhibition of hERG,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> as well as related aspartyl proteases including cathepsin D (CatD), which has confounded early generations of BACE1 inhibitors.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The hERG-mediated cardiovascular liability is traditionally avoided by eliminating basic amine functionality and lowering lipophilicity.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> This is challenging for BACE1, as the active site is most efficiently engaged through utilization of such an amine, thus requiring alternate mitigation strategies. Additionally, the binding sites of CatD and BACE1 have high sequence similarity, and therefore differentiation requires exploitation of subtle architectural variances in order to maintain affinity for BACE1 while avoiding CatD inhibition. Compounds that fail to achieve sufficient selectivity over CatD carry a liability for ocular toxicity due to the resulting accumulation of fluorescent material in the retinal pigment epithelium (RPE) layer.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">The physiological relevance of BACE2 has emerged in recent years, first as an enzyme involved in pigmentation processing, specifically acting on PMEL17 in the periphery.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Improper functioning of BACE2 is believed to result in hypopigmentation.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> BACE2 is also expressed in the pancreas and plays a role in glucose homeostasis. To our knowledge, there are limited examples of BACE1 inhibitors possessing significant selectivity over BACE2. Compounds that lack this selectivity window and exhibit impaired access to the brain will therefore inherently suffer from significant inhibition of BACE2. In summary, agents developed for chronic BACE1 inhibition should be designed to minimize activity against related proteases such as CatD and BACE2.</div><div class="NLM_p">The amidine-containing BACE1 inhibitors, reported by a number of groups, provide a suitable scaffold to systematically address the CatD and hERG liabilities.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> A number of these inhibitors, such as MK-8931 (<b>1</b>), have recently entered clinical studies; two of them are shown in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> A common construct within this class is an amide moiety connecting two aromatic rings that ultimately occupy the S1/S3 pockets when bound in the BACE1 active site. The incorporation of this moiety generally confers potent inhibition of BACE1 in addition to exquisite selectivity over CatD. Unfortunately, these merits are generally offset by increased P-gp-mediated efflux, resulting in decreased brain penetration. There is a correlation between the presence of a third hydrogen bond donor (HBD) and an increased likelihood of efflux transporter liabilities.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Poor brain penetration inherently increases the body burden required to achieve the desired brain concentrations, and thus further exacerbates any issues arising from less than exquisite aspartyl protease selectivity. Moreover, recent reports have shown that there are relevant peripheral substrates for BACE1 in addition to the targeted central APP processing.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/medium/jm-2016-01451z_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selected literature BACE1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01451&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Inhibitors bearing the P1/P3 amide motif not only exhibit higher efflux transporter liability but also contain a metabolic soft spot associated with amidase activity, which in this case would reveal anilines upon amide cleavage.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> In addition to this potential metabolic liability, anilines are themselves a structural alert, known to be a culprit for downstream toxicity associated either with oxidation of the electron-rich aryl ring and subsequent trapping with ambient nucleophiles or oxidation of the nitrogen itself to the <i>N</i>-oxide.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Design Criteria</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20656" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20656" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Despite a significant and sustained effort, the identification of a potent, safe, selective BACE1 inhibitor with a balanced ADME profile, including good brain penetration, remains challenging. Our design criteria were therefore to identify an orally efficacious BACE1 inhibitor that (a) demonstrates excellent selectivity (>100×) over hERG, CatD and the related aspartyl proteases, and (b) maintains good brain penetration (<i>C</i><sub>b,u</sub>/<i>C</i><sub>p,u</sub> > 0.5 as measured in rodents) without the use of an anilide functionality.</div><div class="NLM_p">We therefore sought to identify an amide replacement that provided the opportunity for similar efficiency gains while avoiding the potential for toxicity imparted by the buried aniline moiety. The recent BACE1 crystal structure of <b>2</b>, published by Roche, provides a structural rationale for the high inhibitory efficiency of P1/P3 amides (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The amide N–H is positioned at a near-ideal distance and angle to engage the backbone carbonyl of the Gly230 residue in a hydrogen bonding interaction. Additionally, the coplanar conformation of the rings occupying the S1/S3 pockets serves to efficiently fill the shallow lipophilic binding site.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/medium/jm-2016-01451z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Interaction between Gly230 and <b>2</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZMG">3ZMG</a>, add 61 to residue numbers to match <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZMG">3ZMG</a>’s number).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01451&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Thus, a suitable amide replacement would need to fulfill these two structural requirements: effective engagement of Gly230 and reasonable concomitant occupation of the S1/S3 subpockets. Simple reversal of the amide removes the buried aniline while retaining the hydrogen bond donor, but rotation around the amide bond is then needed to recapitulate the optimum hydrogen bond angle, resulting in significant clashes with the edge of the S3 subpocket. In contrast, a homologated aminomethyl linker (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) addresses both of the aforementioned requirements. Among the salient features of this aminomethyl moiety, one key departure from the amide-derived analogues is its nonplanarity. The sp<sup>3</sup> nature of the benzylic carbon results in the two-atom unit preferring a nearly orthogonal orientation of the C–N bond relative to the fluorophenyl P1 ring, facilitating an optimal geometry for hydrogen bonding to Gly230. Optimization of the amine substituent in this alternative vector therefore becomes crucial to balance the interplay of requisite hydrogen-bond donating ability of the amine with the resultant ADME characteristics of these compounds.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/medium/jm-2016-01451z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Strategy to mitigate challenges associated with amide pharmacophore of literature BACE inhibitors. Modeled alignment of aminomethyl design (orange) with compound <b>2</b> (yellow).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01451&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03720" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03720" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As it was not clear what structural attributes would be required to fill the S3 pocket in this new series, parallel (library) synthesis was employed to broadly evaluate structure–activity relationships for BACE1 inhibition. Compounds <b>6a</b>–<b>u</b> were prepared by the three-step protocol illustrated in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Formylation of the previously described bromide <b>3</b><a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> provided aldehyde <b>4</b>, which could be converted to the corresponding protected amidines <b>5</b> via a reductive amination with the requisite amines. Removal of the amidine protecting group using standard conditions provided the analogues of interest.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/medium/jm-2016-01451z_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0010.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01451&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeLi, Et<sub>2</sub>O, <i>n-</i>BuLi, then DMF, −78 °C, 92%; (b) amine, Na(OAc)<sub>3</sub>BH, DCE, rt, 22–97%; (c) HCl, dioxane, rt, 19–90%; (d) benzoic anhydride, TEA, THF/MeOH (2:1), rt, 86%; (e) N<sub>2</sub>H<sub>4</sub>·H<sub>2</sub>O, EtOH, rt, 31%. P = Boc or benzoyl.</p></p></figure><div class="NLM_p">Analogues were evaluated in a panel of BACE1, BACE2, and CatD enzymatic assays (cell-free assay, CFA), as well as a whole-cell assay (WCA) reporting changes in soluble APP (sAPPβ) protein concentrations, indicative of APP processing by BACE1. The data from this assay panel, as well as key ADME parameters, for <b>6a</b>–<b>6k</b> are provided in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>. The direct replacement of the amide linker with an aminomethylene spacer, as exemplified by <b>6a</b>, yields weak activity at BACE1 (CFA IC<sub>50</sub> = 73.5 μM), in stark contrast to the low nanomolar potency observed for many of the corresponding amides reported in the literature. In addition, the significant ADME challenges for this series are well illustrated by <b>6a</b>, which exhibits a high MDR efflux ratio (Er) and significant clearance in human liver microsomes (HLM). Analogues <b>6b</b>–<b>d</b>, which contain small alkyl substituents, show a modest improvement in BACE1 CFA potency, in concert with a dramatic increase in WCA potency (∼1000× shifted relative to the CFA) and excellent selectivity over CatD. The improvement is most marked when considering ligand and lipophilic efficiencies (LE, LipE) for these low molecular weight, polar, dibasic amine analogues. These compounds have significantly reduced clearance relative to <b>6a</b>, as measured by HLM, although they still exhibit significant P-gp transporter liability. Tertiary amines <b>6d</b>–<b>e</b> are significantly less active in the BACE1 CFA but still exhibit good potency in the WCA, albeit an overall decrease in LipE, relative to the secondary amines. Ether-containing substituents are also well tolerated (<b>6e,f</b>), showing similar potency in the WCA, low microsomal clearance but with modest to high efflux ratios. Introduction of a branched methyl group (<b>6c</b> vs <b>6b</b> and <b>6h</b> vs <b>6f</b>) offers an enhancement in potency (WCA) and a modest improvement in selectivity over BACE2. Tying this branching back into a 1,1,1-bicyclopentane (<b>6i</b>) is tolerated from a potency perspective but negatively impacts the clearance, potentially due to the increased overall lipophilicity.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Data for <b>6a</b>–<b>k</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/medium/jm-2016-01451z_0013.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/medium/jm-2016-01451z_0014.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> values obtained from BACE1 CFA.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">IC<sub>50</sub> values obtained from BACE2 CFA.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">IC<sub>50</sub> values obtained from CatD CFA.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">IC<sub>50</sub> values obtained from BACE1 WCA; value in parentheses is the BACE1 CFA/WCA ratio.</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">Ratio from the MS-based quantification of apical/basal and basal/apical transfer rates of a test compound at 2 μM across contiguous monolayers from MDR1-transfected MDCK cells.</p></div><div class="footnote" id="t1fn6"><sup>Table f</sup><p class="last">Hepatic clearance predicted from in vitro human microsomal stability study.</p></div></div><div></div></div><div class="NLM_p">Reduction in the p<i>K</i><sub>a</sub> of the benzylic amine center (“p<i>K</i><sub>a</sub>2”) was attractive due to the potential to simultaneously impact P-gp efflux and hERG liabilities. Indeed, addition of an electron-withdrawing trifluoromethyl group onto the amine significantly improves both potency and ADME balance. Although the tertiary amine (<b>6j</b>) is much less potent in the WCA, the secondary amine (<b>6k</b>) retains good WCA potency and comparable LipE to the more basic analogues and exhibits enhanced BACE1 CFA potency and improved selectivity over BACE2 (5.8× vs 3.2× for <b>6f</b>). Although both CF<sub>3</sub> analogues have significantly improved MDR-based efflux ratios (1.7 and 1.2), the secondary amine <b>6k</b> shows greater metabolic stability (HLM CL<sub>int</sub> = 12.0 mL/min/kg) than the methylated version <b>6j</b> (HLM = 29.4 mL/min/kg)</div><div class="NLM_p">It was clear that the additional basic amine exerts a profound effect on whole-cell potency, reinforced by comparison to the previously described monocyclic analogue devoid of a P3 group (compound <b>6</b> in ref <a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">21</a>, BACE1 CFA IC<sub>50</sub> = 36 μM, WCA IC<sub>50</sub> = 636 nM).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The low molecular weight and dibasic nature of the small alkyl exemplars result in highly ligand- and lipophilic efficient compounds in the whole-cell assay. While a similar rank order trend is observed for the BACE1 CFA, there is a 20–7750-fold disconnect observed between the two assay formats. This disconnect can be rationalized by the presence of the second basic center increasing the propensity for accumulation into the endosome, an acidic intracellular compartment where BACE1 is thought to be localized,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> in the WCA format. As expected, decreasing the basicity of the amine by the installation of an electron-withdrawing group significantly compresses the CFA/WCA disconnect.</div><div class="NLM_p">It was recognized from the outset that the diversion from an amide moiety would likely result in a very different BACE1 substituent-derived SAR relative to the amides, as well as presenting distinct challenges to achieving a balanced ADME profile. A second round of amine optimization (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) explored utilization of an electron-withdrawing group to balance ADME properties as well as incorporation of branched amines to further enhance potency. In an effort to more clearly define the impact of the EWGs on ADME balance, we measured the p<i>K</i><sub>a</sub>s for the amidine (“p<i>K</i><sub>a</sub>1”) and benzylic amine (“p<i>K</i><sub>a</sub>2”) for each of the analogues.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Removal of one of the fluorines (<b>6l</b>) increases p<i>K</i><sub>a</sub>2 relative to analogue <b>6k</b>, therefore increasing MDR Er (1.2 vs 3.1). Introduction of two geminal methyl groups provides a significant improvement in BACE1 CFA potency (<b>6m</b> vs <b>6k</b>), albeit with a corresponding increase in MDR Er and a decrease in BACE2 selectivity (2×). Removal of one of the methyl groups (<b>6n</b>) decreases potency both in BACE1 CFA (1.9 μM) and WCA (64 nM) but improves efflux and BACE2 selectivity while reducing CYP 2D6 inhibition. Increasing the distance between the amine and trifluoromethyl groups (<b>6o</b>) increases p<i>K</i><sub>a</sub>2 and diminishes potency in both assay formats. In an effort to capitalize on the potency increase associated with increased substitution, cyclopropylamine-containing analogues (<b>6p</b>–<b>q</b>) were prepared. The cyclopropane unit is well tolerated, as exhibited by the excellent WCA potency, but suffers from a significant degradation in BACE1 CFA potency and MDR Er. The addition of a difluoromethyl group (<b>6r</b>) improves the BACE1 CFA potency and reduces the increase in MDR Er but simultaneously introduces a metabolic liability (HLM = 22 mL/min/kg). Replacement with a nitrile (<b>6s</b>) enhances BACE2 selectivity, but the MDR Er increases significantly (MDR Er = 6.0). Use of an oxetane (<b>6t</b>) in place of the cyclopropane improves WCA potency and decreases log <i>D</i> but results in an elevated MDR Er ratio (MDR Er = 3.5) nearly equivalent to that of the parent cyclopropylamine <b>6p</b>. In contrast, the CF<sub>3</sub>-cyclopropyl derivative <b>6u</b> maintains good potency in both assay formats, exhibits a minimal efflux ratio and low clearance, and maintains excellent selectivity over CatD (470×) and modest selectivity over BACE2 (5.9×).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro Data for Compounds <b>6k</b>–<b>6u</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/medium/jm-2016-01451z_0015.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/medium/jm-2016-01451z_0016.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> values obtained from BACE1 CFA.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">IC<sub>50</sub> values obtained from BACE2 CFA.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">IC<sub>50</sub> values obtained from CatD CFA.</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">IC<sub>50</sub> values obtained from BACE1 WCA.</p></div><div class="footnote" id="t2fn5"><sup>Table e</sup><p class="last">Ratio from the MS-based quantification of apical/basal and basal/apical transfer rates of a test compound at 2 μM across contiguous monolayers from MDR1-transfected MDCK cells.</p></div><div class="footnote" id="t2fn6"><sup>Table f</sup><p class="last">Hepatic clearance predicted from in vitro human microsomal stability study.</p></div><div class="footnote" id="t2fn7"><sup>Table g</sup><p class="last">CYP 2D6% inhibition determined in human microsomes using a probe CYP 2D6 substrate (dextromethorphan) and 3 μM of test compound.</p></div><div class="footnote" id="t2fn8"><sup>Table h</sup><p class="last">p<i>K</i><sub>a</sub> values measured.</p></div><div class="footnote" id="t2fn9"><sup>Table i</sup><p class="last">Measured IC<sub>50</sub> in hERG-expressing CHO cells.</p></div></div><div></div></div><div class="NLM_p">Although the decrease in p<i>K</i><sub>a</sub>2 imparted by the introduction of the cyclopropyl group in <b>6u</b> (2.9 vs 3.8 for <b>6k</b>) could contribute to the improved BACE1 CFA potency, it is not sufficient to explain the 20-fold potency increase observed. To better rationalize this improvement, a co-crystal structure of compound <b>6u</b> in BACE1 was obtained (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T1U">5T1U</a>). As shown in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>, the thioamidine and difluorophenyl ring systems are oriented in a similar overall fashion to previously described BACE1 structures, with the difluorophenyl occupying the S1 pocket as expected. As predicted by our initial design hypothesis, the benzylic amine substituent adopts an orientation orthogonal to the plane of the difluorophenyl P1 group to optimally engage the carbonyl of Gly230. Interestingly, the trifluoromethyl group orients toward and fills the entrance to the S3 pocket, while the cyclopropyl substituent fills a small, lipophilic pocket at the back of the interface between the S1 and S3 pockets. Arguably, the significant improvement in BACE1 CFA potency observed for <b>6u</b> is primarily achieved by optimally filling this cleft and locking the CF<sub>3</sub> into the direction of the S3 pocket.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/medium/jm-2016-01451z_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Crystal structure of <b>6u</b> in BACE1 binding site. PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T1U">5T1U</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01451&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Overall, a liability of the series is P-gp-mediated efflux, likely driven in large part by the presence of a third hydrogen bond donor and exacerbated by increasing basicity at the benzylic amine (<b>6o</b>–<b>6q</b>, p<i>K</i><sub>a</sub>2 > 6, MDR Er 3.4–6.9). It was recognized that the installation of an electron-withdrawing group at the amine center aids in overcoming this issue, as illustrated by the difluoromethyl-substituted analogue <b>6r</b>. Although the introduction of a nitrile substituent (<b>6s</b>) further lowers p<i>K</i><sub>a</sub>2, the efflux liability increased, potentially because of the increase in polar surface area, a key factor for P-gp liability. In contrast, the relatively nonpolar trifluoromethyl group in <b>6u</b> decreases p<i>K</i><sub>a</sub>2 sufficiently, resulting in a decreased efflux ratio.</div><div class="NLM_p">Gratifyingly, <b>6u</b> addresses a number of the key challenges that had emerged throughout the optimization of this series. As predicted by the in vitro transporter assay, <b>6u</b> exhibits free access to the CNS compartment in mice (<i>C</i><sub>u,b</sub>/<i>C</i><sub>u,p</sub> = 1.0), as determined by time-course AUC. To assess in vivo potency, analogue <b>6u</b> was dosed in wild-type mouse via subcutaneous administration at two doses, 10 and 100 mg/kg, to measure impact on levels of brain Aβx-42. At the lower dose, a small but significant decrease is observed at early time points, and at 100 mg/kg, robust lowering is observed out to 20 h postdose, providing a <i>C</i><sub>u,b</sub>/<i>C</i><sub>eff</sub> of 31 nM for 25% Aβ lowering using previously described methodology (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/medium/jm-2016-01451z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of trifluoromethylcyclopropyl <b>6u</b> on brain Aβx-42 following subcutaneous administration in wild-type mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01451&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A goal from the outset had been to mitigate the hERG liability often observed for BACE1 inhibitors. Therefore, hERG IC<sub>50</sub> values were generated for this second round of optimization. All analogues exhibit some affinity for hERG (IC<sub>50</sub> 3.5–49 μM), although there is no correlation with increasing log <i>D</i> and decreasing p<i>K</i><sub>a</sub>. The hERG TI, as defined by comparing the hERG IC<sub>50</sub> to the more robust and relevant measured <i>C</i><sub>u,p</sub>/<i>C</i><sub>eff</sub> value for BACE1, provides the most appropriate selectivity descriptor; for <b>6u</b>, this corresponds to an in vivo hERG selectivity of 113×, satisfying our initial criteria.</div><div class="NLM_p">Whereas <b>6u</b> had achieved a balance of Aβ-lowering in brain, CNS penetration, and selectivity over hERG, it was, unfortunately, also characterized by significant inhibition of cytochrome P450 subtype 2D6 (CYP 2D6). CYP inhibition, in general, is undesirable due to the potential for drug–drug interactions (DDI) through inhibition of oxidative metabolism, but the significance is enhanced for subtype 2D6 because of significant polymorphism in 2D6 expression.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Within this set of analogues, CYP 2D6 inhibition appears to be primarily driven by two main factors, namely, p<i>K</i><sub>a</sub> and the size of the benzylamine substituent. Unfortunately, the CYP 2D6 values inversely correlate to p<i>K</i><sub>a</sub>, such that analogues with decreased p<i>K</i><sub>a</sub> at the benzylic amine show greater inhibition, in direct opposition to the SAR utilized to obviate hERG and efflux transporter liabilities. In addition, increasing the size of the amine substituent appears to enhance CYP 2D6 inhibition, tracking with BACE1 potency. In an effort to more accurately gauge the CYP 2D6 inhibition, IC<sub>50</sub> curves were generated for a subset of these compounds. In this assay, the unflanked trifluoroethylamine <b>6k</b> showed only modest CYP 2D6 inhibition (IC<sub>50</sub> = 14 μM), whereas <b>6u</b>, much more potent at BACE1, significantly inhibited CYP 2D6 (IC<sub>50</sub> = 157 nM). The intertwined SAR of CYP 2D6 inhibition, BACE1 potency, and transporter liability suggested that further tuning of the amine was unlikely to balance overall properties. Several alternative strategies were considered, including: (a) disrupting the favorable binding interactions between this series and CYP 2D6 while maintaining the high BACE1 affinity observed for <b>6u</b>, and (b) building upon the modest BACE1 potency and absence of CYP 2D6 liability associated with <b>6k</b>, but utilizing an alternative vector.</div><div class="NLM_p">Disruption of the binding of this series to CYP 2D6 was informed by a recent report of a pyrazole-containing thioamidine series, which described a similar challenge with CYP 2D6 affinity (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/medium/jm-2016-01451z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Metabolic profile of fused THP series.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01451&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In this case, the fused pyrazole <b>7</b> is metabolized exclusively by CYP 2D6. Additionally, the primary metabolism product observed, the demethylated pyrazole, is a potent inhibitor of CYP 2D6 (IC<sub>50</sub> = 0.37 μM). The CYP 2D6 affinity in this series was ultimately conquered through the installation of a substituent [fluoromethyl (<b>8</b>) or methyl (not shown)] adjacent to sulfur that disrupts binding to the CYP 2D6 active site. Utilization of this strategy guided the design of compound <b>12</b>, where a chiral methyl group has been introduced next to the sulfur of the thioamidine (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). This analogue was prepared in a similar fashion to the unsubstituted thioamidines, starting with the known bromide <b>9</b>.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><figure id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/medium/jm-2016-01451z_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0011.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01451&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeLi, Et<sub>2</sub>O, <i>n</i>-BuLi, then DMF, −78 °C, 89%; (b) amine, Na(OAc)<sub>3</sub>BH, DCE, rt, 93%; (c) HCl, dioxane, rt, 19%.</p></p></figure><div class="NLM_p">Overall, compound <b>12</b> maintains potency at BACE1 but exhibits increased clearance and MDR Er as compared to <b>6u</b> (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). These general trends were consistent with the pairwise changes associated with this matched molecular pair, as observed in the fused THP series. Interestingly, however, there was only modest impact on the CYP 2D6 inhibition (IC<sub>50</sub> = 334 nM) for this compound. The lack of translational impact for this methyl group across the two series is striking, and in an effort to better understand the inconsistent impact on CYP 2D6 inhibition, cocrystal structures of <b>6u</b> and <b>12</b> in CYP 2D6 were generated.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro Profile of <b>12</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="/" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">BACE1 CFA IC<sub><b>50</b></sub> (μM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">BACE2 CFA IC<sub><b>50</b></sub> (μM)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">CatD CFA IC<sub><b>50</b></sub> (μM)<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">WCA IC<sub><b>50</b></sub> (nM)<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">MDR Er<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center" char=".">log <i>D</i></th><th class="colsep0 rowsep0" align="center" char=".">HLM<a class="ref internalNav" href="#t3fn6" aria-label="f">f</a> (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char=".">CYP 2D6 IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t3fn7" aria-label="g">g</a></th><th class="colsep0 rowsep0" align="center" char="/">p<i>K</i><sub>a</sub>1/p<i>K</i><sub>a</sub>2</th><th class="colsep0 rowsep0" align="center" char=".">hERG<a class="ref internalNav" href="#t3fn8" aria-label="h">h</a> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="char" char=".">0.078</td><td class="colsep0 rowsep0" align="char" char=".">0.228</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">0.024</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">2.4</td><td class="colsep0 rowsep0" align="char" char=".">38</td><td class="colsep0 rowsep0" align="char" char=".">0.334</td><td class="colsep0 rowsep0" align="char" char="/">8.8/2.8</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values obtained from BACE1 CFA assay.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">IC<sub>50</sub> values obtained from BACE2 CFA assay.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">IC<sub>50</sub> values obtained from CatD CFA assay.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">IC<sub>50</sub> values obtained from BACE1 WCA.</p></div><div class="footnote" id="t3fn5"><sup>e</sup><p class="last">Ratio from the MS-based quantification of apical/basal and basal/apical transfer rates of a test compound at 2 μM across contiguous monolayers from MDR1-transfected MDCK cells.</p></div><div class="footnote" id="t3fn6"><sup>f</sup><p class="last">Hepatic clearance predicted from in vitro human microsomal stability study.</p></div><div class="footnote" id="t3fn7"><sup>g</sup><p class="last">CYP 2D6 inhibition was obtained by measuring inhibition of 5 μM dextromorphan in pooled HLM (HL-MIX-102).</p></div><div class="footnote" id="t3fn8"><sup>h</sup><p class="last">Measured IC<sub>50</sub> in hERG-expressing CHO cells.</p></div></div></div><div class="NLM_p">X-ray crystal structures of CYP 2D6 with <b>6u</b> and <b>12</b> bound were determined as described previously for <b>7</b><a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XRY">4XRY</a>) by soaking crystals of a CYP 2D6 thioridazine complex with the appropriate compound (<b>6u</b> or <b>12</b>). Comparison of the resulting structures (<a class="ref internalNav" href="#fig7" aria-label="Figures 7">Figures 7</a>A–C) illustrates that each of the thioamidines is anchored through an interaction with Glu-216, positioning the difluorophenyl ring proximal to helix I. The aminomethyl substituent in analogues <b>6u</b> (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>A) and <b>12</b> (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>B) is oriented to the lipophilic pocket distal to the heme, whereas the pyrazole of <b>7</b> is oriented toward the heme itself (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>C). The orientations of the thioamidine rings in <b>6u</b> and <b>12</b> are shifted, relative to that of the fused <b>7</b>, to facilitate occupation of the distal pocket by the aminomethyl substituents. This reorientation creates greater distance between helix I and the difluorophenyl ring, and this shift is exacerbated slightly by the chiral methyl group in <b>12</b> (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>B), which is easily accommodated. In contrast, the rigid architecture defined by the ring fusion of the thioamidine and THP restricts the rotation of <b>7</b> (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>C), as the compound occupies the cleft between Phe-120 and the residues Glu-244 and Phe-247 on helix G. The addition of a methyl or fluoromethyl group next to the sulfur of <b>7</b> then creates a direct clash with helix I, as evidenced by the lack of affinity of <b>8</b>. Therefore, this restricted rotation underlies the pronounced substituent impact on CYP 2D6 affinity in the fused series, whereas the facility for reorientation in the monocyclic series <b>6u</b>/<b>12</b> minimizes the substituent effect.</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/medium/jm-2016-01451z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0007.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Comparison of the binding of <b>6u</b> (A) and <b>12</b> (B) with the binding of <b>7</b> (C) in the active site of CYP 2D6.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01451&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Therefore, an alternative strategy to mitigate CYP 2D6 affinity in the aminomethyl series would exploit the restricted rotation imparted by ring fusion, precluding occupation of the distal, lipophilic pocket of CYP 2D6 by an aminomethyl substituent. In addition, from experience in previous series, the fused THP ring would be expected to enhance BACE1 potency relative to the monocyclic congeners. Considering the increased lipophilicity and molecular weight imparted by bolting on the additional THP ring, the unflanked trifluoroethyl amine <b>6k</b> seemed an attractive starting template with which to execute this strategy. Fused analogue <b>16</b> was therefore designed and prepared as shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Starting from bromide <b>13</b>,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> the aminomethyl linker was installed by Pd-mediated cyanation and subsequent reduction using Raney nickel. Alkylation of the resultant primary amine using trifluoroethyl triflate, followed by cleavage of the benzamide protecting group, provided the fused analogue <b>16</b>. The structure of <b>16</b> was confirmed by a single crystal X-ray structure carried out on the phosphate salt (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01451/suppl_file/jm6b01451_si_001.pdf" class="ext-link">Supporting Information</a>).</div><figure id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/medium/jm-2016-01451z_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0012.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01451&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd<sub>2</sub>(dba)<sub>3</sub>, dppf, zinc, Zn(CN)<sub>2</sub>, DMA, 130 °C, 85%; (b) Raney Ni, H<sub>2</sub>, triethylamine, Boc<sub>2</sub>O, H<sub>2</sub>O, EtOH, rt, then HCl, MeOH, 61%; (c) 2,2,2-trifluoroethyl trifluoromethylsulfonate, trimethylamine, MeCN, 70 °C, then DBU, MeOH, 71%.</p></p></figure><div class="NLM_p">As expected, the bicyclic fusion offered a 17× improvement of BACE1 CFA potency for <b>16</b> relative to the monocyclic <b>6k</b> (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>), and <b>16</b> proved to be equipotent to <b>6u</b>, reinforcing the observation that potency can be obtained in either of the two available vectors. Further, <b>16</b> maintained excellent CatD selectivity, similar selectivity over BACE2 (3.8×) and a balanced overall ADME profile, including, gratifyingly, a significantly diminished CYP 2D6 liability (IC<sub>50</sub> = 9.1 μM, 118-fold selectivity over BACE1 CFA) relative to the monocyclic analogues. A modest increase in efflux was observed relative to <b>6k</b>, which translated into asymmetry in brain/plasma ratio (<i>C</i><sub>u,b</sub>/<i>C</i><sub>u,p</sub> = 0.25, AUC ratio). Additionally, <b>16</b> exhibited excellent central Aβ-lowering in mice, with a measured brain <i>C</i><sub>eff</sub> for 25% lowering of Aβx-42 of 31 nM (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>). The hERG value (IC<sub>50</sub> = 4.3 μM) was slightly improved relative to <b>6k</b>, reflecting a better nominal selectivity (139×). However, accounting for brain asymmetry, the resultant hERG TI diminishes to 35× over the requisite plasma concentrations.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro Data for Compound <b>16</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="/" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">BACE1 CFA IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">BACE2 CFA IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">CatD CFA IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">WCA IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">MDR Er<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center" char=".">log <i>D</i></th><th class="colsep0 rowsep0" align="center" char=".">HLM<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a> (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char=".">CYP 2D6 IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t4fn7" aria-label="g">g</a></th><th class="colsep0 rowsep0" align="center" char="/">p<i>K</i><sub>a</sub>1/p<i>K</i><sub>a</sub>2</th><th class="colsep0 rowsep0" align="center" char=".">hERG (μM)<a class="ref internalNav" href="#t4fn8" aria-label="h">h</a></th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>u,b</sub>/<i>C</i><sub>u,p</sub></th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>eff</sub>, (<i>C</i><sub>u,b</sub>, nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="char" char=".">0.077</td><td class="colsep0 rowsep0" align="char" char=".">0.295</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">0.006</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="char" char=".">9.1</td><td class="colsep0 rowsep0" align="char" char="/">7.91/3.80</td><td class="colsep0 rowsep0" align="char" char=".">4.3</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">31</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values obtained from BACE1 CFA.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">IC<sub>50</sub> values obtained from BACE2 CFA.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">IC<sub>50</sub> values obtained from CatD CFA.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">IC<sub>50</sub> values obtained from BACE1 WCA.</p></div><div class="footnote" id="t4fn5"><sup>e</sup><p class="last">Ratio from the MS-based quantification of apical/basal and basal/apical transfer rates of a test compound at 2 μM across contiguous monolayers from MDR1-transfected MDCK cells.</p></div><div class="footnote" id="t4fn6"><sup>f</sup><p class="last">Hepatic clearance predicted from in vitro human microsomal stability study.</p></div><div class="footnote" id="t4fn7"><sup>g</sup><p class="last">CYP 2D6 inhibition was obtained by measuring inhibition of 5 μM dextromorphan in pooled HLM (HL-MIX-102).</p></div><div class="footnote" id="t4fn8"><sup>h</sup><p class="last">Measured IC<sub>50</sub> in hERG- expressing CHO cells.</p></div></div></div><figure id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/medium/jm-2016-01451z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0008.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Effect of fused THP analogue <b>16</b> on brain Aβx-42 following subcutaneous administration in wild-type mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01451&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The observation of such disparate responses in the relative affinities to BACE1 and CYP 2D6 for <b>16</b> versus <b>6k</b> was striking. The addition of the THP ring resulted in a 17× increase in potency at BACE1 while essentially having no impact on CYP 2D6 affinity (CYP 2D6 IC<sub>50</sub> for <b>6k</b> = 14 μM). A crystal structure of <b>16</b> in BACE1 was generated and confirmed that, as expected, reorganization of the S2′ subpocket in BACE1 had occurred, driven by the rotation of Tyr71 to accommodate the THP ring and fluoromethyl substituent of <b>16</b> (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>). Therefore, selectivity is realized because this subpocket in BACE1 is responsive to increases in lipophilic bulk in this vector, whereas the same vector in CYP 2D6 directs toward the heme and has no impact on affinity. In addition, the ring fusion limits the requisite rotation of the thioamidine ring to optimally accommodate the aminomethyl substituent within the CYP 2D6 binding site. This discrepant response contrasts with the parallel responsiveness at BACE1 and CYP 2D6 for small changes in the benzylic amine of the monocyclic series, wherein equivalent increases in lipophilicity afforded corresponding enhancements in affinity for both BACE1 and CYP 2D6 receptors (<b>6k</b> vs <b>6u</b>, 20× BACE1, 9× CYP 2D6). Future BACE1 design efforts focused on avoiding CYP 2D6 liability will therefore target manipulation of the amidine “head group” architecture, rather than optimization of P3 substituents.</div><figure id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/medium/jm-2016-01451z_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0009.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Co-crystal structure of <b>16</b> in BACE1. PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T1W">5T1W</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01451&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Upon the basis of its attractive balance of potency, selectivity, and CNS penetration, <b>16</b> was selected for further safety profiling. The compound showed excellent in vitro selectivity, as gauged by screening against the broad CEREP bioprint panel (<25% inhibition at all targets at 10 μM). Subsequent advancement to long-term in vivo toxicology studies, including a 4-week arm at 100 mg/kg (30× AUC over <i>C</i><sub>eff</sub>), revealed no ocular findings, presumably reflecting the excellent in vitro selectivity observed for <b>16</b>.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66666" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66666" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The optimization of a series of brain-penetrant BACE1 inhibitors with a novel aminomethyl linker has been described. This linker mitigates an aniline structural alert prevalent throughout a large contingent of literature BACE1 series. Careful modulation of the amine substituent aided in garnering a balanced profile, as the inherent efflux transporter liability and potency are dependent upon the resultant p<i>K</i><sub>a</sub>. A number of the more active compounds carried significant CYP 2D6 inhibition that correlated well with the size of the amine substituent. Unlike the fused THP series, substitution on the monocyclic thioamidine ring did not ameliorate CYP 2D6 inhibition, which was rationalized through examination of CYP 2D6 crystal structures. Filling the BACE1 S2′ subpocket by fusing a THP ring onto the monocyclic thioamidine ring improved BACE1 potency dramatically without impacting CYP 2D6 affinity. One such example (<b>16</b>) demonstrates good ADME balance, modest brain asymmetry, no DDI potential, and good in vivo efficacy, illustrating that the aminomethyl linker can serve as a robust replacement to overcome the significant challenges and structural alerts inherent in the classical P1/P3 amide of previously described BACE1 inhibitors.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23385" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23385" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Biology</h3><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> In Vitro Pharmacology</h4><div id="sec5_1_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i12" class="anchor-spacer"></div><h5 class="article-section__title" id="_i12"> sAPPβ Whole-Cell Assay (WCA)</h5><div class="NLM_p last">sAPPβ, the primary cleavage product of BACE1, was determined in H4 human neuroglioma cells overexpressing the wild-type human APP<sub>695</sub>. Cells were treated for 18 h with compound in a final concentration of 1% DMSO. sAPPβ levels were measured by ELISA with a capture APP N-terminal antibody (Affinity BioReagents, OMA1-03132), wild-type sAPPβ-specific reporter antibody p192 (Elan), and tertiary antirabbit-HRP (GE Healthcare). The colorimetric reaction was read by an EnVision (PerkinElmer) plate reader.</div></div><div id="sec5_1_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i13" class="anchor-spacer"></div><h5 class="article-section__title" id="_i13"> BACE1 Enzyme Cell-Free Assay (FP)</h5><div class="NLM_p last">Beta secretase-1 activity was assessed with soluble BACE1 and the synthetic APP substrate Biotin-GLTNIKTEEISEISYEVEFR-C[oregon green]KK-OH in the presence of compounds in a fluorescence polarization (FP) in vitro assay. Enzyme, substrate and test compounds were incubated in 15 μL of 100 mM sodium acetate pH = 4.5 buffer containing 0.001% Tween-20 for 3 h at 37 °C. Following the addition of saturating immunopure streptavidin, fluorescence polarization was measured with a PerkinElmer EnVision plate reader (Ex485 nm/Em530 nm).</div></div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> In Vivo Experiments</h4><div class="NLM_p">All procedures performed on animals in this study were in accordance with established guidelines and regulations, and were reviewed and approved by the Pfizer (or other) Institutional Animal Care and Use Committee. Pfizer animal care facilities that supported this work are fully accredited by AAALAC International.</div><div id="sec5_1_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i15" class="anchor-spacer"></div><h5 class="article-section__title" id="_i15"> Acute Treatment in Mice</h5><div class="NLM_p last">Male 129/SVE wild-type mice (20–25 g) were in a nonfasted state prior to subcutaneous dosing with vehicle, or compound <b>6u</b> or <b>16</b>, using a dosing volume of 10 mL/kg in 5:5:90 DMSO:cremophor:saline vehicle. Mice (<i>n</i> = 5 per group) were sacrificed at 1, 3, 5, 7, 14, 20, and 30 h postdose. Whole blood samples (0.5–1.0 mL) were collected by cardiac puncture into ethylenediaminetetraacetic acid (EDTA)-containing tubes, and plasma was separated by centrifugation (1500<i>g</i> for 10 min at 4 °C). The generated plasma was distributed into separate tubes on wet ice for exposure measurements (50 μL) and Aβ analysis (remainder). CSF samples (8–12 μL) were obtained by cisterna magna puncture using a sterile 25 gauge needle and collected with a P-20 Eppendorf pipet. CSF samples were distributed into separate tubes on dry ice for exposure measurements (3 μL) and Aβ analysis (remainder). Whole brain was removed and divided for exposure measurements (cerebellum) and Aβ analysis (left and right hemispheres), weighed, and frozen on dry ice. All samples were stored at −80 °C prior to assay.</div></div><div id="sec5_1_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i16" class="anchor-spacer"></div><h5 class="article-section__title" id="_i16"> Measurement of Rodent Amyloid-β</h5><div class="NLM_p">Frozen mouse hemibrains were homogenized (10% w/v) in 5 M guanidine HCl, using a Qiagen TissueLyser. Each sample was homogenized with a 5 mm stainless steel bead, four times, at a shaking rate of 24 times/s for 90 s, then incubated at 25 °C for 3 h, and ultracentrifuged at 125000<i>g</i> for 1 h at 4 °C. The resulting supernatant was removed and stored in a 96-well polypropylene deep well plate at −80 °C. The Aβ peptides were further purified through solid-phase extraction using Waters Oasis reversed-phase HLB 96-well column plates (60 mg). Column eluates in ammonium hydroxide from 500 to 800 μL of original brain supernatant were evaporated to complete dryness and stored at −80 °C until assay. For plasma analysis, 140–175 μL of mouse plasma was treated 1:1 with 5 M guanidine HCl and incubated overnight with rotation at 4 °C. The entire volume was then purified through solid-phase extraction as indicated above.</div><div class="NLM_p">Samples were analyzed using a Dissociation-Enhanced Lanthanide Fluorescent Immunoassay (DELFIA) platform Enzyme-Linked Immunosorbent Assay (ELISA). Configuration of the antibodies used in determining the level of Aβx-40 and Aβx-42 utilizes a common detect antibody (4G8) in combination with specific C-terminal antibodies for the 40 and 42 cleavage sites. For the Aβx-40 assay, a 384-well black Nunc Maxisorp plate was coated with 15 μL/well (4 μg/mL) capture antibody (Rinat 1219) in 0.1 M sodium bicarbonate coating buffer, pH 8.2. For the Aβx-42 assay, 15 μL/well (8 μg/mL) capture antibody (Rinat 10G3) was used. The plates were sealed and incubated at 4 °C overnight. Plates were washed with phosphate-buffered saline containing 0.05% Tween-20 (PBS-T) and blocked with 75 μL of blocking buffer (1% BSA in PBS-T) for 2 h at 25 °C.</div><div class="NLM_p last">After washing the plates with PBS-T, rodent Aβx-40 (California Peptide) or Aβx-42 (California Peptide) standard was serially diluted in blocking buffer and 15 μL was applied to the plate in quadruplicate. Dried brain samples were reconstituted in 120 μL of blocking buffer, which corresponds to a 4.16–6.67-fold concentration. Then 15 μL of undiluted brain sample was added to the Aβx-42 assay plate in triplicate or 15 μL of a 1:2 diluted brain sample was added to the Aβx-40 assay plate in triplicate. Dried plasma samples were reconstituted in 40 μL of blocking buffer, which corresponds to a 3.5–4.38-fold concentration, and 15 μL was added to the Aβx-40 assay plate in duplicate. CSF samples were diluted 1:8 in blocking buffer, and 15 μL was added to the Aβx-40 assay plate in duplicate. Plates were incubated with sample or standards for 2 h at 25 °C. The plates were washed with PBS-T, and 15 μL of detecting antibody (4G8-Biotin, Covance), 200 ng/mL in blocking buffer, was added to each well, incubating for 2 h at 25 °C. The plates were then washed with PBS-T, and 15 μL of europium-labeled streptavidin (PerkinElmer), 50 ng/mL in blocking buffer, was added for a 1 h incubation in the dark at 25 °C. The plates were washed with PBS-T, and 15 μL of PerkinElmer Enhancement solution was added to each well with 20 min incubation at rt. Plates were read on an EnVision plate reader using DELFIA time-resolved fluorimetry (Exc340/Em615), and samples were extrapolated against the standard curve using four-parameter logistics. Measurement of human amyloid-β in plasma and CSF from PS1/APP mice utilizes the same capture and detecting antibodies used for wild-type mice. Vehicle-treated samples from plasma and CSF were serially diluted to optimize sample dilution to the linear phase of an Aβ peptide standard curve. Aβ levels were measured using DELFIA ELISA.</div></div><div id="sec5_1_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i17" class="anchor-spacer"></div><h5 class="article-section__title" id="_i17"> Neuropharmacokinetic Studies in Male CD-1 Mice</h5><div class="NLM_p last">The in-life and bioanalytical portions of these studies were conducted at BioDuro, Pharmaceutical Product Development Inc. (Beijing, China). Male CD-1 mice were obtained from PUMC, China. Mice received a 10 mg/kg subcutaneous (sc) dose of compounds <b>6u</b> or <b>16</b>. The doses were prepared in 5% DMSO/95% water containing (v/v) 0.5% methylcellulose (w/v) and delivered in a volume of 5 mL/kg. Animals were sacrificed in a CO<sub>2</sub> chamber. Blood, brain, and CSF samples were collected at 1, 4, and 7 h postdosing. Plasma was isolated after centrifugation. The plasma, brain, and CSF samples were stored at −80 °C prior to analysis.</div></div><div id="sec5_1_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i18" class="anchor-spacer"></div><h5 class="article-section__title" id="_i18"> Measurement of Fractions Unbound in Brain</h5><div class="NLM_p last">The unbound fraction of each compound was determined in brain tissue homogenate using a 96-well equilibrium dialysis method as described by Kalvass et al.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> with the following exceptions. Brain homogenates were prepared from freshly harvested rat brains following dilution with a 4-fold volume of phosphate buffer and spiked with 1 μM compound. The homogenates were dialyzed against an equal volume (150 μL) of phosphate buffer at 37 °C for 6 h. Following the incubation, equal volumes (50 μL) of brain homogenate and buffer samples were collected and mixed with 50 μL of buffer or control homogenate, respectively, for preparation of mixed matrix samples. All samples were then precipitated with internal standard in acetonitrile (200 μL), vortexed, and centrifuged. Supernatants were analyzed using an LC-MS/MS assay. A dilution factor of 5 was applied to the calculation of brain fraction unbound.</div></div><div id="sec5_1_2_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i19" class="anchor-spacer"></div><h5 class="article-section__title" id="_i19"> Generic Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) Assay for Exposure Measurements in Plasma, Brain, and CSF</h5><div class="NLM_p last">Plasma, brain, and CSF were collected as described above and frozen at −80 °C until analysis by LC-MS/MS. Standard curves were prepared in respective matrix via serial dilution at a concentration of 1.0–2000 ng/mL (plasma and CSF) or 0.5–2000 ng/g (brain). For plasma, a 50 mL aliquot of sample was precipitated with 500 mL of MTBE containing an internal standard. Samples were vortexed for 1 min, then centrifuged at 3000 rpm for 10 min. The supernatant was transferred to a 96-well plate. Frozen brain tissue was weighed, and an 2-propanol:water (60:40) volume equivalent to 4 times the mass was added before homogenization in a bead beater (BioSpec Products Inc., Bartlesville, OK). A 50 mL aliquot of sample was precipitated with 500 mL of MTBE containing an internal standard. Samples were vortexed for 1 min, then centrifuged at 3000 rpm for 10 min. The supernatant was transferred to a 96-well plate. For CSF, a 50 mL aliquot of sample was precipitated with 500 mL of MTBE containing an internal standard. Samples were vortexed for 1 min, then centrifuged at 3000 rpm for 10 min. The supernatant (300 mL) was transferred to a 96-well plate. LC-MS/MS analysis was carried out using a high-performance liquid chromatography system consisting of tertiary Shimadzu LC20AD pumps (Shimadzu Scientific Instruments, Columbia, MD) with a CTC PAL autosampler (Leap Technologies, Carrboro, NC) interfaced to an API 4000 LC-MS/MS quadrupole tandem mass spectrometer (AB Sciex Inc., Ontario, Canada). The mobile phase consisted of solvent A (water with 0.1% formic acid) and solvent B (acetonitrile with 0.1% formic acid). The gradient was as follows: solvent B was held at 5% for 0.4 min, linearly ramped from 5% to 95% in 0.5 min, held at 90% for 0.6 min, and then stepped to 5% over 0.01 min. The mass spectrometer was operated using positive electrospray ionization. All raw data was processed using Analyst Software version 1.4.2 (AB Sciex Inc., Ontario, Canada).</div></div><div id="sec5_1_2_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i20" class="anchor-spacer"></div><h5 class="article-section__title" id="_i20"> hERG Patch Clamp Assay</h5><div class="NLM_p last">All testing was carried out in CHO cells transfected with the hERG gene, purchased from Millipore (PrecisION hERG-CHO Recombinant Cell Line CYL3038). The cell line was grown in DMEM/F-12, GlutaMAX with 10% fetal bovine serum, 1% penicillin–streptomycin, 1% geneticin, and 1% of 1 M HEPES buffer solution, and maintained at approximately 37 °C in a humidified atmosphere containing 5% carbon dioxide. The cells were passaged every 3–5 days based on confluency. On the day of the experiment, 50%–80% confluent cells were harvested from a 175 cm<sup>2</sup> culture flask using Detachin. After 10 min of exposure to Detachin at 37 °C, the cells were centrifuged for 1 min at 1000 rpm. The supernatant was removed, and the cell pellet was reconstituted in 5–8 mL of serum-free media with 2.5% of 1 M HEPES, placed on the Qstirrer, and allowed to recover. After a ∼30 min recovery period, experiments were initiated.</div></div><div id="sec5_1_2_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> hERG Potassium Channel Current Recordings</h5><div class="NLM_p">hERG current was elicited and recorded using the automated Qpatch HT system.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The suspended cells in the Qstirrer were transferred to 48 individual recording chambers on a Qplate 48 containing extracellular recording saline composed of (in mM): 132 NaCl, 4 KCl, 1.8 CaCl<sub>2</sub>, 1.2 MgCl<sub>2</sub>, 10 HEPES, 11.1 glucose, and adjusted to pH 7.35 ± 0.1 with NaOH. The intracellular recording saline was composed of (in mM): 70 KF, 60 KCl, 15 NaCl, 5 EGTA, 5 HEPES, and adjusted to pH 7.2 ± 0.1 with KOH. Membrane currents were recorded at room temperature.</div><div class="NLM_p last">hERG current was elicited from a holding potential of −80 mV with a voltage step to +30 mV for 1 s, followed by a ramp back to −80 mV at 0.55 mV/ms. Test pulses were delivered at a frequency of 0.25 Hz. Up to four different concentrations were studied for each cell, each exposure lasting 5 min or until steady-state effects were observed. In a separate set of experiments, full concentration–response relationships were determined for the positive control, cisapride, and an IC<sub>50</sub> was reported for this study.</div></div><div id="sec5_1_2_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> hERG Data Analysis</h5><div class="NLM_p last">Using Sophion Qpatch Assay Software, the amplitude of the peak outward hERG current upon repolarizing ramp was measured. Current amplitude was determined by taking the average of the last five current peaks under each treatment condition. Percent inhibition was determined by taking the ratio of the current measured at steady state in the presence of test article (<i>I</i><sub>test article</sub>) versus the control current (<i>I</i><sub>control</sub>) and expressed as % inhibition = 100 – (<i>I</i><sub>test article</sub>/<i>I</i><sub>control</sub>) × 100. When possible, a concentration–response curve was plotted and the data were fitted using Qpatch software to determine an IC<sub>50</sub>. The <i>P</i> < 0.05 was considered statistically significant. Data were presented as mean ± SEM.</div></div><div id="sec5_1_2_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> Crystallization of BACE</h5><div class="NLM_p last">Crystals of BACE were prepared as previously described,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> with several modifications to the protein purification scheme. Ni<sup>2+</sup> affinity and size exclusion chromatography were used as the initial purification steps yielding homogeneous BACE and eliminating the need for a peptide affinity column. Following removal of the prodomain by furin (0.0375 U/mg BACE), anion exchange chromatography (GE Healthcare 1 mL of Q HP) was used as a final purification step. Compounds <b>6u</b> and <b>16</b> were soaked into crystals grown using the procedure described in ref <a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">21</a>. The crystals were soaked at 0.6 mM for 3 h, transferred to a cryoprotectant comprised of 80% mother liquor/20% glycerol, and subsequently flash cooled in liquid nitrogen. X-ray diffraction data for compound <b>6u</b> was collected at sector 17ID at the Advanced Photon Source (Argonne National Laboratory, Argonne, IL, USA) on a Pilatus 6 M detector at −170 °C. Data for compound <b>16</b> was collected in-house on a Rigaku FRE rotating anode X-ray generator equipped with a Rigaku Saturn 944 CCD detector. All data was processed using AUTOPROC<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and XDS,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and subsequent data manipulation was performed using the CCP4 suite of programs.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Initial structures were determined by rigid body refinement of a reference BACE structure, followed by restrained positional refinement in REFMAC.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Ligands were automatically fit to difference maps calculated after refinement in AUTOBUSTER,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and all further refinement was performed in AUTOBUSTER. Data and refinement statistics are reported in <a href="/doi/suppl/10.1021/acs.jmedchem.6b01451/suppl_file/jm6b01451_si_001.pdf" class="ext-link">Table S1</a> (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01451/suppl_file/jm6b01451_si_001.pdf" class="ext-link">Supporting Information</a>).</div></div><div id="sec5_1_2_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> Crystallization of CYP 2D6</h5><div class="NLM_p last">Structural characterization of the binding of <b>6u</b> and <b>12</b> to CYP 2D6 was determined by X-ray crystallography (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TFT">5TFT</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TFU">5TFU</a>, respectively). Crystals of a CYP 2D6 thioridazine complex were prepared and soaked with an artificial mother liquor containing each of the compounds, with repeated transfers to fresh mother liquor to exchange the thioridazine for the new compound as described previously.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Stock solutions (10×) were prepared in DMSO, and the final concentration of each compound in the artificial mother liquor was 5 mM. Data sets were collected at the Stanford Synchrotron Light Source from single crystals at a temperature of 100 K. The data were integrated with XDS<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and merged, scaled, and processed using the CCP4 suite of programs.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> As the space group and unit cell were highly similar to that used to determine PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XRY">4XRY</a>, molecular replacement by rigid body refinement was used for the four chains of the <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XRY">4XRY</a> structure. Model building and refinement employed COOT<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and Phenix 1.9,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> respectively. The data processing and model refinement statistics are provided in Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.6b01451/suppl_file/jm6b01451_si_001.pdf" class="ext-link">Table S2</a>.</div></div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Chemistry</h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> General Methods</h4><div class="NLM_p last">Solvents and reagents were of reagent grade and were used as supplied by the manufacturer. All reactions were run under a N<sub>2</sub> atmosphere. Organic extracts were routinely dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. Concentration refers to rotary evaporation under reduced pressure. Chromatography refers to flash chromatography using disposable RediSepRf 4–120 g silica columns or Biotage disposable columns on a CombiFlash Companion or Biotage Horizon automatic purification system. Microwave reactions were carried out in a SmithCreator microwave reactor from Personal Chemistry. Purification by mass-triggered HPLC was carried out using Waters XTerra PrepMS C18 columns, 5 μm, 30 mm × 100 mm. Compounds were presalted as TFA salts and diluted with 1 mL of dimethyl sulfoxide. Samples were purified by mass-triggered collection using a mobile phase of 0.1% trifluoroacetic acid in water and acetonitrile with a gradient of 100% aqueous to 100% acetonitrile over 10 min at a flow rate of 20 mL/min. Elemental analyses were performed by QTI, Whitehouse, NJ. All target compounds were analyzed using ultra high performance liquid chromatography/ultraviolet/evaporative light scattering detection coupled to time-of-flight mass spectrometry (UHPLC/UV/ELSD/TOFMS). Unless otherwise noted, all tested compounds were found to be >95% pure by this method. Each of the amine fragments employed in the reductive amination to prepare <b>6a</b>–<b>u</b> has been previously described in the literature.</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> UHPLC/MS Analysis</h4><div class="NLM_p">The UHPLC was performed on a Waters ACQUITY UHPLC system (Waters, Milford, MA), which was equipped with a binary solvent delivery manager, column manager, and sample manager coupled to ELSD and UV detectors (Waters, Milford, MA). Detection was performed on a Waters LCT premier XE mass spectrometer (Waters, Milford, MA). The instrument was fitted with an Acquity Bridged Ethane Hybrid (BEH) C18 column (30 mm × 2.1 mm, 1.7 μm particle size, Waters, Milford, MA) operated at 60 °C.</div><div id="sec5_2_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> <i>tert</i>-Butyl (<i>S</i>)-(4-(2,4-Difluoro-5-formylphenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl)carbamate (<b>4</b>)</h5><div class="NLM_p last">To a cooled solution (−78 °C) of <b>3</b> (2.61 g, 6.17 mmol) in anhydrous ether (61.7 mL) was added methyllithium (4.44 mL, 7.10 mmol) dropwise. The mixture was stirred for 30 min before <i>n</i>-BuLi (3.2 mL, 8.64 mmol) was added dropwise at −78 °C. The reaction mixture was stirred for another 30 min before the addition of DMF (4.78 mL, 61.7 mmol) in one portion. The reaction was stirred for 1 h and slowly warmed up to −20 °C, then quenched with aq NH<sub>4</sub>Cl (50 mL). The layers were separated, and the aqueous layer was extracted with EtOAc (2×). The combined organic layers were washed with brine (1×), dried (Na<sub>2</sub>SO<sub>4</sub>), concentrated, and purified by silica chromatography using a 0–40% EtOAc/heptane gradient to yield the product as a colorless solid. Yield: 92%. LCMS <i>m</i>/<i>z</i> 371.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.27 (s, 1H), 7.87–8.00 (m, 1H), 6.88–7.01 (m, 1H), 2.90–3.02 (m, 1H), 2.75–2.87 (m, 1H), 2.62–2.71 (m, 1H), 2.11–2.21 (m, 1H), 1.68 (br s, 3H), 1.48–1.58 (m, 9H).</div></div><div id="sec5_2_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> <i>tert</i>-Butyl (<i>S</i>)-(4-(2,4-Difluoro-5-(((5-methylpyridin-2-yl)amino)methyl)phenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl)carbamate (<b>5a</b>)</h5><div class="NLM_p last">To a solution of <b>4</b> (75 mg, 0.20 mmol) in dichloroethane (0.68 mL, 0.2 M) was added 5-methylpyridin-2-amine (33 mg, 0.30 mmol, 1.5 equiv) and Na(OAc)<sub>3</sub>BH (84 mg, 0.40 mmol, 2 equiv). The resulting solution was stirred for 2 h at rt. The reaction mixture was then partitioned between aq NaHCO<sub>3</sub> and CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was separated, and the aq layer was back-extracted with CH<sub>2</sub>Cl<sub>2</sub> (2×). The combined organics were then washed with brine (1×), dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated, and purified by silica chromatography (4 g silica column, using a 10–100% EtOAc/heptane gradient) to afford a colorless oil in 60% yield. LCMS <i>m</i>/<i>z</i> 463.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.88–7.95 (m, <i>J</i> = 1.6 Hz, 1H), 7.36 (t, <i>J</i> = 8.8 Hz, 1H), 7.25 (dd, <i>J</i> = 2.2, 8.4 Hz, 1H), 6.83 (dd, <i>J</i> = 9.4, 11.7 Hz, 1H), 6.37 (d, <i>J</i> = 8.2 Hz, 1H), 4.75–4.92 (m, 1H), 4.44–4.58 (m, 2H), 2.74–2.84 (m, 1H), 2.65–2.74 (m, 1H), 2.55 (dt, <i>J</i> = 12.3, 3.1 Hz, 1H), 2.18 (s, 3H), 1.97–2.10 (m, 1H), 1.69 (s, 3H), 1.53 (s, 9H).</div></div><div id="sec5_2_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> <i>tert</i>-Butyl (<i>S</i>)-(4-(5-((Ethylamino)methyl)-2,4-difluorophenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl)carbamate (<b>5b</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>4</b> (150 mg, 0.405 mmol) and ethanamine (27 mg, 0.61 mmol) according to a similar procedure as for the preparation of <b>5a</b> in 88% yield. LCMS <i>m</i>/<i>z</i> 400.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.18–7.27 (m, 1H), 6.81 (dd, <i>J</i> = 11.7, 9.4 Hz, 1H), 3.71–3.85 (m, 2H), 2.77–2.86 (m, 1H), 2.69–2.77 (m, 1H), 2.65 (q, <i>J</i> = 7.0 Hz, 2H), 2.51–2.60 (m, 1H), 1.98–2.09 (m, 2H), 1.70 (s, 3H), 1.50 (s, 9H), 1.11 (t, <i>J</i> = 7.2 Hz, 3H).</div></div><div id="sec5_2_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> <i>tert</i>-Butyl (<i>S</i>)-(4-(2,4-Difluoro-5-((isopropylamino)methyl)phenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl)carbamate (<b>5c</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>4</b> (50 mg, 0.13 mmol) and propan-2-amine (12 mg, 0.20 mmol, 1.5 equiv) according to a similar procedure as for the preparation of <b>5a</b> in 61% yield. LCMS <i>m</i>/<i>z</i> 414.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.28–7.35 (m, 1H), 6.83 (dd, <i>J</i> = 11.7, 9.4 Hz, 1H), 3.77–3.90 (m, 2H), 2.78–2.89 (m, 2H), 2.66–2.75 (m, 1H), 2.60 (dt, <i>J</i> = 12.3, 3.1 Hz, 1H), 2.02–2.12 (m, 1H), 1.70 (s, 3H), 1.52 (s, 9H), 1.13 (d, <i>J</i> = 6.2 Hz, 6H).</div></div><div id="sec5_2_2_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> <i>tert</i>-Butyl (<i>S</i>)-(4-(5-((Dimethylamino)methyl)-2,4-difluorophenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl)carbamate (<b>5d</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>4</b> (78 mg, 0.21 mmol) and dimethylamine (158 μL, 0.32 mmol, 2 M in methanol) according to a similar procedure as for the preparation of <b>5a</b> in 59% yield. LCMS <i>m</i>/<i>z</i> 400.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.25 (t, <i>J</i> = 8.8 Hz, 1H), 6.82 (dd, <i>J</i> = 11.9, 9.2 Hz, 1H), 3.39–3.54 (m, 2H), 2.79–2.89 (m, 1H), 2.67–2.77 (m, 1H), 2.59 (dt, <i>J</i> = 12.3, 3.1 Hz, 1H), 2.23 (s, 6H), 2.03–2.12 (m, 1H), 1.71 (s, 3H), 1.50 (s, 9H).</div></div><div id="sec5_2_2_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> <i>tert</i>-Butyl ((<i>S</i>)-4-(2,4-Difluoro-5-(((<i>R</i>)-3-methoxypyrrolidin-1-yl)methyl)phenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl)carbamate (<b>5e</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>4</b> (160 mg, 0.43 mmol) and (<i>R</i>)-3-methoxypyrrolidine (66 mg, 0.65 mmol) according to a similar procedure as for the preparation of <b>5a</b> in 59% yield. LCMS <i>m</i>/<i>z</i> 456.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.27 (t, <i>J</i> = 8.59 Hz, 1H), 6.80 (dd, <i>J</i> = 8.98, 11.71 Hz, 1H), 3.86–3.96 (m, 1H), 3.57–3.73 (m, 2H), 3.25 (s, 3H), 2.78–2.91 (m, 2H), 2.70–2.78 (m, 1H), 2.59–2.70 (m, 1H), 2.50–2.59 (m, 2H), 2.46 (dd, <i>J</i> = 9.9, 3.7 Hz, 1H), 1.96–2.11 (m, 2H), 1.73–1.82 (m, 1H), 1.71 (s, 3H), 1.51 (s, 9H).</div></div><div id="sec5_2_2_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> <i>tert</i>-Butyl (<i>S</i>)-(4-(2,4-Difluoro-5-(((2-methoxyethyl)amino)methyl)phenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl)carbamate (<b>5f</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>4</b> (115 mg, 0.31 mmol) and 2-methoxyethan-1-amine (35 mg, 0.47 mmol) according to a similar procedure as for the preparation of <b>5a</b> in 72% yield. LCMS <i>m</i>/<i>z</i> 430.5 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.21–7.33 (m, 1H), 6.82 (dd, <i>J</i> = 9.17, 11.90 Hz, 1H), 3.75–3.88 (m, 2H), 3.50 (t, <i>J</i> = 5.1 Hz, 2H), 3.30–3.39 (m, 3H), 2.69–2.88 (m, 4H), 2.59 (dt, <i>J</i> = 12.3, 3.1 Hz, 1H), 1.98–2.10 (m, 2H), 1.71 (s, 3H), 1.52 (s, 9H).</div></div><div id="sec5_2_2_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> <i>tert</i>-Butyl (<i>S</i>)-(4-(2,4-Difluoro-5-(((3-methoxypropyl)amino)methyl)phenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl)carbamate (<b>5g</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>4</b> (95 mg, 0.26 mmol) and 3-methoxypropan-1-amine (34 mg, 0.38 mmol) according to a similar procedure as for the preparation of <b>5a</b> in 58% yield. LCMS <i>m</i>/<i>z</i> 444.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.25 (t, <i>J</i> = 8.7 Hz, 1H), 6.80 (dd, <i>J</i> = 11.7, 9.2 Hz, 1H), 3.74–3.84 (m, 2H), 3.43 (t, <i>J</i> = 6.0 Hz, 2H), 3.28–3.31 (m, 3H), 2.78–2.84 (m, 1H), 2.70 (t, <i>J</i> = 6.8 Hz, 3H), 2.53–2.62 (m, 1H), 1.99–2.08 (m, 1H), 1.76 (quin, <i>J</i> = 6.5 Hz, 2H), 1.69 (s, 3H), 1.49 (s, 9H).</div></div><div id="sec5_2_2_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> <i>tert</i>-Butyl ((<i>S</i>)-4-(2,4-Difluoro-5-((((<i>R</i>)-1-methoxypropan-2-yl)amino)methyl)phenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl)carbamate (<b>5h</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>4</b> (120 mg, 0.32 mmol) and the HCl salt of (<i>R</i>)-1-methoxypropan-2-amine (61 mg, 0.49 mmol) according to a similar procedure as for the preparation of <b>5a</b> in 68% yield. LCMS <i>m</i>/<i>z</i> 444.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.22–7.31 (m, 1H), 6.80 (dd, <i>J</i> = 9.37, 11.71 Hz, 1H), 3.80 (s, 2H), 3.25–3.37 (m, 4H), 3.17–3.25 (m, 1H), 2.69–2.93 (m, 3H), 2.57 (dt, <i>J</i> = 12.2, 2.9 Hz, 1H), 1.96–2.10 (m, 1H), 1.69 (s, 3H), 1.50 (s, 9H), 1.03 (d, <i>J</i> = 6.2 Hz, 3H).</div></div><div id="sec5_2_2_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> <i>tert</i>-Butyl (<i>S</i>)-(4-(5-((Bicyclo[1.1.1]pentan-1-ylamino)methyl)-2,4-difluorophenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl)carbamate (<b>5i</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>4</b> (100 mg, 0.27 mmol) and bicyclo[1.1.1]pentan-1-amine (34 mg, 0.40 mmol) according to a similar procedure as for the preparation of <b>5a</b> in 31% yield. LCMS <i>m</i>/<i>z</i> 438.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.23–7.34 (m, 1H), 6.82 (dd, <i>J</i> = 11.7, 9.4 Hz, 1H), 3.73–3.87 (m, 2H), 2.73–2.90 (m, 2H), 2.52–2.68 (m, 1H), 2.02–2.12 (m, 1H), 1.75–1.81 (m, 5H), 1.72 (s, 3H), 1.54 (s, 9H), 1.20–1.35 (m, 2H).</div></div><div id="sec5_2_2_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> <i>tert</i>-Butyl (<i>S</i>)-(4-(2,4-Difluoro-5-((methyl(2,2,2-trifluoroethyl)amino)methyl)phenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl)carbamate (<b>5j</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>4</b> (165 mg, 0.44 mmol) and the HCl salt of 2,2,2-trifluoro-<i>N</i>-methylethan-1-amine (100 mg, 0.67 mmol) according to a similar procedure as for the preparation of <b>5a</b> in 22% yield. LCMS <i>m</i>/<i>z</i> 468.3 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.32 (t, <i>J</i> = 8.8 Hz, 1H), 6.84 (dd, <i>J</i> = 11.7, 9.0 Hz, 1H), 3.76 (s, 2H), 3.06 (q, <i>J</i> = 9.4 Hz, 2H), 2.80–2.88 (m, 1H), 2.69–2.80 (m, 1H), 2.58 (dt, <i>J</i> = 12.4, 3.3 Hz, 1H), 2.43 (s, 3H), 2.07 (dt, <i>J</i> = 13.1, 3.5 Hz, 1H), 1.73 (s, 3H), 1.52 (s, 9H).</div></div><div id="sec5_2_2_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> <i>tert</i>-Butyl (<i>S</i>)-(4-(2,4-Difluoro-5-(((2,2,2-trifluoroethyl)amino)methyl)phenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl)carbamate (<b>5k</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>4</b> (225 mg, 0.61 mmol) and 2,2,2-trifluoroethan-1-amine (90 mg, 0.91 mmol) according to a similar procedure as for the preparation of <b>5a</b> in 61% yield. LCMS <i>m</i>/<i>z</i> 454.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.28 (t, <i>J</i> = 8.8 Hz, 1H), 6.83 (dd, <i>J</i> = 11.7, 9.4 Hz, 1H), 3.83–3.97 (m, 2H), 3.17 (q, <i>J</i> = 9.2 Hz, 2H), 2.79–2.89 (m, 1H), 2.66–2.79 (m, 1H), 2.57 (dt, <i>J</i> = 12.3, 3.1 Hz, 1H), 2.00–2.11 (m, 1H), 1.70 (s, 3H), 1.50 (s, 9H).</div></div><div id="sec5_2_2_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> <i>tert</i>-Butyl (<i>S</i>)-(4-(5-(((2,2-Difluoroethyl)amino)methyl)-2,4-difluorophenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl)carbamate (<b>5l</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>4</b> (62 mg, 0.17 mmol) and 2,2-difluoroethan-1-amine (20 mg, 0.25 mmol) according to a similar procedure as for the preparation of <b>5a</b> in 85% yield. LCMS <i>m</i>/<i>z</i> 436.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.24–7.33 (m, 1H), 6.84 (dd, <i>J</i> = 11.7, 9.4 Hz, 1H), 5.67–6.03 (m, 1H), 3.80–3.93 (m, 2H), 2.95 (dt, <i>J</i> = 15.0, 4.3 Hz, 2H), 2.78–2.89 (m, 1H), 2.67–2.78 (m, 1H), 2.51–2.63 (m, 1H), 2.04–2.12 (m, 1H), 1.71 (s, 3H), 1.51 (s, 9H).</div></div><div id="sec5_2_2_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> <i>tert</i>-Butyl (<i>S</i>)-(4-(2,4-Difluoro-5-(((1,1,1-trifluoro-2-methylpropan-2-yl)amino)methyl)phenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl)carbamate (<b>5m</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>4</b> (52 mg, 0.14 mmol) and 1,1,1-trifluoro-2-methylpropan-2-amine (34 mg, 0.21 mmol) according to a similar procedure as for the preparation of <b>5a</b> in 58% yield. LCMS <i>m</i>/<i>z</i> 482.3 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.36 (t, <i>J</i> = 8.8 Hz, 1H), 6.81 (dd, <i>J</i> = 11.7, 9.4 Hz, 1H), 3.76–3.99 (m, 2H), 2.70–2.87 (m, 2H), 2.51–2.65 (m, 1H), 1.99–2.13 (m, 1H), 1.63–1.77 (m, 3H), 1.47–1.56 (m, 9H), 1.25–1.34 (m, 6H).</div></div><div id="sec5_2_2_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> <i>tert</i>-Butyl ((<i>S</i>)-4-(2,4-Difluoro-5-((((<i>R</i>)-1,1,1-trifluoropropan-2-yl)amino)methyl)phenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl)carbamate (<b>5n</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>4</b> (76 mg, 0.21 mmol) and (<i>R</i>)-1,1,1-trifluoropropan-2-amine (35 mg, 0.31 mmol) according to a similar procedure as for the preparation of <b>5a</b> in 35% yield. LCMS <i>m</i>/<i>z</i> 468.3 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.29–7.35 (m, 1H), 6.79–6.95 (m, 1H), 3.85–4.00 (m, 2H), 3.12–3.26 (m, 1H), 2.70–2.90 (m, 2H), 2.52–2.70 (m, 1H), 1.98–2.17 (m, 1H), 1.70–1.78 (m, 3H), 1.47–1.57 (m, 9H), 1.27 (d, <i>J</i> = 6.6 Hz, 3H).</div></div><div id="sec5_2_2_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> <i>tert</i>-Butyl (<i>S</i>)-(4-(2,4-Difluoro-5-(((3,3,3-trifluoropropyl)amino)methyl)phenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl)carbamate (<b>5o</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>4</b> (75 mg, 0.20 mmol) and 3,3,3-trifluoropropan-1-amine (34 mg, 0.30 mmol) according to a similar procedure as for the preparation of <b>5a</b> in 79% yield. LCMS <i>m</i>/<i>z</i> 468.3 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.23–7.32 (m, 1H), 6.83 (dd, <i>J</i> = 11.5, 9.2 Hz, 1H), 3.72–3.86 (m, 2H), 2.79–2.89 (m, 3H), 2.68–2.79 (m, 1H), 2.57 (dt, <i>J</i> = 12.5, 3.12 Hz, 1H), 2.23–2.41 (m, 2H), 2.00–2.14 (m, 1H), 1.71 (s, 3H), 1.51 (s, 9H).</div></div><div id="sec5_2_2_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> <i>tert</i>-Butyl (<i>S</i>)-(4-(5-((Cyclopropylamino)methyl)-2,4-difluorophenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl)carbamate (<b>5p</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>4</b> (54 mg, 0.15 mmol) and cyclopropanamine (12 mg, 0.22 mmol) according to a similar procedure as for the preparation of <b>5a</b> in 97% yield. LCMS <i>m</i>/<i>z</i> 412.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.24 (s, 1H), 6.82 (dd, <i>J</i> = 11.7, 9.4 Hz, 1H), 3.85 (d, <i>J</i> = 7.4 Hz, 2H), 2.80 (d, <i>J</i> = 2.3 Hz, 2H), 2.58 (s, 1H), 1.98–2.14 (m, 2H), 1.65–1.79 (m, 3H), 1.46–1.58 (m, 9H), 0.40–0.50 (m, 2H), 0.31–0.40 (m, 2H).</div></div><div id="sec5_2_2_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> <i>tert</i>-Butyl (<i>S</i>)-(4-(5-(((Cyclopropylmethyl)amino)methyl)-2,4-difluorophenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl)carbamate (<b>5q</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>4</b> (58 mg, 0.16 mmol) and cyclopropylmethanamine (36 mg, 0.24 mmol) according to a similar procedure as for the preparation of <b>5a</b> in 57% yield. LCMS <i>m</i>/<i>z</i> 426.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.33 (t, <i>J</i> = 8.6 Hz, 1H), 6.81 (dd, <i>J</i> = 11.7, 9.4 Hz, 1H), 3.79–3.93 (m, 2H), 2.78–2.89 (m, 1H), 2.65–2.74 (m, 1H), 2.60 (dt, <i>J</i> = 12.2, 3.2 Hz, 1H), 2.44–2.56 (m, 2H), 2.00–2.11 (m, 1H), 1.98 (s, 1H), 1.68 (s, 3H), 1.50 (s, 9H), 0.93–1.07 (m, 1H), 0.44–0.56 (m, 2H), 0.07–0.20 (m, 2H).</div></div><div id="sec5_2_2_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> <i>tert</i>-Butyl (<i>S</i>)-(4-(5-(((1-(Difluoromethyl)cyclopropyl)amino)methyl)-2,4-difluorophenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl)carbamate (<b>5r</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>4</b> (55 mg, 0.15 mmol) and 1-(difluoromethyl)cyclopropan-1-amine (32 mg, 0.22 mmol) according to a similar procedure as for the preparation of <b>5a</b> in 86% yield. LCMS <i>m</i>/<i>z</i> 462.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.28 (t, <i>J</i> = 8.8 Hz, 1H), 6.79 (dd, <i>J</i> = 11.7, 9.4 Hz, 1H), 5.41–5.73 (m, 1H), 3.93–4.05 (m, 2H), 2.71–2.84 (m, 2H), 2.52–2.61 (m, 1H), 2.04 (s, 2H), 1.65–1.72 (m, 3H), 1.47–1.54 (m, 9H), 1.13–1.17 (m, 1H), 0.85–0.91 (m, 1H), 0.78–0.84 (m, 3H).</div></div><div id="sec5_2_2_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> <i>tert</i>-Butyl (<i>S</i>)-(4-(5-(((1-Cyanocyclopropyl)amino)methyl)-2,4-difluorophenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl)carbamate (<b>5s</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>4</b> (45 mg, 0.12 mmol) and 1-aminocyclopropane-1-carbonitrile (17 mg, 0.15 mmol) according to a similar procedure as for the preparation of <b>5a</b> in 96% yield. LCMS <i>m</i>/<i>z</i> 437.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.21 (t, <i>J</i> = 8.8 Hz, 1H), 6.84 (dd, <i>J</i> = 11.7, 9.4 Hz, 1H), 3.96 (q, <i>J</i> = 13.66 Hz, 2H), 2.71–2.84 (m, 2H), 2.54–2.66 (m, 1H), 1.97–2.05 (m, 1H), 1.70 (s, 3H), 1.46–1.57 (m, 9H), 1.18–1.29 (m, 2H), 1.03–1.10 (m, 2H).</div></div><div id="sec5_2_2_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> (<i>S</i>)-<i>N</i>-(4-(2,4-Difluoro-5-(((3-(trifluoromethyl)oxetan-3-yl)amino)methyl)phenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl)benzamide (<b>5t</b>)</h5><div class="NLM_p last">A methanol solution (6.75 mL, 0.1 M) of <b>4</b> (250 mg, 0.675 mmol, 1 equiv) was treated with HCl (4 M in dioxane, 3.37 mL, 13.5 mmol, 20 equiv). The resulting yellow solution was stirred at 50 °C for 3 h. The reaction mixture was concentrated under reduced pressure to yield a colorless oil, which was dissolved in H<sub>2</sub>O. The resulting solution was extracted with Et<sub>2</sub>O (3×). The resulting aq layer (pH 1) was basified to pH 10 with 1 N NaOH. The colorless solution was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×). The combined organics were washed with brine (1×), dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated, and purified via silica chromatography using a 10% MeOH/1% NH<sub>4</sub>OH/89% CH<sub>2</sub>Cl<sub>2</sub> mixture as eluent to yield a colorless oil. LCMS <i>m</i>/<i>z</i> 271.3 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.18 (s, 1H), 7.95 (t, <i>J</i> = 8.6 Hz, 1H), 6.81 (dd, <i>J</i> = 11.5, 9.9 Hz, 1H), 4.16–4.56 (m, 2H), 2.89–3.01 (m, 1H), 2.55–2.68 (m, 1H), 2.10–2.21 (m, 1H), 1.85–1.98 (m, 1H), 1.45–1.54 (m, 3H). The purified amidine (135 mg, 0.500 mmol) was immediately dissolved in a 2:1 solution of THF:MeOH (2.1 mL). TEA (0.11 mL, 0.80 mmol) was added followed by benzoic anhydride (150 mg, 0.650 mmol). The reaction was stirred at rt for 18 h. The reaction was then concentrated and redissolved in water and EtOAc. The layers were separated, and the aqueous layer was back extracted with EtOAc (2×). The combined organics were washed with water and with brine, dried over sodium sulfate, concentrated, and subjected to silica gel chromatography using a 0–100% EtOAc/heptane gradient. Yield: 86%. LCMS <i>m</i>/<i>z</i> 375.3 [M – H<sup>+</sup>]. The resultant compound (16 mg, 0.09 mmol) was reacted with the HCl salt of 3-(trifluoromethyl)oxetan-3-amine (28 mg, 0.075 mmol), using a similar procedure as for the preparation of <b>5a</b> in 70% yield. LCMS <i>m</i>/<i>z</i> 500.3 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.23–12.60 (m, 1H), 8.16–8.29 (m, 2H), 7.38–7.56 (m, 4H), 6.82–6.95 (m, 1H), 4.67–4.77 (m, 2H), 4.54 (d, <i>J</i> = 7.0 Hz, 2H), 3.89 (d, <i>J</i> = 7.4 Hz, 2H), 2.85–2.99 (m, 2H), 2.63–2.74 (m, 1H), 2.10–2.22 (m, 1H), 1.81 (s, 3H), 1.22–1.36 (m, 1H).</div></div><div id="sec5_2_2_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> <i>tert</i>-Butyl (<i>S</i>)-(4-(2,4-Difluoro-5-(((1-(trifluoromethyl)cyclopropyl)amino)methyl)phenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl)carbamate (<b>5u</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>4</b> (130 mg, 0.351 mmol) and 1-(trifluoromethyl)cyclopropan-1-amine (66 mg, 0.526 mmol) according to a similar procedure as for the preparation of <b>5a</b> in 67% yield. LCMS <i>m</i>/<i>z</i> 480.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.21–7.28 (m, 1H), 6.72–6.82 (m, 1H), 3.91–4.04 (m, 2H), 2.67–2.84 (m, 2H), 2.47–2.61 (m, 1H), 1.96–2.11 (m, 2H), 1.62–1.74 (m, 3H), 1.44–1.54 (m, 9H), 0.98–1.05 (m, 2H), 0.81–0.90 (m, 2H).</div></div><div id="sec5_2_2_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> (<i>S</i>)-4-(2,4-Difluoro-5-(((5-methylpyridin-2-yl)amino)methyl)phenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-amine (<b>6a</b>)</h5><div class="NLM_p last">A methanol solution (0.6 mL, 0.1 M) of <b>5a</b> (28 mg, 0.06 mmol, 1 equiv) was treated with HCl (4 M in dioxane, 0.3 mL, 4 equiv). The solution was stirred at 50 °C for 2 h. The reaction was then concentrated and redissolved in water. The aqueous solution was extracted with diethyl ether (3×) and then brought to pH ∼ 12 with 1 N NaOH. This solution was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×). The combined organics were dried over sodium sulfate, concentrated, and purified via silica gel chromatography using a 0–60% gradient of a 10% MeOH/1% NH<sub>4</sub>OH/89% CH<sub>2</sub>Cl<sub>2</sub> solution and CH<sub>2</sub>Cl<sub>2</sub> to yield <b>6a</b> in 78% yield. LCMS <i>m</i>/<i>z</i> 363.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.91 (d, <i>J</i> = 1.6 Hz, 1H), 7.40 (t, <i>J</i> = 9.2 Hz, 1H), 7.24 (dd, <i>J</i> = 8.2, 2.3 Hz, 1H), 6.78 (dd, <i>J</i> = 11.7, 9.4 Hz, 1H), 6.33 (d, <i>J</i> = 8.6 Hz, 1H), 5.10 (t, <i>J</i> = 5.8 Hz, 1H), 4.40–4.56 (m, 2H), 2.89 (ddd, <i>J</i> = 12.2, 6.2, 3.9 Hz, 1H), 2.59 (dt, <i>J</i> = 11.5, 3.5 Hz, 1H), 2.31–2.42 (m, 1H), 2.18 (s, 3H), 1.83 (ddd, <i>J</i> = 14.0, 10.7, 3.7 Hz, 1H), 1.57 (d, <i>J</i> = 1.2 Hz, 3H).</div></div><div id="sec5_2_2_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> (<i>S</i>)-4-(5-((Ethylamino)methyl)-2,4-difluorophenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-amine (<b>6b</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>5b</b> (142 mg, 0.355 mmol) according to a similar procedure as for the preparation of <b>6a</b> in 63% yield. LCMS <i>m</i>/<i>z</i> 300.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.32 (t, <i>J</i> = 9.2 Hz, 1H), 6.76 (dd, <i>J</i> = 11.7, 9.8 Hz, 1H), 3.78 (s, 2H), 2.96 (ddd, <i>J</i> = 12.1, 6.8, 3.7 Hz, 1H), 2.58–2.74 (m, 3H), 2.33 (ddd, <i>J</i> = 14.0, 6.7, 3.5 Hz, 1H), 1.89 (ddd, <i>J</i> = 13.8, 10.3, 3.9 Hz, 1H), 1.58 (d, <i>J</i> = 1.2 Hz, 3H), 1.11 (t, <i>J</i> = 7.0 Hz, 3H).</div></div><div id="sec5_2_2_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> (<i>S</i>)-4-(2,4-Difluoro-5-((isopropylamino)methyl)phenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-amine (<b>6c</b>)</h5><div class="NLM_p last">Compound <b>5c</b> (34 mg, 0.08 mmol, 1 equiv) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (0.41 mL, 0.2 M), and trifluoroacetic acid (126 μL, 1.64 mmol, 20 equiv) was added. The reaction was stirred at rt for 18 h. The reaction was concentrated and taken up in EtOAc and aqueous saturated sodium bicarbonate. The layers were separated, and the aqueous layer was extracted with EtOAc (2×). The combined organics were washed with brine, dried over sodium sulfate, and purified via silica gel chromatography using a 0–60% gradient of a 10% MeOH/1% NH<sub>4</sub>OH/89% CH<sub>2</sub>Cl<sub>2</sub> solution and CH<sub>2</sub>Cl<sub>2</sub> to yield <b>6c</b> in 60% yield. LCMS <i>m</i>/<i>z</i> 314.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.07 (t, <i>J</i> = 8.5 Hz, 1H), 6.92 (dd, <i>J</i> = 9.0, 11.5 Hz, 1H), 4.78 (s, 2H), 4.15–4.32 (m, 2H), 3.29 (sept, <i>J</i> = 6.5 Hz, 1H), 2.96–3.10 (m, 1H), 2.78–2.91 (m, 2H), 2.10–2.24 (m, 1H), 1.82 (s, 3H), 1.49 (dd, <i>J</i> = 7.5, 6.8 Hz, 6H).</div></div><div id="sec5_2_2_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> (<i>S</i>)-4-(5-((Dimethylamino)methyl)-2,4-difluorophenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-amine (<b>6d</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>5d</b> (59 mg, 0.15 mmol) according to a similar procedure as for the preparation of <b>6a</b> in 90% yield. LCMS <i>m</i>/<i>z</i> 300.3 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.32 (t, <i>J</i> = 9.0 Hz, 1H), 6.77 (dd, <i>J</i> = 11.9, 9.6 Hz, 1H), 4.55 (br s, 1H), 3.47–3.55 (m, 1H), 3.36–3.47 (m, 1H), 2.97 (ddd, <i>J</i> = 12.1, 6.8, 3.7 Hz, 1H), 2.68 (ddd, <i>J</i> = 12.2, 10.2, 3.7 Hz, 1H), 2.28–2.38 (m, 1H), 2.24 (s, 6H), 1.83–1.96 (m, 1H), 1.59 (d, <i>J</i> = 1.6 Hz, 1H).</div></div><div id="sec5_2_2_27" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> (<i>S</i>)-4-(2,4-Difluoro-5-(((<i>R</i>)-3-methoxypyrrolidin-1-yl)methyl)phenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-amine (<b>6e</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>5e</b> (116 mg, 0.255 mmol) according to a similar procedure as for the preparation of <b>6a</b> in 68% yield. LCMS <i>m</i>/<i>z</i> 356.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.33 (t, <i>J</i> = 9.0 Hz, 1H), 6.74 (dd, <i>J</i> = 11.7, 9.4 Hz, 1H), 3.86–3.97 (m, 1H), 3.65–3.75 (m, 1H), 3.54–3.63 (m, 1H), 3.25 (s, 3H), 2.93 (ddd, <i>J</i> = 12.1, 6.4, 3.7 Hz, 1H), 2.82 (dd, <i>J</i> = 10.2, 6.2 Hz, 1H), 2.59–2.69 (m, 2H), 2.47–2.56 (m, 2H), 2.35 (ddd, <i>J</i> = 14.0, 6.3, 3.5 Hz, 1H), 1.98–2.10 (m, 1H), 1.71–1.89 (m, 2H), 1.57 (d, <i>J</i> = 1.6 Hz, 3H).</div></div><div id="sec5_2_2_28" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> (<i>S</i>)-4-(2,4-Difluoro-5-(((2-methoxyethyl)amino)methyl)phenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-amine (<b>6f</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>6f</b> (96 mg, 0.22 mmol) according to a similar procedure as for the preparation of <b>6a</b> in 56% yield. LCMS <i>m</i>/<i>z</i> 330.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.34 (t, <i>J</i> = 9.0 Hz, 1H), 6.75 (dd, <i>J</i> = 11.7, 9.8 Hz, 1H), 3.80 (s, 2H), 3.49 (t, <i>J</i> = 5.3 Hz, 2H), 3.33 (s, 3H), 2.95 (ddd, <i>J</i> = 12.1, 7.0, 3.9 Hz, 1H), 2.77 (t, <i>J</i> = 5.1 Hz, 2H), 2.67 (ddd, <i>J</i> = 12.1, 10.5, 3.5 Hz, 1H), 2.32 (ddd, <i>J</i> = 14.0, 6.7, 3.5 Hz, 1H), 1.89 (ddd, <i>J</i> = 14.0, 10.2, 3.5 Hz, 1H), 1.57 (s, 3H).</div></div><div id="sec5_2_2_29" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> (<i>S</i>)-4-(2,4-Difluoro-5-(((3-methoxypropyl)amino)methyl)phenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-amine (<b>6g</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>6g</b> (66 mg, 0.15 mmol) according to a similar procedure as for the preparation of <b>6a</b> in 68% yield. LCMS <i>m</i>/<i>z</i> 344.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.33 (t, <i>J</i> = 9.0 Hz, 1H), 6.76 (dd, <i>J</i> = 11.7, 9.8 Hz, 1H), 3.78 (s, 2H), 3.44 (t, <i>J</i> = 6.2 Hz, 2H), 3.32 (s, 3H), 2.96 (ddd, <i>J</i> = 12.1, 6.6, 3.9 Hz, 1H), 2.62–2.72 (m, 3H), 2.34 (ddd, <i>J</i> = 14.0, 6.7, 3.5 Hz, 1H), 1.88 (ddd, <i>J</i> = 14.0, 10.4, 3.7 Hz, 1H), 1.77 (quin, <i>J</i> = 6.6 Hz, 2H), 1.58 (d, <i>J</i> = 1.2 Hz, 3H).</div></div><div id="sec5_2_2_30" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> (<i>S</i>)-4-(2,4-Difluoro-5-((((<i>R</i>)-1-methoxypropan-2-yl)amino)methyl)phenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-amine (<b>6h</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>5h</b> (97 mg, 0.22 mmol) according to a similar procedure as for the preparation of <b>6a</b> in 64% yield. LCMS <i>m</i>/<i>z</i> 344.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.33 (t, <i>J</i> = 9.0 Hz, 1H), 6.76 (dd, <i>J</i> = 11.7, 9.4 Hz, 1H), 3.82–3.91 (m, 1H), 3.71–3.80 (m, 1H), 3.29–3.35 (m, 4H), 3.20–3.29 (m, 1H), 2.95 (ddd, <i>J</i> = 12.2, 6.5, 3.5 Hz, 1H), 2.81–2.91 (m, 1H), 2.67 (ddd, <i>J</i> = 12.0, 10.6, 3.9 Hz, 1H), 2.36 (ddd, <i>J</i> = 14.0, 6.6, 3.5 Hz, 1H), 1.87 (ddd, <i>J</i> = 14.0, 10.4, 3.7 Hz, 1H), 1.58 (d, <i>J</i> = 1.2 Hz, 3H), 1.05 (d, <i>J</i> = 6.2 Hz, 3H).</div></div><div id="sec5_2_2_31" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> (<i>S</i>)-4-(5-((Bicyclo[1.1.1]pentan-1-ylamino)methyl)-2,4-difluorophenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-amine (<b>6i</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>5i</b> (36 mg, 0.08 mmol) according to a similar procedure as for the preparation of <b>6a</b> in 49% yield. LCMS <i>m</i>/<i>z</i> 338.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.34 (t, <i>J</i> = 9.2 Hz, 1H), 6.75 (dd, <i>J</i> = 11.7, 9.8 Hz, 1H), 3.70–3.84 (m, 2H), 2.96 (td, <i>J</i> = 12.3, 3.2 Hz, 1H), 2.62–2.73 (m, 1H), 2.31–2.41 (m, 2H), 1.83–1.94 (m, 1H), 1.76 (s, 6H), 1.57 (d, <i>J</i> = 1.2 Hz, 3H).</div></div><div id="sec5_2_2_32" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> (<i>S</i>)-4-(2,4-Difluoro-5-((methyl(2,2,2-trifluoroethyl)amino)methyl)phenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-amine (<b>6j</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>5j</b> (46 mg, 0.10 mmol) according to a similar procedure as for the preparation of <b>6a</b> in 53% yield. LCMS <i>m</i>/<i>z</i> 368.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.37 (t, <i>J</i> = 9.0 Hz, 1H), 6.79 (dd, <i>J</i> = 11.7, 9.4 Hz, 1H), 3.67–3.84 (m, 2H), 3.06 (q, <i>J</i> = 9.6 Hz, 2H), 2.96 (ddd, <i>J</i> = 12.1, 6.2, 3.9 Hz, 1H), 2.66 (dt, <i>J</i> = 11.4, 3.7 Hz, 1H), 2.43 (s, 3H), 2.39 (ddd, <i>J</i> = 10.4, 6.5, 3.3 Hz, 1H), 1.86 (ddd, <i>J</i> = 14.0, 10.6, 3.9 Hz, 1H), 1.61 (d, <i>J</i> = 1.2 Hz, 3H).</div></div><div id="sec5_2_2_33" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> (<i>S</i>)-4-(2,4-Difluoro-5-(((2,2,2-trifluoroethyl)amino)methyl)phenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-amine (<b>6k</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>5k</b> (166 mg, 0.369 mmol) according to a similar procedure as for the preparation of <b>6a</b> in 57% yield. LCMS <i>m</i>/<i>z</i> 354.3 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.37 (t, <i>J</i> = 9.0 Hz, 1H), 6.79 (dd, <i>J</i> = 11.7, 9.4 Hz, 1H), 4.42 (br s, 2H), 3.91 (d, <i>J</i> = 5.8 Hz, 2H), 3.10–3.23 (m, 2H), 2.98 (ddd, <i>J</i> = 12.2, 6.7, 3.7 Hz, 1H), 2.67 (ddd, <i>J</i> = 12.1, 103, 3.7 Hz, 1H), 2.33 (ddd, <i>J</i> = 13.8, 6.8, 3.9 Hz, 1H), 1.91 (ddd, <i>J</i> = 14.0, 10.2, 3.5 Hz, 1H), 1.62–1.71 (m, 1H), 1.59 (d, <i>J</i> = 1.2 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 160.9, 158.4, 150.8, 131.2, 130.2, 127.2, 121.7, 104.9, 56.4, 49.8, 46.8, 30.6, 29.6, 23.8. HRMS calcd for C<sub>14</sub>H<sub>17</sub>N<sub>3</sub>F<sub>5</sub>S (M+1) 354.1058, found 354.1053.</div></div><div id="sec5_2_2_34" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> (<i>S</i>)-4-(5-(((2,2-Difluoroethyl)amino)methyl)-2,4-difluorophenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-amine (<b>6l</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>5l</b> (62 mg, 0.14 mmol) according to a similar procedure as for the preparation of <b>6a</b> in 46% yield. LCMS <i>m</i>/<i>z</i> 336.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.36 (t, <i>J</i> = 9.0 Hz, 1H), 6.80 (dd, <i>J</i> = 11.9, 9.6 Hz, 1H), 5.69–6.05 (m, 1H), 3.78–3.94 (m, 2H), 2.87–3.04 (m, 3H), 2.68 (ddd, <i>J</i> = 12.2, 10.4, 3.5 Hz, 1H), 2.35 (ddd, <i>J</i> = 13.8, 6.6, 3.7 Hz, 1H), 1.91 (ddd, <i>J</i> = 14.0, 10.4, 3.7 Hz, 1H), 1.60 (s, 3H), 1.43–1.58 (m, 1H).</div></div><div id="sec5_2_2_35" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> (<i>S</i>)-4-(2,4-Difluoro-5-(((1,1,1-trifluoro-2-methylpropan-2-yl)amino)methyl)phenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-amine (<b>6m</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>5m</b> (39 mg, 0.08 mmol) according to a similar procedure as for the preparation of <b>6a</b> in 82% yield. LCMS <i>m</i>/<i>z</i> 382.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.41 (t, <i>J</i> = 9.0 Hz, 1H), 6.71–6.81 (m, 1H), 3.98–4.43 (m, 2H), 3.78–3.92 (m, 2H), 2.98 (ddd, <i>J</i> = 12.1, 6.8, 3.7 Hz, 1H), 2.69 (ddd, <i>J</i> = 12.3, 10.3, 3.9 Hz, 1H), 2.35 (ddd, <i>J</i> = 14.0, 6.8, 3.7 Hz, 1H), 1.91 (ddd, <i>J</i> = 14.0, 10.3, 3.7 Hz, 1H), 1.55–1.63 (m, 3H), 1.47 (t, <i>J</i> = 7.2 Hz, 1H), 1.25–1.37 (m, 6H).</div></div><div id="sec5_2_2_36" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> (<i>S</i>)-4-(2,4-Difluoro-5-((((<i>R</i>)-1,1,1-trifluoropropan-2-yl)amino)methyl)phenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-amine (<b>6n</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>5n</b> (34 mg, 0.07 mmol) according to a similar procedure as for the preparation of <b>6a</b> in 30% yield. LCMS <i>m</i>/<i>z</i> 368.3 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.32–7.43 (m, 1H), 6.74–6.86 (m, 1H), 3.82–4.01 (m, 1H), 3.12–3.27 (m, 1H), 2.89–3.05 (m, 1H), 2.61–2.75 (m, 1H), 2.30–2.42 (m, 1H), 1.81–1.96 (m, 1H), 1.59–1.63 (m, 5H), 1.25 (d, <i>J</i> = 6.6 Hz, 3H).</div></div><div id="sec5_2_2_37" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64"> (<i>S</i>)-4-(2,4-Difluoro-5-(((3,3,3-trifluoropropyl)amino)methyl)phenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-amine (<b>6o</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>5o</b> (75 mg, 0.16 mmol) according to a similar procedure as for the preparation of <b>6a</b> in 19% yield. LCMS <i>m</i>/<i>z</i> 368.3 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.34 (t, <i>J</i> = 8.8 Hz, 1H), 6.78 (dd, <i>J</i> = 11.7, 9.4 Hz, 1H), 3.75–3.85 (m, 2H), 2.97 (ddd, <i>J</i> = 12.1, 6.6, 3.9 Hz, 1H), 2.85 (t, <i>J</i> = 7.0 Hz, 2H), 2.67 (ddd, <i>J</i> = 12.2, 10.4, 3.5 Hz, 1H), 2.25–2.39 (m, 3H), 1.89 (ddd, <i>J</i> = 14.0, 10.4, 3.7 Hz, 1H), 1.59 (d, <i>J</i> = 1.6 Hz, 3H).</div></div><div id="sec5_2_2_38" class="NLM_sec NLM_sec_level_4"><div id="ac_i65" class="anchor-spacer"></div><h5 class="article-section__title" id="_i65"> (<i>S</i>)-4-(5-((Cyclopropylamino)methyl)-2,4-difluorophenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-amine (<b>6p</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>5p</b> (58 mg, 0.14 mmol) according to a similar procedure as for the preparation of <b>6a</b> in 19% yield. LCMS <i>m</i>/<i>z</i> 312.3 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.32 (t, <i>J</i> = 9.0 Hz, 1H), 6.77 (dd, <i>J</i> = 11.9, 9.6 Hz, 1H), 3.79–3.89 (m, 2H), 2.96 (ddd, <i>J</i> = 12.1, 6.4, 3.7 Hz, 1H), 2.67 (ddd, <i>J</i> = 12.2, 10.6, 3.7 Hz, 1H), 2.37 (ddd, <i>J</i> = 14.0, 6.4, 3.7 Hz, 1H), 2.06–2.12 (m, 1H), 1.88 (ddd, <i>J</i> = 14.0, 10.4, 3.7 Hz, 1H), 1.59 (d, <i>J</i> = 1.2 Hz, 3H), 0.40–0.47 (m, 2H), 0.34–0.40 (m, 2H).</div></div><div id="sec5_2_2_39" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66"> (<i>S</i>)-4-(5-(((Cyclopropylmethyl)amino)methyl)-2,4-difluorophenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-amine (<b>6q</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>5q</b> (38 mg, 0.09 mmol) according to a similar procedure as for the preparation of <b>6a</b> in 34% yield. LCMS <i>m</i>/<i>z</i> 327.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.32 (t, <i>J</i> = 9.2 Hz, 1H), 6.75 (dd, <i>J</i> = 11.9, 9.6 Hz, 1H), 3.80 (s, 2H), 2.96 (ddd, <i>J</i> = 12.2, 6.7, 3.7 Hz, 1H), 2.67 (ddd, <i>J</i> = 12.3, 10.3, 3.9 Hz, 1H), 2.39–2.52 (m, 2H), 2.34 (ddd, <i>J</i> = 14.0, 6.7, 3.9 Hz, 1H), 1.89 (ddd, <i>J</i> = 14.0, 10.4, 3.7 Hz, 1H), 1.58 (d, <i>J</i> = 1.6 Hz, 3H), 0.88–1.03 (m, 1H), 0.41–0.50 (m, 2H), 0.04 to 0.13 (m, 2H).</div></div><div id="sec5_2_2_40" class="NLM_sec NLM_sec_level_4"><div id="ac_i67" class="anchor-spacer"></div><h5 class="article-section__title" id="_i67"> (<i>S</i>)-4-(5-(((1-(Difluoromethyl)cyclopropyl)amino)methyl)-2,4-difluorophenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-amine (<b>6r</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>5r</b> (39 mg, 0.08 mmol) according to a similar procedure as for the preparation of <b>6a</b> in 58% yield. LCMS <i>m</i>/<i>z</i> 362.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.35 (t, <i>J</i> = 9.0 Hz, 1H), 6.69–6.80 (m, 1H), 5.45–5.79 (m, 1H), 4.29 (br s, 2H), 3.98 (d, <i>J</i> = 7.0 Hz, 2H), 2.96 (ddd, <i>J</i> = 12.1, 6.6, 3.9 Hz, 1H), 2.67 (ddd, <i>J</i> = 12.1, 10.5, 3.5 Hz, 1H), 2.35 (ddd, <i>J</i> = 14.0, 6.6, 3.5 Hz, 1H), 2.05 (t, <i>J</i> = 6.8 Hz, 1H), 1.88 (ddd, <i>J</i> = 14.0, 10.4, 3.7 Hz, 1H), 1.52–1.62 (m, 3H), 0.78–0.86 (m, 4H).</div></div><div id="sec5_2_2_41" class="NLM_sec NLM_sec_level_4"><div id="ac_i68" class="anchor-spacer"></div><h5 class="article-section__title" id="_i68"> (<i>S</i>)-1-((5-(2-Amino-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-4-yl)-2,4-difluorobenzyl) amino)cyclopropane-1-carbonitrile (<b>6s</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>5s</b> (51 mg, 0.12 mmol) according to a similar procedure as for the preparation of <b>6a</b> in 48% yield. LCMS <i>m</i>/<i>z</i> 337.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.34 (t, <i>J</i> = 9.0 Hz, 1H), 6.78 (dd, <i>J</i> = 11.7, 9.4 Hz, 1H), 3.90–4.02 (m, 2H), 2.95 (ddd, <i>J</i> = 12.2, 6.5, 3.9 Hz, 1H), 2.69 (ddd, <i>J</i> = 12.1, 10.5, 3.5 Hz, 1H), 2.36 (ddd, <i>J</i> = 14.0, 6.6, 3.5 Hz, 1H), 1.88 (ddd, <i>J</i> = 14.0, 10.5, 3.5 Hz, 1H), 1.54–1.61 (m, 3H), 1.16–1.25 (m, 2H), 1.00–1.09 (m, 2H).</div></div><div id="sec5_2_2_42" class="NLM_sec NLM_sec_level_4"><div id="ac_i69" class="anchor-spacer"></div><h5 class="article-section__title" id="_i69"> (<i>S</i>)-4-(2,4-Difluoro-5-(((3-(trifluoromethyl)oxetan-3-yl)amino)methyl)phenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-amine (<b>6t</b>)</h5><div class="NLM_p last">To an ethanolic solution of <b>5t</b> (26 mg, 0.052 mmol) was added hydrazine monohydrate (27.6 μL, 0.364 mmol). The resulting solution was allowed to stir at rt for 4 h, at which point the reaction was concentrated under reduced pressure. The residue was subjected to silica chromatography using a 10% MeOH/1% NH<sub>4</sub>OH/89% CH<sub>2</sub>Cl<sub>2</sub> mixture as eluent to yield <b>6t</b> as a colorless oil. Yield: 31%. LCMS <i>m</i>/<i>z</i> 396.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.45 (t, <i>J</i> = 9.0 Hz, 1H), 6.80 (dd, <i>J</i> = 11.7, 9.8 Hz, 1H), 4.77 (dd, <i>J</i> = 7.0, 1.6 Hz, 2H), 4.61 (d, <i>J</i> = 6.2 Hz, 2H), 3.88 (d, <i>J</i> = 7.4 Hz, 2H), 2.94–3.04 (m, 1H), 2.64–2.75 (m, 1H), 2.33 (ddd, <i>J</i> = 13.8, 6.8, 3.5 Hz, 1H), 1.82–1.99 (m, 2H), 1.59 (d, <i>J</i> = 1.2 Hz, 3H).</div></div><div id="sec5_2_2_43" class="NLM_sec NLM_sec_level_4"><div id="ac_i70" class="anchor-spacer"></div><h5 class="article-section__title" id="_i70"> (<i>S</i>)-4-(2,4-Difluoro-5-(((1-(trifluoromethyl)cyclopropyl)amino)methyl)phenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-amine (<b>6u</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>5u</b> (114 mg, 0.238 mmol) according to a similar procedure as for the preparation of <b>6a</b> in 63% yield. LCMS <i>m</i>/<i>z</i> 380.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.32 (t, <i>J</i> = 9.0 Hz, 1H), 6.70–6.79 (m, 1H), 3.92–4.03 (m, 2H), 2.90–2.99 (m, 1H), 2.60–2.71 (m, 1H), 2.30–2.41 (m, 1H), 1.97–2.10 (m, 1H), 1.83–1.93 (m, 1H), 1.58 (s, 3H), 0.99–1.06 (m, 2H), 0.85–0.94 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 160.8, 158.4, 150.8, 130.6, 129.4, 128.4, 125.6, 122.8, 104.5, 56.1, 44.6, 39.9, 30.4, 29.4, 23.6, 11.7. HRMS calcd for C<sub>16</sub>H<sub>18</sub>N<sub>3</sub>F<sub>5</sub>SNa (M + Na) 402.1017, found 402.1034.</div></div><div id="sec5_2_2_44" class="NLM_sec NLM_sec_level_4"><div id="ac_i71" class="anchor-spacer"></div><h5 class="article-section__title" id="_i71"> <i>tert</i>-Butyl ((4<i>S</i>,6<i>R</i>)-4-(2,4-Difluoro-5-formylphenyl)-4,6-dimethyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl)carbamate (<b>10</b>)</h5><div class="NLM_p last">To a cooled solution (−78 °C) of <b>9</b><a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> (230 mg, 0.53 mmol) in anhydrous ether (5.3 mL) was added methyllithium (0.4 mL, 0.61 mmol) dropwise. The mixture was stirred for 30 min before <i>n</i>-BuLi (0.27 mL, 0.74 mmol) was added dropwise at −78 °C. The reaction mixture was stirred for another 30 min before the addition of DMF (0.41 mL, 5.3 mmol) in one portion. The reaction was stirred for 1 h and slowly warmed up to −20 °C, then quenched with aq NH<sub>4</sub>Cl (10 mL). The layers were separated, and the aqueous layer was extracted with EtOAc (2×). The combined organic layers were washed with brine (1×), dried (Na<sub>2</sub>SO<sub>4</sub>), concentrated, and purified by silica chromatography using a 0–40% EtOAc/heptane gradient to yield the product as a colorless solid. Yield: 89%. LCMS <i>m</i>/<i>z</i> 385.3 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.22 (s, 1H), 7.74 (t, <i>J</i> = 8.4 Hz, 1H), 6.93 (dd, <i>J</i> = 11.7, 98 Hz, 1H), 2.65–2.86 (m, 2H), 1.70–1.75 (m, 1H), 1.68 (s, 3H), 1.51 (s, 9H), 1.24 (d, <i>J</i> = 6.6 Hz, 3H).</div></div><div id="sec5_2_2_45" class="NLM_sec NLM_sec_level_4"><div id="ac_i72" class="anchor-spacer"></div><h5 class="article-section__title" id="_i72"> <i>tert</i>-Butyl ((4<i>S</i>,6<i>R</i>)-4-(2,4-Difluoro-5-(((1-(trifluoromethyl)cyclopropyl)amino)methyl)-phenyl)-4,6-dimethyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl)carbamate (<b>11</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>10</b> (30 mg, 0.08 mmol) and 1-(trifluoromethyl)cyclopropan-1-amine (39 mg, 0.31 mmol) according to a similar procedure as for the preparation of <b>5a</b> in 93% yield. LCMS <i>m</i>/<i>z</i> 494.4 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.21 (t, <i>J</i> = 8.6 Hz, 1H), 6.75–6.85 (m, 1H), 4.00 (br s, 2H), 2.81 (d, <i>J</i> = 13.3 Hz, 2H), 2.02–2.15 (m, 1H), 1.71 (s, 3H), 1.54 (s, 9H), 1.23–1.33 (m, 3H), 1.00–1.11 (m, 2H), 0.86–0.97 (m, 2H).</div></div><div id="sec5_2_2_46" class="NLM_sec NLM_sec_level_4"><div id="ac_i73" class="anchor-spacer"></div><h5 class="article-section__title" id="_i73"> (4<i>S</i>,6<i>R</i>)-4-(2,4-Difluoro-5-(((1-(trifluoromethyl)cyclopropyl)amino)methyl)phenyl)-4,6-dimethyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-amine (<b>12</b>)</h5><div class="NLM_p last">The title compound was prepared from <b>11</b> (35 mg, 0.07 mmol) according to a similar procedure as for the preparation of <b>6a</b> in 19% yield. LCMS <i>m</i>/<i>z</i> 394.3 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.07 (t, <i>J</i> = 9.0 Hz, 1H), 6.67 (dd, <i>J</i> = 11.7, 9.4 Hz, 1H), 3.79–3.98 (m, 2H), 2.66–2.73 (m, 1H), 2.56–2.65 (m, 1H), 1.91–2.03 (m, 1H), 1.55 (s, 3H), 1.15 (d, <i>J</i> = 6.6 Hz, 3H), 0.92–0.98 (m, 2H), 0.77–0.86 (m, 2H).</div></div><div id="sec5_2_2_47" class="NLM_sec NLM_sec_level_4"><div id="ac_i74" class="anchor-spacer"></div><h5 class="article-section__title" id="_i74"> <i>N</i>-((4a<i>R</i>,6<i>R</i>,8a<i>S</i>)-8a-(5-Cyano-2,4-difluorophenyl)-6-(fluoromethyl)-4,4a,5,6,8,8a-hexa-hydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl)benzamide (<b>14</b>)</h5><div class="NLM_p last">An oven-dried pressure tube, equipped with a stir bar, was charged with <b>13</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (19.0 g, 38.0 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (0.438 g, 0.761 mmol), dppf (0.888 g, 1.52 mmol), zinc (0.302 g, 4.57 mmol), and Zn(CN)<sub>2</sub> (3.35 g, 28.5 mmol). After the flask had been purged with N<sub>2</sub>, DMA (70 mL, anhydrous) was added to yield a black solution, which was heated to 130 °C for 16 h. The reaction mixture was cooled and partitioned between EtOAc and NaHCO<sub>3</sub> (aq satd). The organic layer was isolated and the aq was back-extracted with EtOAc (3×). The combined organics were washed with H<sub>2</sub>O (2×) and with brine (1×), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. Flash column chromatography of the organic crude, using a gradient of EtOAc in heptanes (0–100%) afforded <b>13</b> (14.5 g, 32.5 mmol, 85% yield) as a white solid.</div></div><div id="sec5_2_2_48" class="NLM_sec NLM_sec_level_4"><div id="ac_i75" class="anchor-spacer"></div><h5 class="article-section__title" id="_i75"> <i>N</i>-((4a<i>R</i>,6<i>R</i>,8a<i>S</i>)-8a-(5-(Aminomethyl)-2,4-difluorophenyl)-6-(fluoromethyl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl)benzamide (<b>15</b>)</h5><div class="NLM_p last">To a metal pressure vessel equipped with a stir bar was added H<sub>2</sub>O (40 mL) followed by RaNi (24 g, wet). The H<sub>2</sub>O layer was decanted (with a bare minimum left behind to keep the RaNi wet). This process was repeated 3× with H<sub>2</sub>O, followed by 3× with EtOH. To the final EtOH solution of RaNi was added EtOH (140 mL). A solution of <b>13</b> (14.48 g, 32.5 mmol) in THF (140 mL, anhydrous) and TEA (20 mL, 196 mmol) was added to the vessel, followed by addition of Boc anhydride (22 g, 196 mmol). The reaction vessel was closed and purged with N<sub>2</sub> (3×) followed by H<sub>2</sub> (3×). Once the purging was completed, the reaction vessel was placed under a H<sub>2</sub> atmosphere of 70 PSI and was left stirring at rt until complete consumption of starting material was observed. The reaction mixture was filtered through a Celite pad, which was then washed 3× with MeOH. The filtrates were concentrated under reduced pressure and redissolved in MeOH (300 mL). The resulting solution was treated with HCl (4 M in dioxane, 162.6 mL, 650 mmol). Once the Boc-deprotection was complete, the reaction mixture was concentrated under reduced pressure, redissolved in CH<sub>2</sub>Cl<sub>2</sub>, and treated with NaOH (1 N, 1 L, aq). The resulting biphasic solution was left stirring at rt for 15 min. After that time, the layers were separated and the aq layer was washed with CH<sub>2</sub>Cl<sub>2</sub> (3 × 200 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. Flash column chromatography of the organic crude, using a gradient of MeOH in CH<sub>2</sub>Cl<sub>2</sub> (0–5%), afforded <b>14</b> (9.0 g, 20 mmol, 61% yield) as a white solid.</div></div><div id="sec5_2_2_49" class="NLM_sec NLM_sec_level_4"><div id="ac_i76" class="anchor-spacer"></div><h5 class="article-section__title" id="_i76"> (4a<i>R</i>,6<i>R</i>,8a<i>S</i>)-8a-(2,4-Difluoro-5-(((2,2,2-trifluoroethyl)amino)methyl)phenyl)-6-(fluoromethyl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-amine (<b>16</b>)</h5><div class="NLM_p">In a pressure tube equipped with a stir bar, under N<sub>2</sub>, an acetonitrile (225 mL, anhydrous) solution of <b>15</b> (4.76 g, 10.6 mmol) was treated with TEA (2.21 mL, 15.9 mmol) and 2,2,2-trifluoroethyl trifluoromethanesulfonate (2.29 mL, 15.9 mmol). The resulting solution was stirred at 70 °C until the starting material had been completely consumed. The reaction mixture was cooled down to rt and concentrated under reduced pressure. The organic crude was partitioned between H<sub>2</sub>O (150 mL) and EtOAc (150 mL). The layers were separated, and the aq layer was back-extracted with EtOAc (2×). The combined organics were then washed with brine (1×), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to afford <i>N</i>-((4a<i>R</i>,6<i>R</i>,8a<i>S</i>)-8a-(2,4-difluoro-5-(((2,2,2-trifluoroethyl)amino)methyl)phenyl)-6-(fluoromethyl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl)benzamide (4.72 g, 8.88 mmol, 84% yield) as a yellow solid.</div><div class="NLM_p last">DBU (0.947 mL, 6.01 mmol) was added to a methanol solution (407 mL, anhydrous) of <i>N</i>-((4a<i>R</i>,6<i>R</i>,8a<i>S</i>)-8a-(2,4-difluoro-5-(((2,2,2-trifluoroethyl)amino)methyl)phenyl)-6-(fluoromethyl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl)benzamide (4.58 g, 8.62 mmol). The resulting solution was heated to 70 °C until complete consumption of starting material was observed. The reaction mixture was concentrated under reduced pressure. Flash column chromatography of the organic crude, using a gradient of MeOH in CH<sub>2</sub>Cl<sub>2</sub> (0–20%), afforded <b>16</b> (2.60 g, 6.08 mmol, 71% yield) as a white foam. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.43–1.51 (m, 1H) 1.87 (qd, <i>J</i> = 12.3, 2.5 Hz, 1H) 2.62 (dd, <i>J</i> = 12.1, 2.3 Hz, 1H) 2.87–3.00 (m, 2H) 3.08–3.21 (m, 2H) 3.82 (d, <i>J</i> = 11.3 Hz, 1H) 3.86–3.99 (m, 3H) 4.10 (dd, <i>J</i> = 11.1, 2.2 Hz, 1H) 4.34–4.46 (m, 1H) 4.46–4.58 (m, 1H) 4.94 (br s, 1H) 6.81 (dd, <i>J</i> = 11.7, 9.4 Hz, 1H) 7.34 (t, <i>J</i> = 8.8 Hz, 1H). <sup>13</sup>C NMR (400 MHz, CDCl<sub>3</sub>) δ 26.55, 28.46, 28.97, 46.29, 58.31, 75.37, 84.36, 86.06, 104.92, 122.18, 124.95, 132.54, 157.17, 159.08, 159.69, 161.56.</div></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i77"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01451">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58081" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58081" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01451" class="ext-link">10.1021/acs.jmedchem.6b01451</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Data collection and refinement statistics for crystal structures of BACE1 with <b>6u</b> and <b>16</b>, and CYP 2D6 with <b>6u</b> and <b>12</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01451/suppl_file/jm6b01451_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01451/suppl_file/jm6b01451_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01451/suppl_file/jm6b01451_si_001.pdf">jm6b01451_si_001.pdf (218.21 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01451/suppl_file/jm6b01451_si_002.csv">jm6b01451_si_002.csv (1.76 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Atomic coordinates and structure factors for the following BACE1 cocrystal structures have been deposited with the RCSB: compound <b>6u</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T1U">5T1U</a>), compound <b>16</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T1W">5T1W</a>). Atomic coordinates and structure factors have been desposited with the RCSB for crystal structures of CYP 2D6 complexed with compound <b>6u</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TFT">5TFT</a>), and with compound <b>12</b> (PDB:<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TFU">5TFU</a>).</p><div class="testing" data-doi="10.1021/acs.jmedchem.6b01451" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57241" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57241" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher R. Butler</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience
& Pain Medicinal Chemistry, ‡Neuroscience & Pain Research
Unit, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience & Pain Medicinal Chemistry, ∥Center of Chemistry Innovation
and Excellence, ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Molecular
and Experimental Medicine, The Scripps Research
Institute, 10550 Torrey Pines Road, La Jolla, California 92024, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9387-5011" title="Orcid link">http://orcid.org/0000-0002-9387-5011</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#87e4eff5eef4f3e8f7efe2f5a9f5a9e5f2f3ebe2f5c7f7e1eefde2f5a9e4e8ea"><span class="__cf_email__" data-cfemail="1d7e756f746e69726d75786f336f337f686971786f5d6d7b7467786f337e7270">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin Ogilvie</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience
& Pain Medicinal Chemistry, ‡Neuroscience & Pain Research
Unit, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience & Pain Medicinal Chemistry, ∥Center of Chemistry Innovation
and Excellence, ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Molecular
and Experimental Medicine, The Scripps Research
Institute, 10550 Torrey Pines Road, La Jolla, California 92024, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luis Martinez-Alsina</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience
& Pain Medicinal Chemistry, ‡Neuroscience & Pain Research
Unit, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience & Pain Medicinal Chemistry, ∥Center of Chemistry Innovation
and Excellence, ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Molecular
and Experimental Medicine, The Scripps Research
Institute, 10550 Torrey Pines Road, La Jolla, California 92024, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gabriela Barreiro</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience
& Pain Medicinal Chemistry, ‡Neuroscience & Pain Research
Unit, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience & Pain Medicinal Chemistry, ∥Center of Chemistry Innovation
and Excellence, ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Molecular
and Experimental Medicine, The Scripps Research
Institute, 10550 Torrey Pines Road, La Jolla, California 92024, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elizabeth M. Beck</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience
& Pain Medicinal Chemistry, ‡Neuroscience & Pain Research
Unit, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience & Pain Medicinal Chemistry, ∥Center of Chemistry Innovation
and Excellence, ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Molecular
and Experimental Medicine, The Scripps Research
Institute, 10550 Torrey Pines Road, La Jolla, California 92024, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles E. Nolan</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience
& Pain Medicinal Chemistry, ‡Neuroscience & Pain Research
Unit, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience & Pain Medicinal Chemistry, ∥Center of Chemistry Innovation
and Excellence, ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Molecular
and Experimental Medicine, The Scripps Research
Institute, 10550 Torrey Pines Road, La Jolla, California 92024, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin Atchison</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience
& Pain Medicinal Chemistry, ‡Neuroscience & Pain Research
Unit, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience & Pain Medicinal Chemistry, ∥Center of Chemistry Innovation
and Excellence, ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Molecular
and Experimental Medicine, The Scripps Research
Institute, 10550 Torrey Pines Road, La Jolla, California 92024, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric Benvenuti</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience
& Pain Medicinal Chemistry, ‡Neuroscience & Pain Research
Unit, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience & Pain Medicinal Chemistry, ∥Center of Chemistry Innovation
and Excellence, ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Molecular
and Experimental Medicine, The Scripps Research
Institute, 10550 Torrey Pines Road, La Jolla, California 92024, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leanne Buzon</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience
& Pain Medicinal Chemistry, ‡Neuroscience & Pain Research
Unit, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience & Pain Medicinal Chemistry, ∥Center of Chemistry Innovation
and Excellence, ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Molecular
and Experimental Medicine, The Scripps Research
Institute, 10550 Torrey Pines Road, La Jolla, California 92024, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shawn Doran</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience
& Pain Medicinal Chemistry, ‡Neuroscience & Pain Research
Unit, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience & Pain Medicinal Chemistry, ∥Center of Chemistry Innovation
and Excellence, ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Molecular
and Experimental Medicine, The Scripps Research
Institute, 10550 Torrey Pines Road, La Jolla, California 92024, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cathleen Gonzales</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience
& Pain Medicinal Chemistry, ‡Neuroscience & Pain Research
Unit, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience & Pain Medicinal Chemistry, ∥Center of Chemistry Innovation
and Excellence, ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Molecular
and Experimental Medicine, The Scripps Research
Institute, 10550 Torrey Pines Road, La Jolla, California 92024, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher J. Helal</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience
& Pain Medicinal Chemistry, ‡Neuroscience & Pain Research
Unit, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience & Pain Medicinal Chemistry, ∥Center of Chemistry Innovation
and Excellence, ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Molecular
and Experimental Medicine, The Scripps Research
Institute, 10550 Torrey Pines Road, La Jolla, California 92024, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xinjun Hou</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience
& Pain Medicinal Chemistry, ‡Neuroscience & Pain Research
Unit, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience & Pain Medicinal Chemistry, ∥Center of Chemistry Innovation
and Excellence, ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Molecular
and Experimental Medicine, The Scripps Research
Institute, 10550 Torrey Pines Road, La Jolla, California 92024, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mei-Hui Hsu</span> - <span class="hlFld-Affiliation affiliation">Molecular
and Experimental Medicine, The Scripps Research
Institute, 10550 Torrey Pines Road, La Jolla, California 92024, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric F. Johnson</span> - <span class="hlFld-Affiliation affiliation">Molecular
and Experimental Medicine, The Scripps Research
Institute, 10550 Torrey Pines Road, La Jolla, California 92024, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kimberly Lapham</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience
& Pain Medicinal Chemistry, ‡Neuroscience & Pain Research
Unit, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience & Pain Medicinal Chemistry, ∥Center of Chemistry Innovation
and Excellence, ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Molecular
and Experimental Medicine, The Scripps Research
Institute, 10550 Torrey Pines Road, La Jolla, California 92024, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lorraine Lanyon</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience
& Pain Medicinal Chemistry, ‡Neuroscience & Pain Research
Unit, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience & Pain Medicinal Chemistry, ∥Center of Chemistry Innovation
and Excellence, ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Molecular
and Experimental Medicine, The Scripps Research
Institute, 10550 Torrey Pines Road, La Jolla, California 92024, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin Parris</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience
& Pain Medicinal Chemistry, ‡Neuroscience & Pain Research
Unit, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience & Pain Medicinal Chemistry, ∥Center of Chemistry Innovation
and Excellence, ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Molecular
and Experimental Medicine, The Scripps Research
Institute, 10550 Torrey Pines Road, La Jolla, California 92024, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian T. O’Neill</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience
& Pain Medicinal Chemistry, ‡Neuroscience & Pain Research
Unit, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience & Pain Medicinal Chemistry, ∥Center of Chemistry Innovation
and Excellence, ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Molecular
and Experimental Medicine, The Scripps Research
Institute, 10550 Torrey Pines Road, La Jolla, California 92024, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Riddell</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience
& Pain Medicinal Chemistry, ‡Neuroscience & Pain Research
Unit, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience & Pain Medicinal Chemistry, ∥Center of Chemistry Innovation
and Excellence, ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Molecular
and Experimental Medicine, The Scripps Research
Institute, 10550 Torrey Pines Road, La Jolla, California 92024, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ashley Robshaw</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience
& Pain Medicinal Chemistry, ‡Neuroscience & Pain Research
Unit, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience & Pain Medicinal Chemistry, ∥Center of Chemistry Innovation
and Excellence, ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Molecular
and Experimental Medicine, The Scripps Research
Institute, 10550 Torrey Pines Road, La Jolla, California 92024, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Felix Vajdos</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience
& Pain Medicinal Chemistry, ‡Neuroscience & Pain Research
Unit, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience & Pain Medicinal Chemistry, ∥Center of Chemistry Innovation
and Excellence, ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Molecular
and Experimental Medicine, The Scripps Research
Institute, 10550 Torrey Pines Road, La Jolla, California 92024, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael A. Brodney</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience
& Pain Medicinal Chemistry, ‡Neuroscience & Pain Research
Unit, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience & Pain Medicinal Chemistry, ∥Center of Chemistry Innovation
and Excellence, ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Molecular
and Experimental Medicine, The Scripps Research
Institute, 10550 Torrey Pines Road, La Jolla, California 92024, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d60e5050-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i79">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64241" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64241" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank David Karanian for toxicology expertise, Leslie Pustilnik, Stephen Noell, Carol Menard, and Theresa Dickinson for the generation of in vitro data and assay reagents, as well as Romelia Salomon-Ferrer, Katherine Brighty, and Pat Verhoest for helpful discussion in manuscript preparation. Use of the IMCA-CAT beamline 17-ID at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357. This work was supported in part by NIH grant GM031001. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Data collection for crystals of the P450 CYP 2D6 complexes was carried out at the Stanford Synchrotron Radiation Lightsource, a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences under Contact No. DE-AC02-762F00515. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the United States Department of Energy, Office of Biological and Environmental Research and by the National Center for Research Resources, Biomedical Technology Program, and NIGMS (including P41GM103393) of the National Institutes of Health.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i80" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i80"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i81" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i81"> Abbreviations Used</h2><tr><td class="NLM_term">BACE1</td><td class="NLM_def"><p class="first last">β-secretase</p></td></tr><tr><td class="NLM_term">sAPPβ</td><td class="NLM_def"><p class="first last">N-terminal ectodomain of APP</p></td></tr><tr><td class="NLM_term">C99</td><td class="NLM_def"><p class="first last">C-terminal fragment</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term">CatD</td><td class="NLM_def"><p class="first last">cathepsin D</p></td></tr><tr><td class="NLM_term">RPE</td><td class="NLM_def"><p class="first last">retinal pigment epithelium</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>b,u</sub>/<i>C</i><sub>p,u</sub></td><td class="NLM_def"><p class="first last">ratio of unbound concentration in brain to the unbound concentration in plasma</p></td></tr><tr><td class="NLM_term">CFA</td><td class="NLM_def"><p class="first last">cell-free assay</p></td></tr><tr><td class="NLM_term">WCA</td><td class="NLM_def"><p class="first last">whole-cell assay</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsomes</p></td></tr><tr><td class="NLM_term">LipE</td><td class="NLM_def"><p class="first last">lipophilic efficiency</p></td></tr><tr><td class="NLM_term">EWG</td><td class="NLM_def"><p class="first last">electron-withdrawing group</p></td></tr><tr><td class="NLM_term">Er</td><td class="NLM_def"><p class="first last">efflux ratio</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>eff</sub></td><td class="NLM_def"><p class="first last">efficacious concentration</p></td></tr><tr><td class="NLM_term">DELFIA</td><td class="NLM_def"><p class="first last">dissociation-enhanced lanthanide fluorescent immunoassay</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75215" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75215" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 36 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allsop, D.</span><span> </span><span class="NLM_article-title">Amyloid deposition as the central event in the aetiology of Alzheimer’s disease</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span><span class="refDoi"> DOI: 10.1016/0165-6147(91)90609-V</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1016%2F0165-6147%2891%2990609-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1763432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADyaK3MXmslKktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1991&pages=383-388&author=J.+Hardyauthor=D.+Allsop&title=Amyloid+deposition+as+the+central+event+in+the+aetiology+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2F0165-6147%2891%2990609-V"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid deposition as the central event in the etiology of Alzheimer's disease</span></div><div class="casAuthors">Hardy, John; Allsop, David</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">383-8</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    </div><div class="casAbstract">A review with 50 refs. of pathol. and etiol. of Alzheimer's disease; the function of β-amyloid precursor protein and the mechanism of formation of cerebrovascular amyloid peptide β/A4; and the progression of the disease from amyloid formation to neurofibrillary tangles and cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryRPqP0OKB5rVg90H21EOLACvtfcHk0ljScjG4FerpAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXmslKktr8%253D&md5=7756055cd27bec2821c9926267a93872</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2F0165-6147%2891%2990609-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-6147%252891%252990609-V%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DAllsop%26aufirst%3DD.%26atitle%3DAmyloid%2520deposition%2520as%2520the%2520central%2520event%2520in%2520the%2520aetiology%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1991%26volume%3D12%26spage%3D383%26epage%3D388%26doi%3D10.1016%2F0165-6147%2891%2990609-V" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertram, L.</span><span> </span><span class="NLM_article-title">Twenty years of the Alzheimer’s disease amyloid hypothesis: A genetic perspective</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">555</span><span class="refDoi"> DOI: 10.1016/j.cell.2005.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1016%2Fj.cell.2005.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=15734686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVWnu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2005&pages=545-555&author=R.+E.+Tanziauthor=L.+Bertram&title=Twenty+years+of+the+Alzheimer%E2%80%99s+disease+amyloid+hypothesis%3A+A+genetic+perspective&doi=10.1016%2Fj.cell.2005.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective</span></div><div class="casAuthors">Tanzi, Rudolph E.; Bertram, Lars</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">545-555</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  From Alois Alzheimer's description of Auguste D.'s brain in 1907 to George Glenner's biochem. dissection of β-amyloid in 1984, the "amyloid hypothesis" of Alzheimer's disease has continued to gain support over the past two decades, particularly from genetic studies.  Here we assess the amyloid hypothesis based on both known and putative Alzheimer's disease genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPVQvwUmMmXrVg90H21EOLACvtfcHk0lh8KS3q8n_VUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVWnu7k%253D&md5=3f88dc7dda6b726429789c61d5992493</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2005.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2005.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DBertram%26aufirst%3DL.%26atitle%3DTwenty%2520years%2520of%2520the%2520Alzheimer%25E2%2580%2599s%2520disease%2520amyloid%2520hypothesis%253A%2520A%2520genetic%2520perspective%26jtitle%3DCell%26date%3D2005%26volume%3D120%26spage%3D545%26epage%3D555%26doi%3D10.1016%2Fj.cell.2005.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">Proteases and proteolysis in Alzheimer Disease: a multifactorial view on the disease process</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">494</span><span class="refDoi"> DOI: 10.1152/physrev.00023.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1152%2Fphysrev.00023.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=20393191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1erurjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2010&pages=465-494&author=B.+De+Strooper&title=Proteases+and+proteolysis+in+Alzheimer+Disease%3A+a+multifactorial+view+on+the+disease+process&doi=10.1152%2Fphysrev.00023.2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process</span></div><div class="casAuthors">De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">465-494</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  Alzheimer disease is characterized by the accumulation of abnormally folded protein fragments, i.e., amyloid beta peptide (Aβ) and tau that ppt. in amyloid plaques and neuronal tangles, resp.  In this review we discuss the complicated proteolytic pathways that are responsible for the generation and clearance of these fragments, and how disturbances in these pathways interact and provide a background for a novel understanding of Alzheimer disease as a multifactorial disorder.  Recent insights evolve from the static view that the morphol. defined plaques and tangles are disease driving towards a more dynamic, biochem. view in which the intermediary sol. Aβ oligomers and sol. tau fragments are considered as the main mediators of neurotoxicity.  The relevance of proteolytic pathways, centered on the generation and clearance of toxic Aβ, on the cleavage and nucleation of tau, and on the general proteostasis of the neurons, then becomes obvious.  Blocking or stimulating these pathways provide, or have the potential to provide, interesting drug targets, which raises the hope that we will be able to provide a cure for this dreadful disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrstXCXtuTzCrVg90H21EOLACvtfcHk0lh8KS3q8n_VUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1erurjF&md5=be45257bc56a5779b6ef7e18e98b0738</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00023.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00023.2009%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DProteases%2520and%2520proteolysis%2520in%2520Alzheimer%2520Disease%253A%2520a%2520multifactorial%2520view%2520on%2520the%2520disease%2520process%26jtitle%3DPhysiol.%2520Rev.%26date%3D2010%26volume%3D90%26spage%3D465%26epage%3D494%26doi%3D10.1152%2Fphysrev.00023.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovacs, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span> </span><span class="NLM_article-title">The beta-secretase enzyme BACE in health and Alzheimer’s disease: regulation, cell biology, function, and therapeutic potential</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">12787</span><span class="NLM_x">–</span> <span class="NLM_lpage">12794</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.3657-09.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1523%2FJNEUROSCI.3657-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=19828790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSit7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=12787-12794&author=R.+Vassarauthor=D.+M.+Kovacsauthor=R.+Yanauthor=P.+C.+Wong&title=The+beta-secretase+enzyme+BACE+in+health+and+Alzheimer%E2%80%99s+disease%3A+regulation%2C+cell+biology%2C+function%2C+and+therapeutic+potential&doi=10.1523%2FJNEUROSCI.3657-09.2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The β-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential</span></div><div class="casAuthors">Vassar, Robert; Kovacs, Dora M.; Yan, Riqiang; Wong, Philip C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">12787-12794</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">A review.  The β-amyloid (Aβ) peptide is the major constituent of amyloid plaques in Alzheimer's disease (AD) brain and is likely to play a central role in the pathogenesis of this devastating neurodegenerative disorder.  The β-secretase, β-site amyloid precursor protein cleaving enzyme (BACE1; also called Asp2, memapsin 2), is the enzyme responsible for initiating Aβ generation.  Thus, BACE is a prime drug target for the therapeutic inhibition of Aβ prodn. in AD.  Since its discovery 10 years ago, much has been learned about BACE.  This review summarizes BACE properties, describes BACE translation dysregulation in AD, and discusses BACE physiol. functions in sodium current, synaptic transmission, myelination, and schizophrenia.  The therapeutic potential of BACE will also be considered.  This is a summary of topics covered at a symposium held at the 39th annual meeting of the Society for Neuroscience and is not meant to be a comprehensive review of BACE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqGn8h_x-7_bVg90H21EOLACvtfcHk0lh8KS3q8n_VUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSit7bP&md5=a462ad002cf3801570725719d71647c6</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3657-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3657-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DKovacs%26aufirst%3DD.%2BM.%26aulast%3DYan%26aufirst%3DR.%26aulast%3DWong%26aufirst%3DP.%2BC.%26atitle%3DThe%2520beta-secretase%2520enzyme%2520BACE%2520in%2520health%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520regulation%252C%2520cell%2520biology%252C%2520function%252C%2520and%2520therapeutic%2520potential%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D12787%26epage%3D12794%26doi%3D10.1523%2FJNEUROSCI.3657-09.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Marks, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, M. J.</span><span> </span><span class="NLM_article-title">BACE and gamma-secretase characterization and their sorting as therapeutic targets to reduce amyloidogenesis</span> <span class="citation_source-journal">Neurochem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span><span class="refDoi"> DOI: 10.1007/s11064-009-0054-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1007%2Fs11064-009-0054-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=19760173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFentLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=181-210&author=N.+Marksauthor=M.+J.+Berg&title=BACE+and+gamma-secretase+characterization+and+their+sorting+as+therapeutic+targets+to+reduce+amyloidogenesis&doi=10.1007%2Fs11064-009-0054-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">BACE and γ-secretase characterization and their sorting as therapeutic targets to reduce amyloidogenesis</span></div><div class="casAuthors">Marks, Neville; Berg, Martin J.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-210</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Secretases are enzymes that process amyloid precursor protein (APP), a prototypic type-1 membrane protein.  This has led directly to discovery of novel aspartic proteases (β-secretase or BACE), a tetramer complex, γ-secretase (γ-SC) contg. presenilins, nicastrin, aph-1 and pen-2, and a new role for metalloprotease(s) of the ADAM family as α-secretases.  Recent advances in defining pathways that mediate endosomal/lysosomal/autophagic/exosomal trafficking now provide targets for new drugs to attenuate abnormal prodn. of fibril-forming products characteristic of Alzheimer's disease (AD).  A key to success includes not only characterization of relevant secretases, but mechanisms for sorting and transport of key metabolites to abnormal vesicles or sites for assembly of fibrils.  New developments highlighted here include an important role for an 'early recycling endosome' coated in a retromer complex contg. lipoprotein receptor LRP-II (SorLA) for switching APP to a non-amyloidogenic pathway for α-secretase processing, or to shuttle APP to a 'late endosome compartment' to form Aβ or AICD.  LRP11 (SorLA) is of particular importance since it decreases in sporadic AD whose etiol. is otherwise unknown.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptFxOS-WJwAbVg90H21EOLACvtfcHk0lhhwf_PDpmY-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFentLnJ&md5=312eb981ae39671456e316bf050166dc</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs11064-009-0054-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11064-009-0054-1%26sid%3Dliteratum%253Aachs%26aulast%3DMarks%26aufirst%3DN.%26aulast%3DBerg%26aufirst%3DM.%2BJ.%26atitle%3DBACE%2520and%2520gamma-secretase%2520characterization%2520and%2520their%2520sorting%2520as%2520therapeutic%2520targets%2520to%2520reduce%2520amyloidogenesis%26jtitle%3DNeurochem.%2520Res.%26date%3D2010%26volume%3D35%26spage%3D181%26epage%3D210%26doi%3D10.1007%2Fs11064-009-0054-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Jonsson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snaedal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulem, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudbjartsson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyte, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhangale, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huttenlocher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsdottir, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreassen, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palotie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrens, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, O. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorsteinsdottir, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, K.</span><span> </span><span class="NLM_article-title">A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">488</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span><span class="refDoi"> DOI: 10.1038/nature11283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1038%2Fnature11283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=22801501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=96-99&author=T.+Jonssonauthor=J.+K.+Atwalauthor=S.+Steinbergauthor=J.+Snaedalauthor=P.+V.+Jonssonauthor=S.+Bjornssonauthor=H.+Stefanssonauthor=P.+Sulemauthor=D.+Gudbjartssonauthor=J.+Maloneyauthor=K.+Hoyteauthor=A.+Gustafsonauthor=Y.+Liuauthor=Y.+Luauthor=T.+Bhangaleauthor=R.+R.+Grahamauthor=J.+Huttenlocherauthor=G.+Bjornsdottirauthor=O.+A.+Andreassenauthor=E.+G.+Jonssonauthor=A.+Palotieauthor=T.+W.+Behrensauthor=O.+T.+Magnussonauthor=A.+Kongauthor=U.+Thorsteinsdottirauthor=R.+J.+Wattsauthor=K.+Stefansson&title=A+mutation+in+APP+protects+against+Alzheimer%E2%80%99s+disease+and+age-related+cognitive+decline&doi=10.1038%2Fnature11283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">A mutation in APP protects against Alzheimer's disease and age-related cognitive decline</span></div><div class="casAuthors">Jonsson, Thorlakur; Atwal, Jasvinder K.; Steinberg, Stacy; Snaedal, Jon; Jonsson, Palmi V.; Bjornsson, Sigurbjorn; Stefansson, Hreinn; Sulem, Patrick; Gudbjartsson, Daniel; Maloney, Janice; Hoyte, Kwame; Gustafson, Amy; Liu, Yichin; Lu, Yanmei; Bhangale, Tushar; Graham, Robert R.; Huttenlocher, Johanna; Bjornsdottir, Gyda; Andreassen, Ole A.; Joensson, Erik G.; Palotie, Aarno; Behrens, Timothy W.; Magnusson, Olafur T.; Kong, Augustine; Thorsteinsdottir, Unnur; Watts, Ryan J.; Stefansson, Kari</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">488</span>
        (<span class="NLM_cas:issue">7409</span>),
    <span class="NLM_cas:pages">96-99</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prevalence of dementia in the Western world in people over the age of 60 has been estd. to be greater than 5%, about two-thirds of which are due to Alzheimer's disease.  The age-specific prevalence of Alzheimer's disease nearly doubles every 5 years after age 65, leading to a prevalence of greater than 25% in those over the age of 90 (ref. 3).  Here, to search for low-frequency variants in the amyloid-β precursor protein (APP) gene with a significant effect on the risk of Alzheimer's disease, we studied coding variants in APP in a set of whole-genome sequence data from 1795 Icelanders.  We found a coding mutation (A673T) in the APP gene that protects against Alzheimer's disease and cognitive decline in the elderly without Alzheimer's disease.  This substitution is adjacent to the aspartyl protease β-site in APP, and results in an approx. 40% redn. in the formation of amyloidogenic peptides in vitro.  The strong protective effect of the A673T substitution against Alzheimer's disease provides proof of principle for the hypothesis that reducing the β-cleavage of APP may protect against the disease.  Furthermore, as the A673T allele also protects against cognitive decline in the elderly without Alzheimer's disease, the two may be mediated through the same or similar mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4AFwQCLRQOLVg90H21EOLACvtfcHk0lhhwf_PDpmY-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M&md5=4db9cb2e3842d5a9d4af4ce102249b70</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnature11283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11283%26sid%3Dliteratum%253Aachs%26aulast%3DJonsson%26aufirst%3DT.%26aulast%3DAtwal%26aufirst%3DJ.%2BK.%26aulast%3DSteinberg%26aufirst%3DS.%26aulast%3DSnaedal%26aufirst%3DJ.%26aulast%3DJonsson%26aufirst%3DP.%2BV.%26aulast%3DBjornsson%26aufirst%3DS.%26aulast%3DStefansson%26aufirst%3DH.%26aulast%3DSulem%26aufirst%3DP.%26aulast%3DGudbjartsson%26aufirst%3DD.%26aulast%3DMaloney%26aufirst%3DJ.%26aulast%3DHoyte%26aufirst%3DK.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DBhangale%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DR.%2BR.%26aulast%3DHuttenlocher%26aufirst%3DJ.%26aulast%3DBjornsdottir%26aufirst%3DG.%26aulast%3DAndreassen%26aufirst%3DO.%2BA.%26aulast%3DJonsson%26aufirst%3DE.%2BG.%26aulast%3DPalotie%26aufirst%3DA.%26aulast%3DBehrens%26aufirst%3DT.%2BW.%26aulast%3DMagnusson%26aufirst%3DO.%2BT.%26aulast%3DKong%26aufirst%3DA.%26aulast%3DThorsteinsdottir%26aufirst%3DU.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DStefansson%26aufirst%3DK.%26atitle%3DA%2520mutation%2520in%2520APP%2520protects%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520age-related%2520cognitive%2520decline%26jtitle%3DNature%26date%3D2012%26volume%3D488%26spage%3D96%26epage%3D99%26doi%3D10.1038%2Fnature11283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Evin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hince, C.</span><span> </span><span class="NLM_article-title">BACE1 as a therapeutic target in Alzheimer’s disease: rationale and current status</span> <span class="citation_source-journal">Drugs Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">755</span><span class="NLM_x">–</span> <span class="NLM_lpage">764</span><span class="refDoi"> DOI: 10.1007/s40266-013-0099-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1007%2Fs40266-013-0099-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=23842796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVWmt7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2013&pages=755-764&author=G.+Evinauthor=C.+Hince&title=BACE1+as+a+therapeutic+target+in+Alzheimer%E2%80%99s+disease%3A+rationale+and+current+status&doi=10.1007%2Fs40266-013-0099-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 as a Therapeutic Target in Alzheimer's Disease: Rationale and Current Status</span></div><div class="casAuthors">Evin, Genevieve; Hince, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Drugs & Aging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">755-764</span>CODEN:
                <span class="NLM_cas:coden">DRAGE6</span>;
        ISSN:<span class="NLM_cas:issn">1170-229X</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a neurodegenerative disease of the central nervous system that causes dementia in a large percentage of the aged population and for which there are only symptomatic treatments.  Disease-modifying therapies that are currently being pursued are based on the amyloid cascade theory.  This states that accumulation of amyloid β (Aβ) in the brain triggers a cascade of cellular events leading to neurodegeneration.  Aβ, which is the major constituent of amyloid plaques, is a peptidic fragment derived from proteolytic processing of the amyloid precursor protein (APP) by sequential cleavages that involve β-site APP-cleaving enzyme 1 (BACE1) and γ-secretase.  Targeting BACE1 is a rational approach as its cleavage of APP is the rate-limiting step in Aβ prodn. and this enzyme is elevated in the brain of patients with AD.  Furthermore, knocking out the BACE1 gene in mice showed little apparent consequences.  Ten years of intensive research has led to the design of efficacious BACE1 inhibitors with favorable pharmacol. properties.  Several drug candidates have shown promising results in animal models, as they reduce amyloid plaque pathol. in the brain and rescue cognitive deficits.  Phase I clin. trials indicate that these drugs are well tolerated, and the results from further trials in AD patients are now awaited eagerly.  Yet, recent novel information on BACE1 biol., and the discovery that BACE1 cleaves a selection of substrates involved in myelination, retinal homeostasis, brain circuitry, and synaptic function, alert us to potential side effects of BACE1 inhibitors that will require further evaluation to provide a safe therapy for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaEqXQKm8PabVg90H21EOLACvtfcHk0lhhwf_PDpmY-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVWmt7bI&md5=356aae7bd5a2aeb1ea1c208be4b0a5f3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2Fs40266-013-0099-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40266-013-0099-3%26sid%3Dliteratum%253Aachs%26aulast%3DEvin%26aufirst%3DG.%26aulast%3DHince%26aufirst%3DC.%26atitle%3DBACE1%2520as%2520a%2520therapeutic%2520target%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520rationale%2520and%2520current%2520status%26jtitle%3DDrugs%2520Aging%26date%3D2013%26volume%3D30%26spage%3D755%26epage%3D764%26doi%3D10.1007%2Fs40266-013-0099-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tristani-Firouzi, M.</span><span> </span><span class="NLM_article-title">hERG potassium channels and cardiac arrhythmia</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">440</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span><span class="refDoi"> DOI: 10.1038/nature04710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1038%2Fnature04710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=16554806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1OlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=440&publication_year=2006&pages=463-469&author=M.+C.+Sanguinettiauthor=M.+Tristani-Firouzi&title=hERG+potassium+channels+and+cardiac+arrhythmia&doi=10.1038%2Fnature04710"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">hERG potassium channels and cardiac arrhythmia</span></div><div class="casAuthors">Sanguinetti, Michael C.; Tristani-Firouzi, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">440</span>
        (<span class="NLM_cas:issue">7083</span>),
    <span class="NLM_cas:pages">463-469</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  HERG potassium channels are essential for normal elec. activity in the heart.  Inherited mutations in the HERG gene cause long QT syndrome, a disorder that predisposes individuals to life-threatening arrhythmias.  Arrhythmia can also be induced by a blockage of hERG channels by a surprisingly diverse group of drugs.  This side effect is a common reason for drug failure in preclin. safety trials.  Insights gained from the crystal structures of other potassium channels have helped our understanding of the block of hERG channels and the mechanisms of gating.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopS3WBEpuAUrVg90H21EOLACvtfcHk0ljFSwD2HsPQ-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1OlsLs%253D&md5=3f355dcd51da3488d73c7c91cbe8d3b8</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1038%2Fnature04710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04710%26sid%3Dliteratum%253Aachs%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26aulast%3DTristani-Firouzi%26aufirst%3DM.%26atitle%3DhERG%2520potassium%2520channels%2520and%2520cardiac%2520arrhythmia%26jtitle%3DNature%26date%3D2006%26volume%3D440%26spage%3D463%26epage%3D469%26doi%3D10.1038%2Fnature04710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keating, M. T.</span><span> </span><span class="NLM_article-title">A mechanistic link between an inherited and an acquired cardiac arrhythmia: hERG encodes the IKr potassium channel</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span><span class="refDoi"> DOI: 10.1016/0092-8674(95)90340-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1016%2F0092-8674%2895%2990340-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=7736582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADyaK2MXlt1Kis7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1995&pages=299-307&author=M.+C.+Sanguinettiauthor=C.+Jiangauthor=M.+E.+Curranauthor=M.+T.+Keating&title=A+mechanistic+link+between+an+inherited+and+an+acquired+cardiac+arrhythmia%3A+hERG+encodes+the+IKr+potassium+channel&doi=10.1016%2F0092-8674%2895%2990340-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">A mechanistic link between an inherited and an acquired cardiac arrhythmia and HERG encodes the IKr potassium channel</span></div><div class="casAuthors">Sanguinetti, Michael C.; Jiang, Changan; Curran, Mark E.; Keating, Mark T.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">299-307</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Mutations in HERG cause an inherited cardiac arrhythmia, long QT syndrome (LQT).  To define the function of HERG, we expressed the protein in Xenopus oocytes.  The biophys. properties of expressed HERG are nearly identical to the rapidly activating delayed rectifier K+ current (IKr) in cardiac myocytes.  HERG current is K+ selective, declines with depolarizations above 0 mV, is activated by extracellular K+, and is blocked by lanthanum.  Interestingly, HERG current is not blocked by drugs that specifically block IKr, in cardiac myocytes.  These data indicate that HERG proteins form IKr, channels, but that an addnl. subunit may be required for drug sensitivity.  Since block of IKr is a known mechanism for drug-induced cardiac arrhythmias, the finding that HERG encodes IKr channels provides a mechanistic link between certain forms of inherited and acquired LQT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFu74-_mCypbVg90H21EOLACvtfcHk0ljFSwD2HsPQ-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlt1Kis7w%253D&md5=a417e4c5e8e9f1457a304b2651e025d0</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2895%2990340-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252895%252990340-2%26sid%3Dliteratum%253Aachs%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DCurran%26aufirst%3DM.%2BE.%26aulast%3DKeating%26aufirst%3DM.%2BT.%26atitle%3DA%2520mechanistic%2520link%2520between%2520an%2520inherited%2520and%2520an%2520acquired%2520cardiac%2520arrhythmia%253A%2520hERG%2520encodes%2520the%2520IKr%2520potassium%2520channel%26jtitle%3DCell%26date%3D1995%26volume%3D81%26spage%3D299%26epage%3D307%26doi%3D10.1016%2F0092-8674%2895%2990340-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Roden, D. M.</span><span> </span><span class="NLM_article-title">Drug-induced prolongation of the QT interval</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1022</span><span class="refDoi"> DOI: 10.1056/NEJMra032426</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1056%2FNEJMra032426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=14999113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFGjs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2004&pages=1013-1022&author=D.+M.+Roden&title=Drug-induced+prolongation+of+the+QT+interval&doi=10.1056%2FNEJMra032426"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-induced prolongation of the QT interval</span></div><div class="casAuthors">Roden, Dan M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1013-1022</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA8PoMXlMg57Vg90H21EOLACvtfcHk0ljFSwD2HsPQ-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFGjs7Y%253D&md5=a020a545700649d9914ed8dc61910244</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1056%2FNEJMra032426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra032426%26sid%3Dliteratum%253Aachs%26aulast%3DRoden%26aufirst%3DD.%2BM.%26atitle%3DDrug-induced%2520prolongation%2520of%2520the%2520QT%2520interval%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D350%26spage%3D1013%26epage%3D1022%26doi%3D10.1056%2FNEJMra032426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martenyi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monk, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathes, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergott, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timm, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith LaBell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhee, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ereshefsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocke, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span> </span><span class="NLM_article-title">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">16507</span><span class="NLM_x">–</span> <span class="NLM_lpage">16516</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.3647-11.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1523%2FJNEUROSCI.3647-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=22090477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=16507-16516&author=P.+C.+Mayauthor=R.+A.+Deanauthor=S.+L.+Loweauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=L.+N.+Boggsauthor=S.+A.+Monkauthor=B.+M.+Mathesauthor=D.+J.+Mergottauthor=B.+M.+Watsonauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=E.+Smith+LaBellauthor=C.+R.+Gonzalesauthor=M.+Nakanoauthor=S.+S.+Jheeauthor=M.+Yenauthor=L.+Ereshefskyauthor=T.+D.+Lindstromauthor=D.+O.+Calligaroauthor=P.+J.+Cockeauthor=D.+G.+Hallauthor=S.+Friedrichauthor=M.+Citronauthor=J.+E.+Audia&title=Robust+central+reduction+of+amyloid-%CE%B2+in+humans+with+an+orally+available%2C+non-peptidic+%CE%B2-secretase+inhibitor&doi=10.1523%2FJNEUROSCI.3647-11.2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span></div><div class="casAuthors">May, Patrick C.; Dean, Robert A.; Lowe, Stephen L.; Martenyi, Ferenc; Sheehan, Scott M.; Boggs, Leonard N.; Monk, Scott A.; Mathes, Brian M.; Mergott, Dustin J.; Watson, Brian M.; Stout, Stephanie L.; Timm, David E.; LaBell, Elizabeth Smith; Gonzales, Celedon R.; Nakano, Masako; Jhee, Stanford S.; Yen, Mark; Ereshefsky, Larry; Lindstrom, Terry D.; Calligaro, David O.; Cocke, Patrick J.; Hall, D. Greg; Friedrich, Stuart; Citron, Martin; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16507-16516</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ) is crit. for Alzheimer's disease (AD) pathogenesis.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  For more than a decade, BACE1 has been a prime target for designing drugs to prevent or treat AD.  However, development of such agents has turned out to be extremely challenging, with major hurdles in cell penetration, oral bioavailability/metabolic clearance, and brain access.  Using a fragment-based chem. strategy, we have generated LY2811376 [(S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine], the first orally available non-peptidic BACE1 inhibitor that produces profound Aβ-lowering effects in animals.  The biomarker changes obtained in preclin. animal models translate into man at doses of LY2811376 that were safe and well tolerated in healthy volunteers.  Prominent and long-lasting Aβ redns. in lumbar CSF were measured after oral dosing of 30 or 90 mg of LY2811376.  This represents the first translation of BACE1-driven biomarker changes in CNS from preclin. animal models to man.  Because of toxicol. findings identified in longer-term preclin. studies, this compd. is no longer progressing in clin. development.  However, BACE1 remains a viable target because the adverse effects reported here were recapitulated in LY2811376-treated BACE1 KO mice and thus are unrelated to BACE1 inhibition.  The magnitude and duration of central Aβ redn. obtainable with BACE1 inhibition positions this protease as a tractable small-mol. target through which to test the amyloid hypothesis in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqns_TvT2bZrVg90H21EOLACvtfcHk0liB_R9b4rWNMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F&md5=8f21f91ebd77e5fcf8b58b51c73a1a6b</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3647-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3647-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DSmith%2BLaBell%26aufirst%3DE.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DHall%26aufirst%3DD.%2BG.%26aulast%3DFriedrich%26aufirst%3DS.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DRobust%2520central%2520reduction%2520of%2520amyloid-%25CE%25B2%2520in%2520humans%2520with%2520an%2520orally%2520available%252C%2520non-peptidic%2520%25CE%25B2-secretase%2520inhibitor%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D16507%26epage%3D16516%26doi%3D10.1523%2FJNEUROSCI.3647-11.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Waring, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, C.</span><span> </span><span class="NLM_article-title">A quantitative assessment of hERG liability as a function of lipophilicity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1759</span><span class="NLM_x">–</span> <span class="NLM_lpage">1764</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2006.12.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1016%2Fj.bmcl.2006.12.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=17239590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1yrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1759-1764&author=M.+J.+Waringauthor=C.+Johnstone&title=A+quantitative+assessment+of+hERG+liability+as+a+function+of+lipophilicity&doi=10.1016%2Fj.bmcl.2006.12.061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative assessment of hERG liability as a function of lipophilicity</span></div><div class="casAuthors">Waring, Michael J.; Johnstone, Craig</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1759-1764</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The impact of lipophilicity as a factor contributing to hERG potency is assessed for a large dataset of compds. of differing ionization type.  This dataset is derived from compds. tested in the Ionworks-based in vitro electrophysiol. hERG assay at AstraZeneca.  Using logistic regression, a quantification of the risk assocd. with increasing lipophilicity is presented.  The anticipated differences between acidic, basic and neutral compds. are apparent in the data but lipophilicity is shown to be a stronger driver for hERG potency than might have been expected.  Simple rules defining target lipophilicity values for minimizing hERG liability are derived.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlCr9mVGL2-LVg90H21EOLACvtfcHk0liB_R9b4rWNMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1yrtb8%253D&md5=3819e045d7b773f129773f1ff567b980</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.12.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.12.061%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26aulast%3DJohnstone%26aufirst%3DC.%26atitle%3DA%2520quantitative%2520assessment%2520of%2520hERG%2520liability%2520as%2520a%2520function%2520of%2520lipophilicity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1759%26epage%3D1764%26doi%3D10.1016%2Fj.bmcl.2006.12.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, G.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of hERG optimizations: highlights and hang-ups</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5029</span><span class="NLM_x">–</span> <span class="NLM_lpage">5046</span><span class="refDoi"> DOI: 10.1021/jm060379l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060379l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5029-5046&author=C.+Jamiesonauthor=E.+M.+Moirauthor=Z.+Rankovicauthor=G.+Wishart&title=Medicinal+chemistry+of+hERG+optimizations%3A+highlights+and+hang-ups&doi=10.1021%2Fjm060379l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of hERG optimizations: Highlights and hang-ups</span></div><div class="casAuthors">Jamieson, Craig; Moir, Elizabeth M.; Rankovic, Zoran; Wishart, Grant</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5029-5046</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  A brief summary of the in silico, in vitro, and in vivo approaches employed to measure blockade of hERG and QT prolongation is detailed.  The discussion aims to summarize the approaches engaged to circumvent activity at hERG, identified through an extensive literature survey.  The optimizations are recorded as pairs of compds., which have been categorized in terms of the tactics employed to diminish hERG activity. Examn. of the properties of the compds. within each category has enabled formulation os some empirical guidelines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv6eM5w53KebVg90H21EOLACvtfcHk0liB_R9b4rWNMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D&md5=117c84a010f877c835b7dbc945996b92</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1021%2Fjm060379l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060379l%26sid%3Dliteratum%253Aachs%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DMoir%26aufirst%3DE.%2BM.%26aulast%3DRankovic%26aufirst%3DZ.%26aulast%3DWishart%26aufirst%3DG.%26atitle%3DMedicinal%2520chemistry%2520of%2520hERG%2520optimizations%253A%2520highlights%2520and%2520hang-ups%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5029%26epage%3D5046%26doi%3D10.1021%2Fjm060379l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Rochin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurbain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serneels, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fort, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raposo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Niel, G.</span><span> </span><span class="NLM_article-title">BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">10658</span><span class="NLM_x">–</span> <span class="NLM_lpage">10663</span><span class="refDoi"> DOI: 10.1073/pnas.1220748110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1073%2Fpnas.1220748110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=23754390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFejs7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=10658-10663&author=L.+Rochinauthor=I.+Hurbainauthor=L.+Serneelsauthor=C.+Fortauthor=B.+Wattauthor=P.+Leblancauthor=M.+S.+Marksauthor=B.+De+Strooperauthor=G.+Raposoauthor=G.+van+Niel&title=BACE2+processes+PMEL+to+form+the+melanosome+amyloid+matrix+in+pigment+cells&doi=10.1073%2Fpnas.1220748110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells</span></div><div class="casAuthors">Rochin, Leila; Hurbain, Ilse; Serneels, Lutgarde; Fort, Cecile; Watt, Brenda; Leblanc, Pascal; Marks, Michael S.; De Strooper, Bart; Raposo, Graca; van Niel, Guillaume</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">10658-10663,S10658/1-S10658/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Amyloids are often assocd. with pathol. processes such as in Alzheimer's disease (AD), but can also underlie physiol. processes such as pigmentation.  Formation of pathol. and functional amyloidogenic substrates can require precursor processing by proteases, as exemplified by the generation of Aβ peptide from amyloid precursor protein (APP) by beta-site APP cleaving enzyme (BACE)1 and γ-secretase.  Proteolytic processing of the pigment cell-specific Melanocyte Protein (PMEL) is also required to form functional amyloid fibrils during melanogenesis, but the enzymes involved are incompletely characterized.  Here we show that the BACE1 homolog BACE2 processes PMEL to generate functional amyloids.  BACE2 is highly expressed in pigment cells and Bace2-/- but not Bace1-/- mice display coat color defects, implying a specific role for BACE2 during melanogenesis.  By using biochem. and morphol. analyses, combined with RNA silencing, pharmacol. inhibition, and BACE2 overexpression in a human melanocytic cell line, we show that BACE2 cleaves the integral membrane form of PMEL within the juxtamembrane domain, releasing the PMEL luminal domain into endosomal precursors for the formation of amyloid fibrils and downstream melanosome morphogenesis.  These studies identify an amyloidogenic substrate of BACE2, reveal an important physiol. role for BACE2 in pigmentation, and highlight analogies in the generation of PMEL-derived functional amyloids and APP-derived pathol. amyloids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLBEney5KFyLVg90H21EOLACvtfcHk0lh8FDEabpvncg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFejs7rK&md5=3deb3f80dca6a32748aa6fe2e50c2df1</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1220748110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1220748110%26sid%3Dliteratum%253Aachs%26aulast%3DRochin%26aufirst%3DL.%26aulast%3DHurbain%26aufirst%3DI.%26aulast%3DSerneels%26aufirst%3DL.%26aulast%3DFort%26aufirst%3DC.%26aulast%3DWatt%26aufirst%3DB.%26aulast%3DLeblanc%26aufirst%3DP.%26aulast%3DMarks%26aufirst%3DM.%2BS.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DRaposo%26aufirst%3DG.%26aulast%3Dvan%2BNiel%26aufirst%3DG.%26atitle%3DBACE2%2520processes%2520PMEL%2520to%2520form%2520the%2520melanosome%2520amyloid%2520matrix%2520in%2520pigment%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D10658%26epage%3D10663%26doi%3D10.1073%2Fpnas.1220748110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Shimshek, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolly, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamurovic, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balavenkatraman, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morawiec, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreutzer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schelle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jucker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertschi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theil, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigot, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beltz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machauer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brzak, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrot, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumann, U.</span><span> </span><span class="NLM_article-title">Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">21917</span><span class="refDoi"> DOI: 10.1038/srep21917</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1038%2Fsrep21917" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=26912421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1eku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=21917&author=D.+R.+Shimshekauthor=L.+H.+Jacobsonauthor=C.+Kollyauthor=N.+Zamurovicauthor=K.+K.+Balavenkatramanauthor=L.+Morawiecauthor=R.+Kreutzerauthor=J.+Schelleauthor=M.+Juckerauthor=B.+Bertschiauthor=D.+Theilauthor=A.+Heierauthor=K.+Bigotauthor=K.+Beltzauthor=R.+Machauerauthor=I.+Brzakauthor=L.+Perrotauthor=U.+Neumann&title=Pharmacological+BACE1+and+BACE2+inhibition+induces+hair+depigmentation+by+inhibiting+PMEL17+processing+in+mice&doi=10.1038%2Fsrep21917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice</span></div><div class="casAuthors">Shimshek, Derya R.; Jacobson, Laura H.; Kolly, Carine; Zamurovic, Natasa; Balavenkatraman, Kamal Kumar; Morawiec, Laurent; Kreutzer, Robert; Schelle, Juliane; Jucker, Mathias; Bertschi, Barbara; Theil, Diethilde; Heier, Annabelle; Bigot, Karine; Beltz, Karen; Machauer, Rainer; Brzak, Irena; Perrot, Ludovic; Neumann, Ulf</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21917</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Melanocytes of the hair follicle produce melanin and are essential in detg. the differences in hair color.  Pigment cell-specific MELanocyte Protein (PMEL17) plays a crucial role in melanogenesis.  One of the crit. steps is the amyloid-like functional oligomerization of PMEL17.  Beta Site APP Cleaving Enzyme-2 (BACE2) and γ-secretase have been shown to be key players in generating the proteolytic fragments of PMEL17.  The β-secretase (BACE1) is responsible for the generation of amyloid-β (Aβ) fragments in the brain and is therefore proposed as a therapeutic target for Alzheimer's disease (AD).  Currently BACE1 inhibitors, most of which lack selectivity over BACE2, have demonstrated efficacious redn. of amyloid-β peptides in animals and the CSF of humans.  BACE2 knock-out mice have a deficiency in PMEL17 proteolytic processing leading to impaired melanin storage and hair depigmentation.  Here, we confirm BACE2-mediated inhibition of PMEL17 proteolytic processing in vitro in mouse and human melanocytes.  Furthermore, we show that wildtype as well as bace2+/- and bace2-/- mice treated with a potent dual BACE1/BACE2 inhibitor NB-360 display dose-dependent appearance of irreversibly depigmented hair.  Retinal pigmented epithelium showed no morphol. changes.  Our data demonstrates that BACE2 as well as addnl. BACE1 inhibition affects melanosome maturation and induces hair depigmentation in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtlQ-3Lxc4CLVg90H21EOLACvtfcHk0lh8FDEabpvncg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1eku7Y%253D&md5=e3641d48cc7fcf08c4502b5899a49066</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fsrep21917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep21917%26sid%3Dliteratum%253Aachs%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26aulast%3DKolly%26aufirst%3DC.%26aulast%3DZamurovic%26aufirst%3DN.%26aulast%3DBalavenkatraman%26aufirst%3DK.%2BK.%26aulast%3DMorawiec%26aufirst%3DL.%26aulast%3DKreutzer%26aufirst%3DR.%26aulast%3DSchelle%26aufirst%3DJ.%26aulast%3DJucker%26aufirst%3DM.%26aulast%3DBertschi%26aufirst%3DB.%26aulast%3DTheil%26aufirst%3DD.%26aulast%3DHeier%26aufirst%3DA.%26aulast%3DBigot%26aufirst%3DK.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DBrzak%26aufirst%3DI.%26aulast%3DPerrot%26aufirst%3DL.%26aulast%3DNeumann%26aufirst%3DU.%26atitle%3DPharmacological%2520BACE1%2520and%2520BACE2%2520inhibition%2520induces%2520hair%2520depigmentation%2520by%2520inhibiting%2520PMEL17%2520processing%2520in%2520mice%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D21917%26doi%3D10.1038%2Fsrep21917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokopcova, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H. J.</span><span> </span><span class="NLM_article-title">The evolution of amidine-based brain penetrant BACE1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2033</span><span class="NLM_x">–</span> <span class="NLM_lpage">2045</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.03.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1016%2Fj.bmcl.2014.03.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=24704031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2033-2045&author=D.+Oehlrichauthor=H.+Prokopcovaauthor=H.+J.+Gijsen&title=The+evolution+of+amidine-based+brain+penetrant+BACE1+inhibitors&doi=10.1016%2Fj.bmcl.2014.03.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of amidine-based brain penetrant BACE1 inhibitors</span></div><div class="casAuthors">Oehlrich, Daniel; Prokopcova, Hana; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2033-2045</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Beta site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors hold great potential as disease modifying anti-Alzheimer's drugs.  This digest provides an overview of the amidine contg. class of BACE1 inhibitors, of which multiple examples are now progressing through clin. trials.  The various structural modifications highlight the struggle to combine potency with the optimal properties for a brain penetrant BACE1 inhibitor, and illustrate the crowded competitive landscape.  This overview concludes with a summary of potential issues including substrate and target selectivity and a synopsis of the status of the current and past clin. assets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-4h1WxzUvbbVg90H21EOLACvtfcHk0liTc24Rd9BcCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D&md5=a929f7f1be0c7d2ff1a10fc5853de06b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.025%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%26atitle%3DThe%2520evolution%2520of%2520amidine-based%2520brain%2520penetrant%2520BACE1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2033%26epage%3D2045%26doi%3D10.1016%2Fj.bmcl.2014.03.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Woltering, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wostl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilpert, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers-Evans, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayweg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travagli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollastrini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marconi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabellieri, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guba, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narquizian, R.</span><span> </span><span class="NLM_article-title">BACE1 inhibitors: a head group scan on a series of amides</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4239</span><span class="NLM_x">–</span> <span class="NLM_lpage">4243</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1016%2Fj.bmcl.2013.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=23735744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovFaktLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4239-4243&author=T.+J.+Wolteringauthor=W.+Wostlauthor=H.+Hilpertauthor=M.+Rogers-Evansauthor=E.+Pinardauthor=A.+Maywegauthor=M.+Gobelauthor=D.+W.+Bannerauthor=J.+Benzauthor=M.+Travagliauthor=M.+Pollastriniauthor=G.+Marconiauthor=E.+Gabellieriauthor=W.+Gubaauthor=H.+Mauserauthor=M.+Andreiniauthor=H.+Jacobsenauthor=E.+Powerauthor=R.+Narquizian&title=BACE1+inhibitors%3A+a+head+group+scan+on+a+series+of+amides&doi=10.1016%2Fj.bmcl.2013.05.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 inhibitors: A head group scan on a series of amides</span></div><div class="casAuthors">Woltering, Thomas J.; Wostl, Wolfgang; Hilpert, Hans; Rogers-Evans, Mark; Pinard, Emmanuel; Mayweg, Alexander; Gobel, Martin; Banner, David W.; Benz, Jorg; Travagli, Massimiliano; Pollastrini, Martina; Marconi, Guido; Gabellieri, Emanuele; Guba, Wolfgang; Mauser, Harald; Andreini, Matteo; Jacobsen, Helmut; Power, Eoin; Narquizian, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4239-4243</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of amides bearing a variety of amidine head groups was investigated as BACE1 inhibitors with respect to inhibitory activity in a BACE1 enzyme as well as a cell-based assay.  Detn. of their basicity as well as their properties as substrates of P-glycoprotein revealed that a 2-amino-1,3-oxazine head group would be a suitable starting point for further development of brain penetrating compds. for potential Alzheimer's disease treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEF94wd3_rd7Vg90H21EOLACvtfcHk0liTc24Rd9BcCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovFaktLk%253D&md5=3da315c76199617083b762ea111057fd</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DWoltering%26aufirst%3DT.%2BJ.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DMayweg%26aufirst%3DA.%26aulast%3DGobel%26aufirst%3DM.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DBenz%26aufirst%3DJ.%26aulast%3DTravagli%26aufirst%3DM.%26aulast%3DPollastrini%26aufirst%3DM.%26aulast%3DMarconi%26aufirst%3DG.%26aulast%3DGabellieri%26aufirst%3DE.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DMauser%26aufirst%3DH.%26aulast%3DAndreini%26aufirst%3DM.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DPower%26aufirst%3DE.%26aulast%3DNarquizian%26aufirst%3DR.%26atitle%3DBACE1%2520inhibitors%253A%2520a%2520head%2520group%2520scan%2520on%2520a%2520series%2520of%2520amides%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4239%26epage%3D4243%26doi%3D10.1016%2Fj.bmcl.2013.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hilpert, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guba, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woltering, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wostl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayweg, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers-Evans, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humm, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krummenacher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muser, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnider, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozmen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergadano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochstrasser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuglstatter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David-Pierson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narquizian, R.</span><span> </span><span class="NLM_article-title">beta-Secretase (BACE1) inhibitors with high in vivo efficacy suitable for clinical evaluation in Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3980</span><span class="NLM_x">–</span> <span class="NLM_lpage">3995</span><span class="refDoi"> DOI: 10.1021/jm400225m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400225m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtVymuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3980-3995&author=H.+Hilpertauthor=W.+Gubaauthor=T.+J.+Wolteringauthor=W.+Wostlauthor=E.+Pinardauthor=H.+Mauserauthor=A.+V.+Maywegauthor=M.+Rogers-Evansauthor=R.+Hummauthor=D.+Krummenacherauthor=T.+Muserauthor=C.+Schniderauthor=H.+Jacobsenauthor=L.+Ozmenauthor=A.+Bergadanoauthor=D.+W.+Bannerauthor=R.+Hochstrasserauthor=A.+Kuglstatterauthor=P.+David-Piersonauthor=H.+Fischerauthor=A.+Polaraauthor=R.+Narquizian&title=beta-Secretase+%28BACE1%29+inhibitors+with+high+in+vivo+efficacy+suitable+for+clinical+evaluation+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm400225m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase (BACE1) Inhibitors with High in Vivo Efficacy Suitable for Clinical Evaluation in Alzheimer's Disease</span></div><div class="casAuthors">Hilpert, Hans; Guba, Wolfgang; Woltering, Thomas J.; Wostl, Wolfgang; Pinard, Emmanuel; Mauser, Harald; Mayweg, Alexander V.; Rogers-Evans, Mark; Humm, Roland; Krummenacher, Daniela; Muser, Thorsten; Schnider, Christian; Jacobsen, Helmut; Ozmen, Laurence; Bergadano, Alessandra; Banner, David W.; Hochstrasser, Remo; Kuglstatter, Andreas; David-Pierson, Pascale; Fischer, Holger; Polara, Alessandra; Narquizian, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3980-3995</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An extensive fluorine scan of 1,3-oxazines revealed the power of fluorine(s) to lower the pKa and thereby dramatically change the pharmacol. profile of this class of BACE1 inhibitors.  The CF3 substituted oxazine 89, a potent and highly brain penetrant BACE1 inhibitor, was able to reduce significantly CSF Aβ40 and 42 in rats at oral doses as low as 1 mg/kg.  The effect was long lasting, showing a significant redn. of Aβ40 and 42 even after 24 h.  In contrast to 89, compd. 1b lacking the CF3 group was virtually inactive in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmoKRrAxxHErVg90H21EOLACvtfcHk0ljX5WXICv9bQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtVymuro%253D&md5=e5d311d1c8fecfaed043d3a0bf16c168</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1021%2Fjm400225m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400225m%26sid%3Dliteratum%253Aachs%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DWoltering%26aufirst%3DT.%2BJ.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DMauser%26aufirst%3DH.%26aulast%3DMayweg%26aufirst%3DA.%2BV.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DHumm%26aufirst%3DR.%26aulast%3DKrummenacher%26aufirst%3DD.%26aulast%3DMuser%26aufirst%3DT.%26aulast%3DSchnider%26aufirst%3DC.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DBergadano%26aufirst%3DA.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DHochstrasser%26aufirst%3DR.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DDavid-Pierson%26aufirst%3DP.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DPolara%26aufirst%3DA.%26aulast%3DNarquizian%26aufirst%3DR.%26atitle%3Dbeta-Secretase%2520%2528BACE1%2529%2520inhibitors%2520with%2520high%2520in%2520vivo%2520efficacy%2520suitable%2520for%2520clinical%2520evaluation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3980%26epage%3D3995%26doi%3D10.1021%2Fjm400225m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rombouts, F. J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez-Lamenca, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Gool, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Molina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso de Diego, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokopcova, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borghys, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Brandt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surkyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Cleyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span> </span><span class="NLM_article-title">1,4-Oxazine β-secretase 1 (BACE1) inhibitors: from hit generation to orally bioavailable brain penetrant leads</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">8216</span><span class="NLM_x">–</span> <span class="NLM_lpage">8235</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01101</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01101" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFWktL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8216-8235&author=F.+J.+R.+Romboutsauthor=G.+Tresadernauthor=O.+Delgadoauthor=C.+Mart%C3%ADnez-Lamencaauthor=M.+Van+Goolauthor=A.+Garc%C3%ADa-Molinaauthor=S.+A.+Alonso+de+Diegoauthor=D.+Oehlrichauthor=H.+Prokopcovaauthor=J.+M.+Alonsoauthor=N.+Austinauthor=H.+Borghysauthor=S.+Van+Brandtauthor=M.+Surkynauthor=M.+De+Cleynauthor=A.+Vosauthor=R.+Alexanderauthor=G.+Macdonaldauthor=D.+Moecharsauthor=H.+Gijsenauthor=A.+A.+Trabanco&title=1%2C4-Oxazine+%CE%B2-secretase+1+%28BACE1%29+inhibitors%3A+from+hit+generation+to+orally+bioavailable+brain+penetrant+leads&doi=10.1021%2Facs.jmedchem.5b01101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14cR"><div class="casContent"><span class="casTitleNuber">14c</span><div class="casTitle"><span class="NLM_cas:atitle">1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors: From Hit Generation to Orally Bioavailable Brain Penetrant Leads</span></div><div class="casAuthors">Rombouts, Frederik J. R.; Tresadern, Gary; Delgado, Oscar; Martinez-Lamenca, Carolina; Van Gool, Michiel; Garcia-Molina, Aranzazu; Alonso de Diego, Sergio A.; Oehlrich, Daniel; Prokopcova, Hana; Alonso, Jose Manuel; Austin, Nigel; Borghys, Herman; Van Brandt, Sven; Surkyn, Michel; De Cleyn, Michel; Vos, Ann; Alexander, Richard; Macdonald, Gregor; Moechars, Dieder; Gijsen, Harrie; Trabanco, Andres A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8216-8235</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1,4-Oxazines are presented, which show good in vitro inhibition in enzymic and cellular BACE1 assays.  We describe lead optimization focused on reducing the amidine pKa while optimizing interactions in the BACE1 active site.  Our strategy permitted modulation of properties such as permeation and esp. P-glycoprotein efflux.  This led to compds. which were orally bioavailable, centrally active, and which demonstrated robust lowering of brain and CSF Aβ levels, resp., in mouse and dog models.  The amyloid lowering potential of these mols. makes them valuable leads in the search for new BACE1 inhibitors for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHVm9JF2kNa7Vg90H21EOLACvtfcHk0ljX5WXICv9bQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFWktL3L&md5=d3563a26a17a1c86c45a4f99b18be251</span></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01101%26sid%3Dliteratum%253Aachs%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%2BR.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DMart%25C3%25ADnez-Lamenca%26aufirst%3DC.%26aulast%3DVan%2BGool%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa-Molina%26aufirst%3DA.%26aulast%3DAlonso%2Bde%2BDiego%26aufirst%3DS.%2BA.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DAustin%26aufirst%3DN.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%26aulast%3DVos%26aufirst%3DA.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3D1%252C4-Oxazine%2520%25CE%25B2-secretase%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520from%2520hit%2520generation%2520to%2520orally%2520bioavailable%2520brain%2520penetrant%2520leads%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8216%26epage%3D8235%26doi%3D10.1021%2Facs.jmedchem.5b01101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span><span class="refDoi"> DOI: 10.1021/cn100008c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties&doi=10.1021%2Fcn100008c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0ljX5WXICv9bQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449%26doi%3D10.1021%2Fcn100008c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dislich, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtenthaler, S. F.</span><span> </span><span class="NLM_article-title">The membrane-bound aspartyl protease BACE1: molecular and functional properties in Alzheimer’s disease and beyond</span> <span class="citation_source-journal">Front. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="refDoi"> DOI: 10.3389/fphys.2012.00008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.3389%2Ffphys.2012.00008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=22363289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsFyitro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=8&author=B.+Dislichauthor=S.+F.+Lichtenthaler&title=The+membrane-bound+aspartyl+protease+BACE1%3A+molecular+and+functional+properties+in+Alzheimer%E2%80%99s+disease+and+beyond&doi=10.3389%2Ffphys.2012.00008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">The membrane-bound aspartyl protease BACE1: molecular and functional properties in Alzheimer's disease and beyond</span></div><div class="casAuthors">Dislich, Bastian; Lichtenthaler, Stefan F.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Membrane Physiology and Biophysics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">Feb.</span>),
    <span class="NLM_cas:pages">8</span>CODEN:
                <span class="NLM_cas:coden">FMPBBG</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  The β-site APP cleaving enzyme 1 (BACE1) is a transmembrane aspartyl protease involved in Alzheimer's disease (AD) pathogenesis and in myelination.  BACE1 initiates the generation of the pathogenic amyloid β-peptide, which makes BACE1 a major drug target for AD.  BACE1 also cleaves and activates neuregulin 1, thereby contributing to postnatal myelination, in particular in the peripheral nervous system.  Addnl. proteins are also cleaved by BACE1, but less is known about the physiol. consequences of their cleavage.  Recently, new phenotypes were described in BACE1-deficient mice.  Although it remains unclear through which BACE1 substrates they are mediated, the phenotypes suggest a versatile role of this protease for diverse physiol. processes.  This review summarizes the enzymic and cellular properties of BACE1 as well as its regulation by lipids, by transcriptional, and by translational mechanisms.  The main focus will be on the recent progress in understanding BACE1 function and its implication for potential mechanism-based side effects upon therapeutic inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQnIcCfG4zsbVg90H21EOLACvtfcHk0lh0vNsGOhjlzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsFyitro%253D&md5=b83b7fd1542cc2bba7d73b4710c26bcd</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.3389%2Ffphys.2012.00008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphys.2012.00008%26sid%3Dliteratum%253Aachs%26aulast%3DDislich%26aufirst%3DB.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26atitle%3DThe%2520membrane-bound%2520aspartyl%2520protease%2520BACE1%253A%2520molecular%2520and%2520functional%2520properties%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520beyond%26jtitle%3DFront.%2520Physiol.%26date%3D2012%26volume%3D3%26spage%3D8%26doi%3D10.3389%2Ffphys.2012.00008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Decourt, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marwan, N.</span><span> </span><span class="NLM_article-title">BACE1 as a potential biomarker for Alzheimer’s Disease</span> <span class="citation_source-journal">J. Alzheimers Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span><span class="refDoi"> DOI: 10.3233/JAD-2011-110017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.3233%2FJAD-2011-110017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=21403391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A280%3ADC%252BC3Mvms1Gjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=53-59&issue=Suppl+2&author=B.+S.+Decourtauthor=N.+Marwan&title=BACE1+as+a+potential+biomarker+for+Alzheimer%E2%80%99s+Disease&doi=10.3233%2FJAD-2011-110017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 as a potential biomarker for Alzheimer's disease</span></div><div class="casAuthors">Decourt Boris; Sabbagh Marwan N</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24 Suppl 2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">53-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The diagnosis of Alzheimer's disease (AD) relies principally on clinical criteria for probable and possible AD as defined by the NINCDS-ADRDRA.  The field is desperately lacking of biological markers to assist with AD diagnosis and verification of treatment efficacy.  According to the Consensus Report of the Working Group on Molecular and Biochemical Markers of Alzheimer's Disease, in order to qualify as a biomarker the sample in question must adhere to certain basic requirements, including the ability to: reflect AD pathology and differentiate it from other dementia with an 80% sensitivity; be reliable and reproducible; be easy to perform and analyze; remain relatively inexpensive.  Beta secretases are crucial enzymes in the pathogenesis of AD.  Given its primary role in brain amyloidogenesis and its ubiquitous expression, one may consider measuring peripheral BACE1 levels and activity as biomarkers of AD, like performed in the brain and cerebrospinal fluid.  However, very little is known about the periphery and whether peripheral BACE1 is involved in AD pathogenesis or mirrors AD progression.  Moreover, no investigation has focused on the possibility of monitoring peripheral BACE1 to assess the efficiency of BACE1 inhibitors during the course of clinical trials.  Part of the problem may be attributed to the lack of sensitive molecular tools which are absolutely necessary to use BACE1 as a biomarker.  In this review we evaluate the progress and feasibility of developing BACE1 as a biomarker for AD in different tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS1uOMHNMCFBdLIORRPd5lbfW6udTcc2ebhNlDOV5tKarntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mvms1Gjuw%253D%253D&md5=33dfdcede9bae5dc2eaf047676576e05</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.3233%2FJAD-2011-110017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2011-110017%26sid%3Dliteratum%253Aachs%26aulast%3DDecourt%26aufirst%3DB.%2BS.%26aulast%3DMarwan%26aufirst%3DN.%26atitle%3DBACE1%2520as%2520a%2520potential%2520biomarker%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Alzheimers%2520Dis.%26date%3D2011%26volume%3D24%26issue%3DSuppl%25202%26spage%3D53%26epage%3D59%26doi%3D10.3233%2FJAD-2011-110017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Cole, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassar, R.</span><span> </span><span class="NLM_article-title">The Alzheimer’s disease β-secretase enzyme, BACE1</span> <span class="citation_source-journal">Mol. Neurodegener.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="refDoi"> DOI: 10.1186/1750-1326-2-22</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1186%2F1750-1326-2-22" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=18005427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A280%3ADC%252BD1c%252FltFChsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=22&author=S.+L.+Coleauthor=R.+Vassar&title=The+Alzheimer%E2%80%99s+disease+%CE%B2-secretase+enzyme%2C+BACE1&doi=10.1186%2F1750-1326-2-22"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16cR"><div class="casContent"><span class="casTitleNuber">16c</span><div class="casTitle"><span class="NLM_cas:atitle">The Alzheimer's disease beta-secretase enzyme, BACE1</span></div><div class="casAuthors">Cole Sarah L; Vassar Robert</div><div class="citationInfo"><span class="NLM_cas:title">Molecular neurodegeneration</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract"> The pathogenesis of Alzheimer's disease is highly complex.  While several pathologies characterize this disease, amyloid plaques, composed of the beta-amyloid peptide are hallmark neuropathological lesions in Alzheimer's disease brain.  Indeed, a wealth of evidence suggests that beta-amyloid is central to the pathophysiology of AD and is likely to play an early role in this intractable neurodegenerative disorder.  The BACE1 enzyme is essential for the generation of beta-amyloid.  BACE1 knockout mice do not produce beta-amyloid and are free from Alzheimer's associated pathologies including neuronal loss and certain memory deficits.  The fact that BACE1 initiates the formation of beta-amyloid, and the observation that BACE1 levels are elevated in this disease provide direct and compelling reasons to develop therapies directed at BACE1 inhibition thus reducing beta-amyloid and its associated toxicities.  However, new data indicates that complete abolishment of BACE1 may be associated with specific behavioral and physiological alterations.  Recently a number of non-APP BACE1 substrates have been identified.  It is plausible that failure to process certain BACE1 substrates may underlie some of the reported abnormalities in the BACE1-deficient mice.  Here we review BACE1 biology, covering aspects ranging from the initial identification and characterization of this enzyme to recent data detailing the apparent dysregulation of BACE1 in Alzheimer's disease.  We pay special attention to the putative function of BACE1 during healthy conditions and discuss in detail the relationship that exists between key risk factors for AD, such as vascular disease (and downstream cellular consequences), and the pathogenic alterations in BACE1 that are observed in the diseased state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcScU9UDiunWZtyzdcP07UmufW6udTcc2ebhNlDOV5tKarntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c%252FltFChsA%253D%253D&md5=160fdfd98cdd29db707de7a6c4c03fa0</span></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=10.1186%2F1750-1326-2-22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1326-2-22%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DS.%2BL.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DThe%2520Alzheimer%25E2%2580%2599s%2520disease%2520%25CE%25B2-secretase%2520enzyme%252C%2520BACE1%26jtitle%3DMol.%2520Neurodegener.%26date%3D2007%26volume%3D2%26spage%3D22%26doi%3D10.1186%2F1750-1326-2-22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Georgievska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustavsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundkvist, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neelissen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eketjäll, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramberg, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bueters, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agerman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juréus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lendahl, U.</span><span> </span><span class="NLM_article-title">Revisiting the peripheral sink hypothesis: inhibiting BACE1 activity in the periphery does not alter β-amyloid levels in the CNS</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">486</span><span class="refDoi"> DOI: 10.1111/jnc.12937</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1111%2Fjnc.12937" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=25156639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisFems7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2015&pages=477-486&author=B.+Georgievskaauthor=S.+Gustavssonauthor=J.+Lundkvistauthor=J.+Neelissenauthor=S.+Eketj%C3%A4llauthor=V.+Rambergauthor=T.+Buetersauthor=K.+Agermanauthor=A.+Jur%C3%A9usauthor=S.+Svenssonauthor=S.+Bergauthor=J.+F%C3%A4ltingauthor=U.+Lendahl&title=Revisiting+the+peripheral+sink+hypothesis%3A+inhibiting+BACE1+activity+in+the+periphery+does+not+alter+%CE%B2-amyloid+levels+in+the+CNS&doi=10.1111%2Fjnc.12937"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16dR"><div class="casContent"><span class="casTitleNuber">16d</span><div class="casTitle"><span class="NLM_cas:atitle">Revisiting the peripheral sink hypothesis: inhibiting BACE1 activity in the periphery does not alter β-amyloid levels in the CNS</span></div><div class="casAuthors">Georgievska, Biljana; Gustavsson, Susanne; Lundkvist, Johan; Neelissen, Jan; Eketjaell, Susanna; Ramberg, Veronica; Bueters, Tjerk; Agerman, Karin; Jureus, Anders; Svensson, Samuel; Berg, Stefan; Faelting, Johanna; Lendahl, Urban</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">477-486</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aggregation of BACE1 beta (Aβ) peptides and the subsequent neural plaque formation is a central aspect of Alzheimer's disease.  Various strategies to reduce Aβ load in the brain are therefore intensely pursued.  It has been hypothesized that reducing Aβ peptides in the periphery, that is in organs outside the brain, would be a way to diminish Aβ levels and plaque load in the brain.  In this report, we put this peripheral sink hypothesis to test by investigating how selective inhibition of Aβ prodn. in the periphery using a β-secretase (BACE)1 inhibitor or reduced BACE1 gene dosage affects Aβ load in the brain.  Selective inhibition of peripheral BACE1 activity in wild-type mice or mice over-expressing amyloid precursor protein (APPswe transgenic mice; Tg2576) reduced Aβ levels in the periphery but not in the brain, not even after chronic treatment over several months.  In contrast, a BACE1 inhibitor with improved brain disposition reduced Aβ levels in both brain and periphery already after acute dosing.  Mice heterozygous for BACE1, displayed a 62% redn. in plasma Aβ40, whereas brain Aβ40 was only lowered by 11%.  These data suggest that redn. of Aβ in the periphery is not sufficient to reduce brain Aβ levels and that BACE1 is not the rate-limiting enzyme for Aβ processing in the brain.  This provides evidence against the peripheral sink hypothesis and suggests that a decrease in Aβ via BACE1 inhibition would need to be carried out in the brain.  Aggregation of amyloid beta (Aβ) peptides in the brain is a central aspect of Alzheimer's disease.  In this study, we demonstrate that inhibition of Aβ formation by BACE1 inhibitors needs to be carried out in the brain and that redn. of Aβ in the periphery is not sufficient to reduce brain Aβ levels.  This information is useful for developing future Aβ-targeting therapies for Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqUV5DivLL-bVg90H21EOLACvtfcHk0ljB8vj4RHuZ1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisFems7s%253D&md5=1a670fea82983689d586cd9bea83eae5</span></div><a href="/servlet/linkout?suffix=cit16d&amp;dbid=16384&amp;doi=10.1111%2Fjnc.12937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.12937%26sid%3Dliteratum%253Aachs%26aulast%3DGeorgievska%26aufirst%3DB.%26aulast%3DGustavsson%26aufirst%3DS.%26aulast%3DLundkvist%26aufirst%3DJ.%26aulast%3DNeelissen%26aufirst%3DJ.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DRamberg%26aufirst%3DV.%26aulast%3DBueters%26aufirst%3DT.%26aulast%3DAgerman%26aufirst%3DK.%26aulast%3DJur%25C3%25A9us%26aufirst%3DA.%26aulast%3DSvensson%26aufirst%3DS.%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26aulast%3DLendahl%26aufirst%3DU.%26atitle%3DRevisiting%2520the%2520peripheral%2520sink%2520hypothesis%253A%2520inhibiting%2520BACE1%2520activity%2520in%2520the%2520periphery%2520does%2520not%2520alter%2520%25CE%25B2-amyloid%2520levels%2520in%2520the%2520CNS%26jtitle%3DJ.%2520Neurochem.%26date%3D2015%26volume%3D132%26spage%3D477%26epage%3D486%26doi%3D10.1111%2Fjnc.12937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Wu, Y.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guernon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClure, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajamani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camac, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlijanian, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albright, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. A.</span><span> </span><span class="NLM_article-title">Targeting the BACE1 active site flap leads to a potent inhibitor that elicits robust brain Aβ reduction in rodents</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00432</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00432" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslensA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=271-276&author=Y.-J.+Wuauthor=J.+Guernonauthor=F.+Yangauthor=L.+Snyderauthor=J.+Shiauthor=A.+McClureauthor=R.+Rajamaniauthor=H.+Parkauthor=A.+Ngauthor=H.+Lewisauthor=C.+Y.+Changauthor=D.+Camacauthor=J.+H.+Toynauthor=M.+K.+Ahlijanianauthor=C.+F.+Albrightauthor=J.+E.+Macorauthor=L.+A.+Thompson&title=Targeting+the+BACE1+active+site+flap+leads+to+a+potent+inhibitor+that+elicits+robust+brain+A%CE%B2+reduction+in+rodents&doi=10.1021%2Facsmedchemlett.5b00432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the BACE1 Active Site Flap Leads to a Potent Inhibitor That Elicits Robust Brain Aβ Reduction in Rodents</span></div><div class="casAuthors">Wu, Yong-Jin; Guernon, Jason; Yang, Fukang; Snyder, Lawrence; Shi, Jianliang; McClure, Andrea; Rajamani, Ramkumar; Park, Hyunsoo; Ng, Alicia; Lewis, Hal; Chang, Chieh Ying; Camac, Dan; Toyn, Jeremy H.; Ahlijanian, Michael K.; Albright, Charles F.; Macor, John E.; Thompson, Lorin A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">271-276</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By targeting the flap backbone of the BACE1 active site, the authors discovered 6-dimethylisoxazole-substituted biaryl aminothiazine I with 34-fold improved BACE1 inhibitory activity over the lead compd.  The cocrystal structure of I bound to the active site indicated two hydrogen-bond interactions between the dimethylisoxazole and threonine 72 and glutamine 73 of the flap.  Incorporation of the dimethylisoxazole substitution onto the related aminothiazine carboxamide series led to pyrazine-carboxamide II as a very potent BACE1 inhibitor (IC50 < 1 nM).  This compd. demonstrated robust brain Aβ redn. in rat dose-response studies.  Thus, compd. II may be useful in testing the amyloid hypothesis of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9dTGWVgGmmrVg90H21EOLACvtfcHk0ljB8vj4RHuZ1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslensA%253D%253D&md5=b1bd7b0b6cb22ca8d2f49807b905daa9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00432%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.-J.%26aulast%3DGuernon%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DSnyder%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DMcClure%26aufirst%3DA.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DNg%26aufirst%3DA.%26aulast%3DLewis%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DC.%2BY.%26aulast%3DCamac%26aufirst%3DD.%26aulast%3DToyn%26aufirst%3DJ.%2BH.%26aulast%3DAhlijanian%26aufirst%3DM.%2BK.%26aulast%3DAlbright%26aufirst%3DC.%2BF.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26atitle%3DTargeting%2520the%2520BACE1%2520active%2520site%2520flap%2520leads%2520to%2520a%2520potent%2520inhibitor%2520that%2520elicits%2520robust%2520brain%2520A%25CE%25B2%2520reduction%2520in%2520rodents%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D271%26epage%3D276%26doi%3D10.1021%2Facsmedchemlett.5b00432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Stepan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aleo, M. D.</span><span> </span><span class="NLM_article-title">Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1345</span><span class="NLM_x">–</span> <span class="NLM_lpage">1410</span><span class="refDoi"> DOI: 10.1021/tx200168d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx200168d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC3MXos1Whtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1345-1410&author=A.+F.+Stepanauthor=D.+P.+Walkerauthor=J.+Baumanauthor=D.+A.+Priceauthor=T.+A.+Baillieauthor=A.+S.+Kalgutkarauthor=M.+D.+Aleo&title=Structural+alert%2Freactive+metabolite+concept+as+applied+in+medicinal+chemistry+to+mitigate+the+risk+of+idiosyncratic+drug+toxicity%3A+a+perspective+based+on+the+critical+examination+of+trends+in+the+top+200+drugs+marketed+in+the+United+States&doi=10.1021%2Ftx200168d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States</span></div><div class="casAuthors">Stepan, Antonia F.; Walker, Daniel P.; Bauman, Jonathan; Price, David A.; Baillie, Thomas A.; Kalgutkar, Amit S.; Aleo, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1345-1410</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Because of a preconceived notion that eliminating reactive metabolite (RM) formation with new drug candidates could mitigate the risk of idiosyncratic drug toxicity, the potential for RM formation is routinely examd. as part of lead optimization efforts in drug discovery.  Likewise, avoidance of "structural alerts" is almost a norm in drug design.  However, there is a growing concern that the perceived safety hazards assocd. with structural alerts and/or RM screening tools as standalone predictors of toxicity risks may be over exaggerated.  In addn., the multifactorial nature of idiosyncratic toxicity is now well recognized based upon observations that mechanisms other than RM formation (e.g., mitochondrial toxicity and inhibition of bile salt export pump (BSEP)) also can account for certain target organ toxicities.  Hence, fundamental questions arise such as: When is a mol. that contains a structural alert (RM pos. or neg.) a cause for concern.  Could the mol. in its parent form exert toxicity.  Can a low dose drug candidate truly mitigate metab.-dependent and -independent idiosyncratic toxicity risks.  In an effort to address these questions, we have retrospectively examd. 68 drugs (recalled or assocd. with a black box warning due to idiosyncratic toxicity) and the top 200 drugs (prescription and sales) in the United States in 2009 for trends in physiochem. characteristics, daily doses, presence of structural alerts, evidence for RM formation as well as toxicity mechanism(s) potentially mediated by parent drugs.  Collectively, our anal. revealed that a significant proportion (∼78-86%) of drugs assocd. with toxicity contained structural alerts and evidence indicating that RM formation as a causative factor for toxicity has been presented in 62-69% of these mols.  In several cases, mitochondrial toxicity and BSEP inhibition mediated by parent drugs were also noted as potential causative factors.  Most drugs were administered at daily doses exceeding several hundred milligrams.  There was no obvious link between idiosyncratic toxicity and physicochem. properties such as mol. wt., lipophilicity, etc.  Approx. half of the top 200 drugs for 2009 (prescription and sales) also contained one or more alerts in their chem. architecture, and many were found to be RM-pos.  Several instances of BSEP and mitochondrial liabilities were also noted with agents in the top 200 category.  However, with relatively few exceptions, the vast majority of these drugs are rarely assocd. with idiosyncratic toxicity, despite years of patient use.  The major differentiating factor appeared to be the daily dose; most of the drugs in the top 200 list are administered at low daily doses.  In addn., competing detoxication pathways and/or alternate nonmetabolic clearance routes provided suitable justifications for the safety records of RM-pos. drugs in the top 200 category.  Thus, while RM elimination may be a useful and pragmatic starting point in mitigating idiosyncratic toxicity risks, our anal. suggests a need for a more integrated screening paradigm for chem. hazard identification in drug discovery.  Thus, in addn. to a detailed assessment of RM formation potential (in relationship to the overall elimination mechanisms of the compd.(s)) for lead compds., effects on cellular health (e.g., cytotoxicity assays), BSEP inhibition, and mitochondrial toxicity are the recommended suite of assays to characterize compd. liabilities.  However, the prospective use of such data in compd. selection will require further validation of the cellular assays using marketed agents.  Until we gain a better understanding of the pathophysiol. mechanisms assocd. with idiosyncratic toxicities, improving pharmacokinetics and intrinsic potency as means of decreasing the dose size and the assocd. "body burden" of the parent drug and its metabolites will remain an overarching goal in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3IhczIcvVDLVg90H21EOLACvtfcHk0ljB8vj4RHuZ1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXos1Whtbo%253D&md5=632b73f755738e49eb233bc8dca1fbcc</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Ftx200168d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx200168d%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DBauman%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DAleo%26aufirst%3DM.%2BD.%26atitle%3DStructural%2520alert%252Freactive%2520metabolite%2520concept%2520as%2520applied%2520in%2520medicinal%2520chemistry%2520to%2520mitigate%2520the%2520risk%2520of%2520idiosyncratic%2520drug%2520toxicity%253A%2520a%2520perspective%2520based%2520on%2520the%2520critical%2520examination%2520of%2520trends%2520in%2520the%2520top%2520200%2520drugs%2520marketed%2520in%2520the%2520United%2520States%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26spage%3D1345%26epage%3D1410%26doi%3D10.1021%2Ftx200168d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Hilpert, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guba, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woltering, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wostl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayweg, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers-Evans, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humm, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krummenacher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muser, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnider, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozmen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergadano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochstrasser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuglstatter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David-Pierson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narquizian, R.</span><span> </span><span class="NLM_article-title">β-Secretase (BACE1) inhibitors with high in vivo efficacy suitable for clinical evaluation in Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3980</span><span class="NLM_x">–</span> <span class="NLM_lpage">3995</span><span class="refDoi"> DOI: 10.1021/jm400225m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400225m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtVymuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3980-3995&author=H.+Hilpertauthor=W.+Gubaauthor=T.+J.+Wolteringauthor=W.+Wostlauthor=E.+Pinardauthor=H.+Mauserauthor=A.+V.+Maywegauthor=M.+Rogers-Evansauthor=R.+Hummauthor=D.+Krummenacherauthor=T.+Muserauthor=C.+Schniderauthor=H.+Jacobsenauthor=L.+Ozmenauthor=A.+Bergadanoauthor=D.+W.+Bannerauthor=R.+Hochstrasserauthor=A.+Kuglstatterauthor=P.+David-Piersonauthor=H.+Fischerauthor=A.+Polaraauthor=R.+Narquizian&title=%CE%B2-Secretase+%28BACE1%29+inhibitors+with+high+in+vivo+efficacy+suitable+for+clinical+evaluation+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm400225m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase (BACE1) Inhibitors with High in Vivo Efficacy Suitable for Clinical Evaluation in Alzheimer's Disease</span></div><div class="casAuthors">Hilpert, Hans; Guba, Wolfgang; Woltering, Thomas J.; Wostl, Wolfgang; Pinard, Emmanuel; Mauser, Harald; Mayweg, Alexander V.; Rogers-Evans, Mark; Humm, Roland; Krummenacher, Daniela; Muser, Thorsten; Schnider, Christian; Jacobsen, Helmut; Ozmen, Laurence; Bergadano, Alessandra; Banner, David W.; Hochstrasser, Remo; Kuglstatter, Andreas; David-Pierson, Pascale; Fischer, Holger; Polara, Alessandra; Narquizian, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3980-3995</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An extensive fluorine scan of 1,3-oxazines revealed the power of fluorine(s) to lower the pKa and thereby dramatically change the pharmacol. profile of this class of BACE1 inhibitors.  The CF3 substituted oxazine 89, a potent and highly brain penetrant BACE1 inhibitor, was able to reduce significantly CSF Aβ40 and 42 in rats at oral doses as low as 1 mg/kg.  The effect was long lasting, showing a significant redn. of Aβ40 and 42 even after 24 h.  In contrast to 89, compd. 1b lacking the CF3 group was virtually inactive in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmoKRrAxxHErVg90H21EOLACvtfcHk0lgVPM26970FBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtVymuro%253D&md5=e5d311d1c8fecfaed043d3a0bf16c168</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm400225m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400225m%26sid%3Dliteratum%253Aachs%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DWoltering%26aufirst%3DT.%2BJ.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DMauser%26aufirst%3DH.%26aulast%3DMayweg%26aufirst%3DA.%2BV.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DHumm%26aufirst%3DR.%26aulast%3DKrummenacher%26aufirst%3DD.%26aulast%3DMuser%26aufirst%3DT.%26aulast%3DSchnider%26aufirst%3DC.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DBergadano%26aufirst%3DA.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DHochstrasser%26aufirst%3DR.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DDavid-Pierson%26aufirst%3DP.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DPolara%26aufirst%3DA.%26aulast%3DNarquizian%26aufirst%3DR.%26atitle%3D%25CE%25B2-Secretase%2520%2528BACE1%2529%2520inhibitors%2520with%2520high%2520in%2520vivo%2520efficacy%2520suitable%2520for%2520clinical%2520evaluation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3980%26epage%3D3995%26doi%3D10.1021%2Fjm400225m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Audia, J. E.; Mergot, D. J.; Sheehan, S. M.; Watson, B. M.</span><span> </span><span class="NLM_article-title">Aminodihydrothiazine derivatives as BACE inhibitors for the treatment of Alzheimer’s disease</span>. WO2009134617,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=J.+E.+Audia&author=D.+J.+Mergot&author=S.+M.+Sheehan&author=B.+M.+Watson&title=Aminodihydrothiazine+derivatives+as+BACE+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DAminodihydrothiazine%2520derivatives%2520as%2520BACE%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Butler, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreiro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vajdos, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parris, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varghese, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helal, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lira, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzon, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutra, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Alsina, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogilvie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atchison, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robshaw, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. T.</span><span> </span><span class="NLM_article-title">Discovery of a series of efficient, centrally efficacious BACE1 inhibitors through structure-based drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2678</span><span class="NLM_x">–</span> <span class="NLM_lpage">2702</span><span class="refDoi"> DOI: 10.1021/jm501833t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501833t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtVSjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2678-2702&author=C.+R.+Butlerauthor=M.+A.+Brodneyauthor=E.+M.+Beckauthor=G.+Barreiroauthor=C.+E.+Nolanauthor=F.+Panauthor=F.+Vajdosauthor=K.+Parrisauthor=A.+H.+Vargheseauthor=C.+J.+Helalauthor=R.+Liraauthor=S.+D.+Doranauthor=D.+R.+Riddellauthor=L.+M.+Buzonauthor=J.+K.+Dutraauthor=L.+A.+Martinez-Alsinaauthor=K.+Ogilvieauthor=J.+C.+Murrayauthor=J.+M.+Youngauthor=K.+Atchisonauthor=A.+Robshawauthor=C.+Gonzalesauthor=J.+Wangauthor=Y.+Zhangauthor=B.+T.+O%E2%80%99Neill&title=Discovery+of+a+series+of+efficient%2C+centrally+efficacious+BACE1+inhibitors+through+structure-based+drug+design&doi=10.1021%2Fjm501833t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Series of Efficient, Centrally Efficacious BACE1 Inhibitors through Structure-Based Drug Design</span></div><div class="casAuthors">Butler, Christopher R.; Brodney, Michael A.; Beck, Elizabeth M.; Barreiro, Gabriela; Nolan, Charles E.; Pan, Feng; Vajdos, Felix; Parris, Kevin; Varghese, Alison H.; Helal, Christopher J.; Lira, Ricardo; Doran, Shawn D.; Riddell, David R.; Buzon, Leanne M.; Dutra, Jason K.; Martinez-Alsina, Luis A.; Ogilvie, Kevin; Murray, John C.; Young, Joseph M.; Atchison, Kevin; Robshaw, Ashley; Gonzales, Cathleen; Wang, Jinlong; Zhang, Yong; O'Neill, Brian T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2678-2702</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of centrally efficacious β-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease (AD) has historically been thwarted by an inability to maintain alignment of potency, brain availability, and desired absorption, distribution, metab., and excretion (ADME) properties.  In this paper, the authors describe a series of truncated, fused thioamidines that are efficiently selective in garnering BACE1 activity without simultaneously inhibiting the closely related cathepsin D or neg. impacting brain penetration and ADME alignment, as exemplified by I.  Upon oral administration, these inhibitors exhibit robust brain availability and are efficacious in lowering central Amyloid β (Aβ) levels in mouse and dog.  In addn., chronic treatment in aged PS1/APP mice effects a decrease in the no. and size of Aβ-derived plaques.  Most importantly, evaluation of I in a 2-wk exploratory toxicol. study revealed no accumulation of autofluorescent material in retinal pigment epithelium or histol. findings in the eye, issues obsd. with earlier BACE1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiNT62AGyml7Vg90H21EOLACvtfcHk0lgVPM26970FBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtVSjtro%253D&md5=ac2a6fd661f7e9fd8b925deffd5e1010</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm501833t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501833t%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DC.%2BR.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DPan%26aufirst%3DF.%26aulast%3DVajdos%26aufirst%3DF.%26aulast%3DParris%26aufirst%3DK.%26aulast%3DVarghese%26aufirst%3DA.%2BH.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DRiddell%26aufirst%3DD.%2BR.%26aulast%3DBuzon%26aufirst%3DL.%2BM.%26aulast%3DDutra%26aufirst%3DJ.%2BK.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%2BA.%26aulast%3DOgilvie%26aufirst%3DK.%26aulast%3DMurray%26aufirst%3DJ.%2BC.%26aulast%3DYoung%26aufirst%3DJ.%2BM.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DRobshaw%26aufirst%3DA.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DDiscovery%2520of%2520a%2520series%2520of%2520efficient%252C%2520centrally%2520efficacious%2520BACE1%2520inhibitors%2520through%2520structure-based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2678%26epage%3D2702%26doi%3D10.1021%2Fjm501833t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Shalaeva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenseth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastin, A.</span><span> </span><span class="NLM_article-title">Measurement of dissociation constants (p<i>K</i><sub>a</sub> values) of organic compounds by multiplexed capillary electrophoresis using aqueous and cosolvent buffers</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">2581</span><span class="NLM_x">–</span> <span class="NLM_lpage">2606</span><span class="refDoi"> DOI: 10.1002/jps.21287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1002%2Fjps.21287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=18228610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotF2mu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2008&pages=2581-2606&author=M.+Shalaevaauthor=J.+Kensethauthor=F.+Lombardoauthor=A.+Bastin&title=Measurement+of+dissociation+constants+%28pKa+values%29+of+organic+compounds+by+multiplexed+capillary+electrophoresis+using+aqueous+and+cosolvent+buffers&doi=10.1002%2Fjps.21287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Measurement of dissociation constants (pKa values) of organic compounds by multiplexed capillary electrophoresis using aqueous and cosolvent buffers</span></div><div class="casAuthors">Shalaeva, Marina; Kenseth, Jeremy; Lombardo, Franco; Bastin, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2581-2606</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Evaluation of a multiplexed capillary electrophoresis (CE) method for pKa measurements of org. compds., including low soly. compds., is presented.  The method is validated on a set of 105 diverse compds., mostly drugs, and results are compared to literature values obtained from multiple refs.  Two versions of the instrument in two different labs were used to collect data over a period of 3 years and inter-lab. and inter-instrument variations are discussed.  Twenty-four point aq. and mixed cosolvent buffer systems were employed to improve the accuracy of pKa measurements.  It has been demonstrated that the method allows direct pKa measurements in aq. buffers for many compds. of low soly., often unattainable by other methods.  The pKa measurements of compds. with extremely low soly. using multiplexed CE with methanol/water cosolvent buffers are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIyedITaWF77Vg90H21EOLACvtfcHk0liQYlBiK2xAlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotF2mu78%253D&md5=0945460c6ace92ced07cfc4209995c7d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fjps.21287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21287%26sid%3Dliteratum%253Aachs%26aulast%3DShalaeva%26aufirst%3DM.%26aulast%3DKenseth%26aufirst%3DJ.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DBastin%26aufirst%3DA.%26atitle%3DMeasurement%2520of%2520dissociation%2520constants%2520%2528pKa%2520values%2529%2520of%2520organic%2520compounds%2520by%2520multiplexed%2520capillary%2520electrophoresis%2520using%2520aqueous%2520and%2520cosolvent%2520buffers%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2008%26volume%3D97%26spage%3D2581%26epage%3D2606%26doi%3D10.1002%2Fjps.21287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos-Korcsok, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robshaw, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barricklow, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, M.</span><span> </span><span class="NLM_article-title">Cerebrospinal fluid amyloid-β (Aβ) as an effect biomarker for brain Aβ lowering verified by quantitative preclinical analyses</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">342</span><span class="NLM_x">, </span> <span class="NLM_fpage">366</span><span class="NLM_x">–</span> <span class="NLM_lpage">375</span><span class="refDoi"> DOI: 10.1124/jpet.112.192625</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1124%2Fjpet.112.192625" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=22562771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOru7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2012&pages=366-375&author=Y.+Luauthor=D.+Riddellauthor=E.+Hajos-Korcsokauthor=K.+Balesauthor=K.+M.+Woodauthor=C.+E.+Nolanauthor=A.+E.+Robshawauthor=L.+Zhangauthor=L.+Leungauthor=S.+L.+Beckerauthor=E.+Tsengauthor=J.+Barricklowauthor=E.+H.+Millerauthor=S.+Osgoodauthor=B.+T.+O%E2%80%99Neillauthor=M.+A.+Brodneyauthor=D.+S.+Johnsonauthor=M.+Pettersson&title=Cerebrospinal+fluid+amyloid-%CE%B2+%28A%CE%B2%29+as+an+effect+biomarker+for+brain+A%CE%B2+lowering+verified+by+quantitative+preclinical+analyses&doi=10.1124%2Fjpet.112.192625"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Cerebrospinal fluid amyloid-β (Aβ) as an effect biomarker for brain Aβ lowering verified by quantitative preclinical analyses</span></div><div class="casAuthors">Lu, Yasong; Riddell, David; Hajos-Korcsok, Eva; Bales, Kelly; Wood, Kathleen M.; Nolan, Charles E.; Robshaw, Ashley E.; Zhang, Liming; Leung, Louis; Becker, Stacey L.; Tseng, Elaine; Barricklow, Jason; Miller, Emily H.; Osgood, Sarah; O'Neill, Brian T.; Brodney, Michael A.; Johnson, Douglas S.; Pettersson, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">342</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">366-375</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Reducing the generation of amyloid-β (Aβ) in the brain via inhibition of β-secretase or inhibition/modulation of γ-secretase has been pursued as a potential disease-modifying treatment for Alzheimer's disease.  For the discovery and development of β-secretase inhibitors (BACEi), γ-secretase inhibitors (GSI), and γ-secretase modulators (GSM), Aβ in cerebrospinal fluid (CSF) has been presumed to be an effect biomarker for Aβ lowering in the brain.  However, this presumption is challenged by the lack of quant. understanding of the relationship between brain and CSF Aβ lowering.  In this study, we strived to elucidate how the intrinsic pharmacokinetic (PK)/pharmacodynamic (PD) relationship for CSF Aβ lowering is related to that for brain Aβ through quant. modeling of preclin. data for numerous BACEi, GSI, and GSM across multiple species.  Our results indicate that the intrinsic PK/PD relationship in CSF is predictive of that in brain, at least in the postulated pharmacol. relevant range, with excellent consistency across mechanisms and species.  As such, the validity of CSF Aβ as an effect biomarker for brain Aβ lowering is confirmed preclinically.  Meanwhile, we have been able to reproduce the dose-dependent sepn. between brain and CSF effect profiles using simulations.  We further discuss the implications of our findings to drug discovery and development with regard to preclin. PK/PD characterization and clin. prediction of Aβ lowering in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0fekVpcL50rVg90H21EOLACvtfcHk0liQYlBiK2xAlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOru7vN&md5=65443990fd05b2244ce611e91629341e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.192625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.192625%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DY.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DHajos-Korcsok%26aufirst%3DE.%26aulast%3DBales%26aufirst%3DK.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DRobshaw%26aufirst%3DA.%2BE.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLeung%26aufirst%3DL.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DBarricklow%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DE.%2BH.%26aulast%3DOsgood%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DPettersson%26aufirst%3DM.%26atitle%3DCerebrospinal%2520fluid%2520amyloid-%25CE%25B2%2520%2528A%25CE%25B2%2529%2520as%2520an%2520effect%2520biomarker%2520for%2520brain%2520A%25CE%25B2%2520lowering%2520verified%2520by%2520quantitative%2520preclinical%2520analyses%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D342%26spage%3D366%26epage%3D375%26doi%3D10.1124%2Fjpet.112.192625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rendic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlo, F. J. D.</span><span> </span><span class="NLM_article-title">Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors</span> <span class="citation_source-journal">Drug Metab. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">580</span><span class="refDoi"> DOI: 10.3109/03602539709037591</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.3109%2F03602539709037591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=9187528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADyaK2sXkt1Onur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1997&pages=413-580&author=S.+Rendicauthor=F.+J.+D.+Carlo&title=Human+cytochrome+P450+enzymes%3A+a+status+report+summarizing+their+reactions%2C+substrates%2C+inducers%2C+and+inhibitors&doi=10.3109%2F03602539709037591"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors</span></div><div class="casAuthors">Rendic, Slobodan; Di Carlo, Frederick J.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1 & 2</span>),
    <span class="NLM_cas:pages">413-580</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Dekker</span>)
        </div><div class="casAbstract">A review with 295 refs.  Topics discussed include: cytochrome P 450 enzymes; superfamily of CYP enzymes and metab. of xenobiotics and physiol. compds.; an extensive compilation of information on human cytochrome P 450 enzymes (catalytic activity, substrate specificity, inducers, inhibitors).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKNrQWd5tzi7Vg90H21EOLACvtfcHk0lix0AreIrGveQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkt1Onur8%253D&md5=f9261b74fbf47c6eeb965c6a3eb35635</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.3109%2F03602539709037591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F03602539709037591%26sid%3Dliteratum%253Aachs%26aulast%3DRendic%26aufirst%3DS.%26aulast%3DCarlo%26aufirst%3DF.%2BJ.%2BD.%26atitle%3DHuman%2520cytochrome%2520P450%2520enzymes%253A%2520a%2520status%2520report%2520summarizing%2520their%2520reactions%252C%2520substrates%252C%2520inducers%252C%2520and%2520inhibitors%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D1997%26volume%3D29%26spage%3D413%26epage%3D580%26doi%3D10.3109%2F03602539709037591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Teh, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertilsson, L.</span><span> </span><span class="NLM_article-title">Pharmacogenomics of CYP 2D6: molecular genetics, interethnic differences and clinical importance</span> <span class="citation_source-journal">Drug Metab. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span><span class="refDoi"> DOI: 10.2133/dmpk.DMPK-11-RV-121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.2133%2Fdmpk.DMPK-11-RV-121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=22185816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1Ggtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2012&pages=55-67&author=L.+K.+Tehauthor=L.+Bertilsson&title=Pharmacogenomics+of+CYP+2D6%3A+molecular+genetics%2C+interethnic+differences+and+clinical+importance&doi=10.2133%2Fdmpk.DMPK-11-RV-121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacogenomics of CYP2D6: molecular genetics, interethnic differences and clinical importance</span></div><div class="casAuthors">Teh, Lay Kek; Bertilsson, Leif</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-67</span>CODEN:
                <span class="NLM_cas:coden">DMPRB8</span>;
        ISSN:<span class="NLM_cas:issn">1347-4367</span>.
    
            (<span class="NLM_cas:orgname">Japanese Society for the Study of Xenobiotics</span>)
        </div><div class="casAbstract">A review.  CYP2D6 has received intense attention since the beginning of the pharmacogenetic era in the 1970s.  This is because of its involvement in the metab. of more than 25% of the marketed drugs, the large geog. and inter-ethnic differences in the genetic polymorphism and possible drug-induced toxicity.  Many interesting reviews have been published on CYP2D6 and this review aims to reinstate the importance of the genetic polymorphism of CYP2D6 in different populations as well as some clin. implications and important drug interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvyrqscYrvpLVg90H21EOLACvtfcHk0lix0AreIrGveQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1Ggtrw%253D&md5=3e5ec4e479ebd0d03f6e4d4b7415e6ef</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.2133%2Fdmpk.DMPK-11-RV-121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2133%252Fdmpk.DMPK-11-RV-121%26sid%3Dliteratum%253Aachs%26aulast%3DTeh%26aufirst%3DL.%2BK.%26aulast%3DBertilsson%26aufirst%3DL.%26atitle%3DPharmacogenomics%2520of%2520CYP%25202D6%253A%2520molecular%2520genetics%252C%2520interethnic%2520differences%2520and%2520clinical%2520importance%26jtitle%3DDrug%2520Metab.%2520Pharmacokinet.%26date%3D2012%26volume%3D27%26spage%3D55%26epage%3D67%26doi%3D10.2133%2Fdmpk.DMPK-11-RV-121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bertilsson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahl, M.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalén, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Shurbaji, A.</span><span> </span><span class="NLM_article-title">Molecular genetics of CYP 2D6: Clinical relevance with focus on psychotropic drugs</span> <span class="citation_source-journal">br J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span><span class="refDoi"> DOI: 10.1046/j.0306-5251.2001.01548.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1046%2Fj.0306-5251.2001.01548.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2002&pages=111-122&author=L.+Bertilssonauthor=M.-L.+Dahlauthor=P.+Dal%C3%A9nauthor=A.+Al-Shurbaji&title=Molecular+genetics+of+CYP+2D6%3A+Clinical+relevance+with+focus+on+psychotropic+drugs&doi=10.1046%2Fj.0306-5251.2001.01548.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24c&amp;dbid=16384&amp;doi=10.1046%2Fj.0306-5251.2001.01548.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.0306-5251.2001.01548.x%26sid%3Dliteratum%253Aachs%26aulast%3DBertilsson%26aufirst%3DL.%26aulast%3DDahl%26aufirst%3DM.-L.%26aulast%3DDal%25C3%25A9n%26aufirst%3DP.%26aulast%3DAl-Shurbaji%26aufirst%3DA.%26atitle%3DMolecular%2520genetics%2520of%2520CYP%25202D6%253A%2520Clinical%2520relevance%2520with%2520focus%2520on%2520psychotropic%2520drugs%26jtitle%3Dbr%2520J.%2520Clin.%2520Pharmacol.%26date%3D2002%26volume%3D53%26spage%3D111%26epage%3D122%26doi%3D10.1046%2Fj.0306-5251.2001.01548.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Brodney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreiro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parris, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atchison, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robshaw, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundesmann, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutra, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henegar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaChapelle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lira, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Alsina, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikochik, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogilvie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakya, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. T.</span><span> </span><span class="NLM_article-title">Utilizing structures of CYP 2D6 and BACE1 complexes to reduce risk of drug–drug interactions with a novel series of centrally efficacious BACE1 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3223</span><span class="NLM_x">–</span> <span class="NLM_lpage">3252</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00191</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00191" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3223-3252&author=M.+A.+Brodneyauthor=E.+M.+Beckauthor=C.+R.+Butlerauthor=G.+Barreiroauthor=E.+F.+Johnsonauthor=D.+Riddellauthor=K.+Parrisauthor=C.+E.+Nolanauthor=Y.+Fanauthor=K.+Atchisonauthor=C.+Gonzalesauthor=A.+E.+Robshawauthor=S.+D.+Doranauthor=M.+W.+Bundesmannauthor=L.+Buzonauthor=J.+Dutraauthor=K.+Henegarauthor=E.+LaChapelleauthor=X.+Houauthor=B.+N.+Rogersauthor=J.+Panditauthor=R.+Liraauthor=L.+Martinez-Alsinaauthor=P.+Mikochikauthor=J.+C.+Murrayauthor=K.+Ogilvieauthor=L.+Priceauthor=S.+M.+Sakyaauthor=A.+Yuauthor=Y.+Zhangauthor=B.+T.+O%E2%80%99Neill&title=Utilizing+structures+of+CYP+2D6+and+BACE1+complexes+to+reduce+risk+of+drug%E2%80%93drug+interactions+with+a+novel+series+of+centrally+efficacious+BACE1+inhibitors&doi=10.1021%2Facs.jmedchem.5b00191"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00191%26sid%3Dliteratum%253Aachs%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DButler%26aufirst%3DC.%2BR.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DParris%26aufirst%3DK.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DRobshaw%26aufirst%3DA.%2BE.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DBundesmann%26aufirst%3DM.%2BW.%26aulast%3DBuzon%26aufirst%3DL.%26aulast%3DDutra%26aufirst%3DJ.%26aulast%3DHenegar%26aufirst%3DK.%26aulast%3DLaChapelle%26aufirst%3DE.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%26aulast%3DMikochik%26aufirst%3DP.%26aulast%3DMurray%26aufirst%3DJ.%2BC.%26aulast%3DOgilvie%26aufirst%3DK.%26aulast%3DPrice%26aufirst%3DL.%26aulast%3DSakya%26aufirst%3DS.%2BM.%26aulast%3DYu%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DUtilizing%2520structures%2520of%2520CYP%25202D6%2520and%2520BACE1%2520complexes%2520to%2520reduce%2520risk%2520of%2520drug%25E2%2580%2593drug%2520interactions%2520with%2520a%2520novel%2520series%2520of%2520centrally%2520efficacious%2520BACE1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3223%26epage%3D3252%26doi%3D10.1021%2Facs.jmedchem.5b00191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="note"><p class="first last">Compound <b>13</b> was prepared in analogous fashion to ref <a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">21</a>. Preparation and characterization information is included in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01451/suppl_file/jm6b01451_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Kalvass, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, T. S.</span><span> </span><span class="NLM_article-title">Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery</span> <span class="citation_source-journal">Biopharm. Drug Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span><span class="refDoi"> DOI: 10.1002/bdd.325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1002%2Fbdd.325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=12415573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVansbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=327-338&author=J.+C.+Kalvassauthor=T.+S.+Maurer&title=Influence+of+nonspecific+brain+and+plasma+binding+on+CNS+exposure%3A+implications+for+rational+drug+discovery&doi=10.1002%2Fbdd.325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery</span></div><div class="casAuthors">Kalvass, J. Cory; Maurer, Tristan S.</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">327-338</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Relative plasma, brain and cerebrospinal fluid (CSF) exposures and unbound fractions in plasma and brain were examd. for 18 proprietary compds. in rats.  The relation between in vivo brain-to-plasma ratio and in vitro plasma-to-brain unbound fraction (fu) was examd.  In addn., plasma fu and brain fu were examd. for their relation to in vivo CSF-to-plasma and CSF-to-brain ratios, resp.  Findings were delineated based on the presence or absence of active efflux.  Finally, the same comparisons were examd. in FVB vs. MDR 1a/1b knockout mice for a selected P-glycoprotein (Pgp) substrate.  For the nine compds. without indications of active efflux, predictive correlations were obsd. between ratios of brain-to-plasma exposure and plasma-to-brain fu (r2 = 0.98), CSF-to-brain exposure vs. brain fu (r2 = 0.72), and CSF-to-plasma exposure vs. plasma fu (r2 = 0.82).  For the nine compds. with indications of active efflux, nonspecific binding data tended to over predict the brain-to-plasma and CSF-to-plasma exposure ratios.  Interestingly, CSF-to-brain exposure ratio was consistently under predicted by brain fu for this set.  Using a select Pgp substrate, it was demonstrated that the brain-to-plasma exposure ratio was identical to that predicted by plasma-to-brain fu ratio in MDR 1a/1b knockout mice.  In FVB mice, plasma-to-brain fu over predicted brain-to-plasma exposure ratio to the same degree as the difference in brain-to-plasma exposure ratio between MDR 1a/1b and FVB mice.  Consistent results were obtained in rats, suggesting a similar kinetic behavior between species.  These data illustrate how an understanding of relative tissue binding (plasma, brain) can allow for a quant. examn. of active processes that det. CNS exposure.  The general applicability of this approach offers advantages over species- and mechanism-specific approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfFvLLvDQohLVg90H21EOLACvtfcHk0lj3gOSYFlbXqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsVansbk%253D&md5=96b80d1a745b254f74b9c19e8e8af627</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fbdd.325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.325%26sid%3Dliteratum%253Aachs%26aulast%3DKalvass%26aufirst%3DJ.%2BC.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26atitle%3DInfluence%2520of%2520nonspecific%2520brain%2520and%2520plasma%2520binding%2520on%2520CNS%2520exposure%253A%2520implications%2520for%2520rational%2520drug%2520discovery%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2002%26volume%3D23%26spage%3D327%26epage%3D338%26doi%3D10.1002%2Fbdd.325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Kutchinsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asmild, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taboryski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vestergaard, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krzywkowski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroder, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ljungstrom, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helix, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorensen, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bech, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willumsen, N. J.</span><span> </span><span class="NLM_article-title">Characterization of potassium channel modulators with QPatch automated patch-clamp technology: system characteristics and performance</span> <span class="citation_source-journal">Assay Drug Dev. Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">693</span><span class="refDoi"> DOI: 10.1089/154065803770381048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1089%2F154065803770381048" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=685-693&author=J.+Kutchinskyauthor=S.+Friisauthor=M.+Asmildauthor=R.+Taboryskiauthor=S.+Pedersenauthor=R.+K.+Vestergaardauthor=R.+B.+Jacobsenauthor=K.+Krzywkowskiauthor=R.+L.+Schroderauthor=T.+Ljungstromauthor=N.+Helixauthor=C.+B.+Sorensenauthor=M.+Bechauthor=N.+J.+Willumsen&title=Characterization+of+potassium+channel+modulators+with+QPatch+automated+patch-clamp+technology%3A+system+characteristics+and+performance&doi=10.1089%2F154065803770381048"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1089%2F154065803770381048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252F154065803770381048%26sid%3Dliteratum%253Aachs%26aulast%3DKutchinsky%26aufirst%3DJ.%26aulast%3DFriis%26aufirst%3DS.%26aulast%3DAsmild%26aufirst%3DM.%26aulast%3DTaboryski%26aufirst%3DR.%26aulast%3DPedersen%26aufirst%3DS.%26aulast%3DVestergaard%26aufirst%3DR.%2BK.%26aulast%3DJacobsen%26aufirst%3DR.%2BB.%26aulast%3DKrzywkowski%26aufirst%3DK.%26aulast%3DSchroder%26aufirst%3DR.%2BL.%26aulast%3DLjungstrom%26aufirst%3DT.%26aulast%3DHelix%26aufirst%3DN.%26aulast%3DSorensen%26aufirst%3DC.%2BB.%26aulast%3DBech%26aufirst%3DM.%26aulast%3DWillumsen%26aufirst%3DN.%2BJ.%26atitle%3DCharacterization%2520of%2520potassium%2520channel%2520modulators%2520with%2520QPatch%2520automated%2520patch-clamp%2520technology%253A%2520system%2520characteristics%2520and%2520performance%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2003%26volume%3D1%26spage%3D685%26epage%3D693%26doi%3D10.1089%2F154065803770381048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Bridges, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svenson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowling, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovering, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akopian, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiBlasio-Smith, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annis-Freeman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marvell, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaVallie, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zollner, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somers, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kriz, R. W.</span><span> </span><span class="NLM_article-title">A novel approach to identifying β-secretase inhibitors: Bis-statine peptide mimetics discovered using structure and spot synthesis</span> <span class="citation_source-journal">Peptides (N. Y., NY, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1877</span><span class="NLM_x">–</span> <span class="NLM_lpage">1885</span><span class="refDoi"> DOI: 10.1016/j.peptides.2006.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1016%2Fj.peptides.2006.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=16574278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsFCis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=1877-1885&author=K.+G.+Bridgesauthor=R.+Chopraauthor=L.+Linauthor=K.+Svensonauthor=A.+Tamauthor=G.+Jinauthor=R.+Cowlingauthor=F.+Loveringauthor=T.+N.+Akopianauthor=E.+DiBlasio-Smithauthor=B.+Annis-Freemanauthor=T.+H.+Marvellauthor=E.+R.+LaVallieauthor=R.+S.+Zollnerauthor=J.+Bardauthor=W.+S.+Somersauthor=M.+L.+Stahlauthor=R.+W.+Kriz&title=A+novel+approach+to+identifying+%CE%B2-secretase+inhibitors%3A+Bis-statine+peptide+mimetics+discovered+using+structure+and+spot+synthesis&doi=10.1016%2Fj.peptides.2006.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">A novel approach to identifying β-secretase inhibitors: Bis-statine peptide mimetics discovered using structure and spot synthesis</span></div><div class="casAuthors">Bridges, Kristie Grove; Chopra, Rajiv; Lin, Laura; Svenson, Kristine; Tam, Amy; Jin, Guixian; Cowling, Rebecca; Lovering, Frank; Akopian, Tatos N.; DiBlasio-Smith, Elizabeth; Annis-Freeman, Bethany; Marvell, Tod H.; LaVallie, Edward R.; Zollner, Richard S.; Bard, Jonathan; Somers, William S.; Stahl, Mark L.; Kriz, Ronald W.</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1877-1885</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">β-Secretase 1 (BACE1) is an aspartic protease believed to play a crit. role in Alzheimer's disease.  Inhibitors of this enzyme have been designed by incorporating the noncleavable hydroxyethylene and statine isosteres into peptides corresponding to BACE1 substrate sequences.  The authors sought to develop new methods to quickly characterize and optimize inhibitors based on the statine core.  Minimal sequence requirements for binding were first established using both crystallog. and peptide spot synthesis.  These shortened peptide inhibitors were then optimized by using spot synthesis to perform iterative cycles of substitution and deletion.  The present study resulted in the identification of novel "bis-statine" inhibitors shown by crystallog. to have a unique binding mode.  Our results demonstrate the application of peptide spot synthesis as an effective method for enhancing peptidomimetic drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkQbYX8NmEhLVg90H21EOLACvtfcHk0lj3gOSYFlbXqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsFCis7c%253D&md5=bb58fc3d1bc2d6233295a6847a0b54fc</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.peptides.2006.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.peptides.2006.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DK.%2BG.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DSvenson%26aufirst%3DK.%26aulast%3DTam%26aufirst%3DA.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DCowling%26aufirst%3DR.%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DAkopian%26aufirst%3DT.%2BN.%26aulast%3DDiBlasio-Smith%26aufirst%3DE.%26aulast%3DAnnis-Freeman%26aufirst%3DB.%26aulast%3DMarvell%26aufirst%3DT.%2BH.%26aulast%3DLaVallie%26aufirst%3DE.%2BR.%26aulast%3DZollner%26aufirst%3DR.%2BS.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DSomers%26aufirst%3DW.%2BS.%26aulast%3DStahl%26aufirst%3DM.%2BL.%26aulast%3DKriz%26aufirst%3DR.%2BW.%26atitle%3DA%2520novel%2520approach%2520to%2520identifying%2520%25CE%25B2-secretase%2520inhibitors%253A%2520Bis-statine%2520peptide%2520mimetics%2520discovered%2520using%2520structure%2520and%2520spot%2520synthesis%26jtitle%3DPeptides%2520%2528N.%2520Y.%252C%2520NY%252C%2520U.%2520S.%2529%26date%3D2006%26volume%3D27%26spage%3D1877%26epage%3D1885%26doi%3D10.1016%2Fj.peptides.2006.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Vonrhein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flensburg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smart, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paciorek, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Womack, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bricogne, G.</span><span> </span><span class="NLM_article-title">Data processing and analysis with the <i>autoPROC</i> toolbox</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span><span class="refDoi"> DOI: 10.1107/S0907444911007773</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1107%2FS0907444911007773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=21460447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=293-302&author=C.+Vonrheinauthor=C.+Flensburgauthor=P.+Kellerauthor=A.+Sharffauthor=O.+Smartauthor=W.+Paciorekauthor=T.+Womackauthor=G.+Bricogne&title=Data+processing+and+analysis+with+the+autoPROC+toolbox&doi=10.1107%2FS0907444911007773"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Data processing and analysis with the autoPROC toolbox</span></div><div class="casAuthors">Vonrhein, Clemens; Flensburg, Claus; Keller, Peter; Sharff, Andrew; Smart, Oliver; Paciorek, Wlodek; Womack, Thomas; Bricogne, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">293-302</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A typical diffraction expt. will generate many images and data sets from different crystals in a very short time.  This creates a challenge for the high-throughput operation of modern synchrotron beamlines as well as for the subsequent data processing.  Novice users in particular may feel overwhelmed by the tables, plots and nos. that the different data-processing programs and software packages present to them.  Here, some of the more common problems that a user has to deal with when processing a set of images that will finally make up a processed data set are shown, concg. on difficulties that may often show up during the first steps along the path of turning the expt. (i.e. data collection) into a model (i.e. interpreted electron d.).  Difficulties such as unexpected crystal forms, issues in crystal handling and suboptimal choices of data-collection strategies can often be dealt with, or at least diagnosed, by analyzing specific data characteristics during processing.  In the end, one wants to distinguish problems over which one has no immediate control once the expt. is finished from problems that can be remedied a posteriori.  A new software package, autoPROC, is also presented that combines third-party processing programs with new tools and an automated workflow script that is intended to provide users with both guidance and insight into the offline processing of data affected by the difficulties mentioned above, with particular emphasis on the automated treatment of multi-sweep data sets collected on multi-axis goniostats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmah7iUrMLXLVg90H21EOLACvtfcHk0lg4PFWJ94dAVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLs%253D&md5=a0a3579f6b371b6312819883864aa80d</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1107%2FS0907444911007773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911007773%26sid%3Dliteratum%253Aachs%26aulast%3DVonrhein%26aufirst%3DC.%26aulast%3DFlensburg%26aufirst%3DC.%26aulast%3DKeller%26aufirst%3DP.%26aulast%3DSharff%26aufirst%3DA.%26aulast%3DSmart%26aufirst%3DO.%26aulast%3DPaciorek%26aufirst%3DW.%26aulast%3DWomack%26aufirst%3DT.%26aulast%3DBricogne%26aufirst%3DG.%26atitle%3DData%2520processing%2520and%2520analysis%2520with%2520the%2520autoPROC%2520toolbox%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D293%26epage%3D302%26doi%3D10.1107%2FS0907444911007773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Kabsch, W.</span><span> </span><span class="NLM_article-title">XDS</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=XDS&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0lg4PFWJ94dAVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">French, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K.</span><span> </span><span class="NLM_article-title">On the treatment of negative intensity observations</span> <span class="citation_source-journal">Acta Crystallogr., Sect. A: Cryst. Phys., Diffr., Theor. Gen. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">A34</span><span class="NLM_x">, </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">525</span><span class="refDoi"> DOI: 10.1107/S0567739478001114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1107%2FS0567739478001114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADyaE1cXkvVehu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=A34&publication_year=1978&pages=517-525&author=S.+Frenchauthor=K.+Wilson&title=On+the+treatment+of+negative+intensity+observations&doi=10.1107%2FS0567739478001114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32aR"><div class="casContent"><span class="casTitleNuber">32a</span><div class="casTitle"><span class="NLM_cas:atitle">On the treatment of negative intensity observations</span></div><div class="casAuthors">French, Simon; Wilson, Keith</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section A:  Crystal Physics, Diffraction, Theoretical and General Crystallography</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">A34</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">517-25</span>CODEN:
                <span class="NLM_cas:coden">ACACBN</span>;
        ISSN:<span class="NLM_cas:issn">0567-7394</span>.
    </div><div class="casAbstract">A method is described which produces sensible ests. of the structure factor moduli from intensity observations, whether the latter are pos. or neg.  Preliminary applications of the method to data from the protein phosphorylase b are summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyzMPfrZ9OTbVg90H21EOLACvtfcHk0lg4PFWJ94dAVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXkvVehu7o%253D&md5=7506d033509f63ebc9c5a06bcdd3e388</span></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.1107%2FS0567739478001114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0567739478001114%26sid%3Dliteratum%253Aachs%26aulast%3DFrench%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DK.%26atitle%3DOn%2520the%2520treatment%2520of%2520negative%2520intensity%2520observations%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520A%253A%2520Cryst.%2520Phys.%252C%2520Diffr.%252C%2520Theor.%2520Gen.%2520Crystallogr.%26date%3D1978%26volume%3DA34%26spage%3D517%26epage%3D525%26doi%3D10.1107%2FS0567739478001114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Collaborative computational project, number 4</span><span> </span><span class="NLM_article-title">The <i>CCP4</i> suite: programs for protein crystallography</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">760</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span><span class="refDoi"> DOI: 10.1107/S0907444994003112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1107%2FS0907444994003112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=15299374" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1994&pages=760-763&author=Collaborative+computational+project%2C+number+4&title=The+CCP4+suite%3A+programs+for+protein+crystallography&doi=10.1107%2FS0907444994003112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=10.1107%2FS0907444994003112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444994003112%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DThe%2520CCP4%2520suite%253A%2520programs%2520for%2520protein%2520crystallography%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1994%26volume%3D50%26spage%3D760%26epage%3D763%26doi%3D10.1107%2FS0907444994003112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span> </span><span class="NLM_article-title">Refinement of macromolecular structures by the maximum-likelihood method</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">D53</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span><span class="refDoi"> DOI: 10.1107/S0907444996012255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D53&publication_year=1997&pages=240-255&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+macromolecular+structures+by+the+maximum-likelihood+method&doi=10.1107%2FS0907444996012255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. σA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial α-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0lhuNApNM7-ImA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520macromolecular%2520structures%2520by%2520the%2520maximum-likelihood%2520method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3DD53%26spage%3D240%26epage%3D255%26doi%3D10.1107%2FS0907444996012255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Bricogne, G.; Blanc, E.; Brandl, M.; Flensburg, C.; Keller, P.; Paciorek, W.; Roversi, P.; Smart, O. S.; Vonrhein, C.; Womack, T. O.</span>BUSTER; <span class="NLM_publisher-name">Global Phasing Ltd</span>: <span class="NLM_publisher-loc">Cambridge, UK</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=P.+Roversi&author=O.+S.+Smart&author=C.+Vonrhein&author=T.+O.+Womack&title=BUSTER"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26jtitle%3DBUSTER%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title"><i>Coot</i>: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">D60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span><span class="refDoi"> DOI: 10.1107/S0907444904019158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics&doi=10.1107%2FS0907444904019158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0lhuNApNM7-ImA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3DD60%26spage%3D2126%26epage%3D2132%26doi%3D10.1107%2FS0907444904019158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afonine, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunkoczi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Echols, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headd, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, L.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapral, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriarty, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oeffner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terwilliger, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwart, P. H.</span><span> </span><span class="NLM_article-title">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span><span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunkocziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.-W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+a+comprehensive+Python-based+system+for+macromolecular+structure+solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0lhuNApNM7-ImA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunkoczi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.-W.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520a%2520comprehensive%2520Python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8a','cit8b','cit8c'],'ref9':['cit9'],'ref10':['cit10a','cit10b'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14a','cit14b','cit14c'],'ref15':['cit15'],'ref16':['cit16a','cit16b','cit16c','cit16d'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24a','cit24b','cit24c'],'ref25':['cit25'],'ref26':[],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32a','cit32b'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 22 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jianzhong Chen, Shaolong Zhang, Wei Wang, Haibo Sun, Qinggang Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Xinguo Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Binding of Inhibitors to BACE1 Affected by pH-Dependent Protonation: An Exploration from Multiple Replica Gaussian Accelerated Molecular Dynamics and MM-GBSA Calculations. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (14)
                                     , 2591-2607. <a href="https://doi.org/10.1021/acschemneuro.0c00813" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00813</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00813%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DBinding%252Bof%252BInhibitors%252Bto%252BBACE1%252BAffected%252Bby%252BpH-Dependent%252BProtonation%25253A%252BAn%252BExploration%252Bfrom%252BMultiple%252BReplica%252BGaussian%252BAccelerated%252BMolecular%252BDynamics%252Band%252BMM-GBSA%252BCalculations%26aulast%3DChen%26aufirst%3DJianzhong%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D22122020%26date%3D14062021%26date%3D29062021%26volume%3D12%26issue%3D14%26spage%3D2591%26epage%3D2607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Shikha Kumari, Angelica V. Carmona, Amit K. Tiwari, <span class="NLM_string-name hlFld-ContribAuthor">Paul C. Trippier</span>. </span><span class="cited-content_cbyCitation_article-title">Amide Bond Bioisosteres: Strategies, Synthesis, and Successes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (21)
                                     , 12290-12358. <a href="https://doi.org/10.1021/acs.jmedchem.0c00530" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00530</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00530%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAmide%252BBond%252BBioisosteres%25253A%252BStrategies%25252C%252BSynthesis%25252C%252Band%252BSuccesses%26aulast%3DKumari%26aufirst%3DShikha%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D31032020%26date%3D04082020%26date%3D20072020%26volume%3D63%26issue%3D21%26spage%3D12290%26epage%3D12358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Chibueze I. Onyeagusi, <span class="NLM_string-name hlFld-ContribAuthor">Steven J. Malcolmson</span>. </span><span class="cited-content_cbyCitation_article-title">Strategies for the Catalytic Enantioselective Synthesis of α-Trifluoromethyl Amines. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2020,</strong> <em>10 </em>
                                    (21)
                                     , 12507-12536. <a href="https://doi.org/10.1021/acscatal.0c03569" title="DOI URL">https://doi.org/10.1021/acscatal.0c03569</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.0c03569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.0c03569%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DStrategies%252Bfor%252Bthe%252BCatalytic%252BEnantioselective%252BSynthesis%252Bof%252B%2525CE%2525B1-Trifluoromethyl%252BAmines%26aulast%3DOnyeagusi%26aufirst%3DChibueze%2BI.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D14082020%26date%3D02102020%26date%3D12102020%26volume%3D10%26issue%3D21%26spage%3D12507%26epage%3D12536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jianzhong Chen, Baohua Yin, Wei Wang, <span class="NLM_string-name hlFld-ContribAuthor">Haibo Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of Disulfide Bonds on Binding of Inhibitors to β-Amyloid Cleaving Enzyme 1 Decoded by Multiple Replica Accelerated Molecular Dynamics Simulations. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2020,</strong> <em>11 </em>
                                    (12)
                                     , 1811-1826. <a href="https://doi.org/10.1021/acschemneuro.0c00234" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00234</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00234%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DEffects%252Bof%252BDisulfide%252BBonds%252Bon%252BBinding%252Bof%252BInhibitors%252Bto%252B%2525CE%2525B2-Amyloid%252BCleaving%252BEnzyme%252B1%252BDecoded%252Bby%252BMultiple%252BReplica%252BAccelerated%252BMolecular%252BDynamics%252BSimulations%26aulast%3DChen%26aufirst%3DJianzhong%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D21042020%26date%3D27052020%26date%3D08062020%26date%3D27052020%26volume%3D11%26issue%3D12%26spage%3D1811%26epage%3D1826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">André Fischer, Charleen G. Don, <span class="NLM_string-name hlFld-ContribAuthor">Martin Smieško</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Dynamics Simulations Reveal Structural Differences among Allelic Variants of Membrane-Anchored Cytochrome P450 2D6. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2018,</strong> <em>58 </em>
                                    (9)
                                     , 1962-1975. <a href="https://doi.org/10.1021/acs.jcim.8b00080" title="DOI URL">https://doi.org/10.1021/acs.jcim.8b00080</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.8b00080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.8b00080%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DMolecular%252BDynamics%252BSimulations%252BReveal%252BStructural%252BDifferences%252Bamong%252BAllelic%252BVariants%252Bof%252BMembrane-Anchored%252BCytochrome%252BP450%252B2D6%26aulast%3DFischer%26aufirst%3DAndr%25C3%25A9%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D09022018%26date%3D04092018%26date%3D20082018%26volume%3D58%26issue%3D9%26spage%3D1962%26epage%3D1975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ibidapo
S. Williams, Linda Gatchie, Sandip B. Bharate, <span class="NLM_string-name hlFld-ContribAuthor">Bhabatosh Chaudhuri</span>. </span><span class="cited-content_cbyCitation_article-title">Biotransformation, Using Recombinant CYP450-Expressing Baker’s Yeast Cells, Identifies a Novel CYP2D6.10A122V Variant Which Is a Superior Metabolizer of Codeine to Morphine Than the Wild-Type Enzyme. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2018,</strong> <em>3 </em>
                                    (8)
                                     , 8903-8912. <a href="https://doi.org/10.1021/acsomega.8b00809" title="DOI URL">https://doi.org/10.1021/acsomega.8b00809</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.8b00809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.8b00809%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DBiotransformation%25252C%252BUsing%252BRecombinant%252BCYP450-Expressing%252BBaker%2525E2%252580%252599s%252BYeast%252BCells%25252C%252BIdentifies%252Ba%252BNovel%252BCYP2D6.10A122V%252BVariant%252BWhich%252BIs%252Ba%252BSuperior%252BMetabolizer%252Bof%252BCodeine%252Bto%252BMorphine%252BThan%252Bthe%252BWild-Type%252BEnzyme%26aulast%3DWilliams%26aufirst%3DIbidapo%2BS.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D25042018%26date%3D30072018%26volume%3D3%26issue%3D8%26spage%3D8903%26epage%3D8912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Nicholas A. Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (14)
                                     , 5822-5880. <a href="https://doi.org/10.1021/acs.jmedchem.7b01788" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01788</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01788%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFluorine%252Band%252BFluorinated%252BMotifs%252Bin%252Bthe%252BDesign%252Band%252BApplication%252Bof%252BBioisosteres%252Bfor%252BDrug%252BDesign%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D05122017%26date%3D05022018%26volume%3D61%26issue%3D14%26spage%3D5822%26epage%3D5880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">The Design and Application of Bioisosteres in Drug Design. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-81. <a href="https://doi.org/10.1002/0471266949.bmc259" title="DOI URL">https://doi.org/10.1002/0471266949.bmc259</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc259%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDesign%252Band%252BApplication%252Bof%252BBioisosteres%252Bin%252BDrug%252BDesign%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D81%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frederik  Rombouts</span>, <span class="hlFld-ContribAuthor ">Ken-ichi  Kusakabe</span>, <span class="hlFld-ContribAuthor ">Chien-Chi  Hsiao</span>, <span class="hlFld-ContribAuthor ">Harrie J. M.  Gijsen</span>. </span><span class="cited-content_cbyCitation_article-title">Small-molecule BACE1 inhibitors: a patent literature review (2011 to 2020). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>31 </em>
                                    (1)
                                     , 25-52. <a href="https://doi.org/10.1080/13543776.2021.1832463" title="DOI URL">https://doi.org/10.1080/13543776.2021.1832463</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1832463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1832463%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DSmall-molecule%252BBACE1%252Binhibitors%25253A%252Ba%252Bpatent%252Bliterature%252Breview%252B%2525282011%252Bto%252B2020%252529%26aulast%3DRombouts%26aufirst%3DFrederik%26date%3D2021%26date%3D2020%26volume%3D31%26issue%3D1%26spage%3D25%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennifer R.  Baker</span>, <span class="hlFld-ContribAuthor ">Adam  McCluskey</span>, <span class="hlFld-ContribAuthor ">Cecilia C.  Russell</span>. </span><span class="cited-content_cbyCitation_article-title">1,3-Thiazines and Their Benzo Derivatives. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00104-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00104-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00104-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00104-9%26sid%3Dliteratum%253Aachs%26atitle%3D1%25252C3-Thiazines%252Band%252BTheir%252BBenzo%252BDerivatives%26aulast%3DBaker%26aufirst%3DJennifer%2BR.%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2021%26volume%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muslum  Yildiz</span>. </span><span class="cited-content_cbyCitation_article-title">Docking studies suggest the important role of interactions among the catalytic dyad and inhibitors for designing Bace1 specific inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2020,</strong> <em>1208 </em>, 127893. <a href="https://doi.org/10.1016/j.molstruc.2020.127893" title="DOI URL">https://doi.org/10.1016/j.molstruc.2020.127893</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2020.127893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2020.127893%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DDocking%252Bstudies%252Bsuggest%252Bthe%252Bimportant%252Brole%252Bof%252Binteractions%252Bamong%252Bthe%252Bcatalytic%252Bdyad%252Band%252Binhibitors%252Bfor%252Bdesigning%252BBace1%252Bspecific%252Binhibitors%26aulast%3DYildiz%26aufirst%3DMuslum%26date%3D2020%26volume%3D1208%26spage%3D127893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiayang  Xie</span>, <span class="hlFld-ContribAuthor ">Ruirui  Liang</span>, <span class="hlFld-ContribAuthor ">Yajiang  Wang</span>, <span class="hlFld-ContribAuthor ">Junyi  Huang</span>, <span class="hlFld-ContribAuthor ">Xin  Cao</span>, <span class="hlFld-ContribAuthor ">Bing  Niu</span>. </span><span class="cited-content_cbyCitation_article-title">Progress in Target Drug Molecules for Alzheimer's Disease. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (1)
                                     , 4-36. <a href="https://doi.org/10.2174/1568026619666191203113745" title="DOI URL">https://doi.org/10.2174/1568026619666191203113745</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666191203113745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666191203113745%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DProgress%252Bin%252BTarget%252BDrug%252BMolecules%252Bfor%252BAlzheimer%252527s%252BDisease%26aulast%3DXie%26aufirst%3DJiayang%26date%3D2020%26volume%3D20%26issue%3D1%26spage%3D4%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D.R.  Tonholo</span>, <span class="hlFld-ContribAuthor ">V.G.  Maltarollo</span>, <span class="hlFld-ContribAuthor ">T.  Kronenberger</span>, <span class="hlFld-ContribAuthor ">I.R.  Silva</span>, <span class="hlFld-ContribAuthor ">P.O.  Azevedo</span>, <span class="hlFld-ContribAuthor ">R.B.  Oliveira</span>, <span class="hlFld-ContribAuthor ">L.C.R.  Souza</span>, <span class="hlFld-ContribAuthor ">C.A.  Tagliati</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical toxicity of innovative molecules: In vitro, in vivo and metabolism prediction. </span><span class="cited-content_cbyCitation_journal-name">Chemico-Biological Interactions</span><span> <strong>2020,</strong> <em>315 </em>, 108896. <a href="https://doi.org/10.1016/j.cbi.2019.108896" title="DOI URL">https://doi.org/10.1016/j.cbi.2019.108896</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbi.2019.108896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbi.2019.108896%26sid%3Dliteratum%253Aachs%26jtitle%3DChemico-Biological%2520Interactions%26atitle%3DPreclinical%252Btoxicity%252Bof%252Binnovative%252Bmolecules%25253A%252BIn%252Bvitro%25252C%252Bin%252Bvivo%252Band%252Bmetabolism%252Bprediction%26aulast%3DTonholo%26aufirst%3DD.R.%26date%3D2020%26volume%3D315%26spage%3D108896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaoyi  Sun</span>, <span class="hlFld-ContribAuthor ">Qi  Jia</span>, <span class="hlFld-ContribAuthor ">Zaihui  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Applications of amide isosteres in medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (18)
                                     , 2535-2550. <a href="https://doi.org/10.1016/j.bmcl.2019.07.033" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.07.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.07.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.07.033%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DApplications%252Bof%252Bamide%252Bisosteres%252Bin%252Bmedicinal%252Bchemistry%26aulast%3DSun%26aufirst%3DShaoyi%26date%3D2019%26volume%3D29%26issue%3D18%26spage%3D2535%26epage%3D2550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yung-Chih  Kuo</span>, <span class="hlFld-ContribAuthor ">Rajendiran  Rajesh</span>. </span><span class="cited-content_cbyCitation_article-title">Challenges in the treatment of Alzheimer’s disease: recent progress and treatment strategies of pharmaceuticals targeting notable pathological factors. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Neurotherapeutics</span><span> <strong>2019,</strong> <em>19 </em>
                                    (7)
                                     , 623-652. <a href="https://doi.org/10.1080/14737175.2019.1621750" title="DOI URL">https://doi.org/10.1080/14737175.2019.1621750</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14737175.2019.1621750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14737175.2019.1621750%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Neurotherapeutics%26atitle%3DChallenges%252Bin%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%25253A%252Brecent%252Bprogress%252Band%252Btreatment%252Bstrategies%252Bof%252Bpharmaceuticals%252Btargeting%252Bnotable%252Bpathological%252Bfactors%26aulast%3DKuo%26aufirst%3DYung-Chih%26date%3D2019%26date%3D2019%26volume%3D19%26issue%3D7%26spage%3D623%26epage%3D652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chien-Chi  Hsiao</span>, <span class="hlFld-ContribAuthor ">Frederik  Rombouts</span>, <span class="hlFld-ContribAuthor ">Harrie J.M.  Gijsen</span>. </span><span class="cited-content_cbyCitation_article-title">New evolutions in the BACE1 inhibitor field from 2014 to 2018. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (6)
                                     , 761-777. <a href="https://doi.org/10.1016/j.bmcl.2018.12.049" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.12.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.12.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.12.049%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNew%252Bevolutions%252Bin%252Bthe%252BBACE1%252Binhibitor%252Bfield%252Bfrom%252B2014%252Bto%252B2018%26aulast%3DHsiao%26aufirst%3DChien-Chi%26date%3D2019%26volume%3D29%26issue%3D6%26spage%3D761%26epage%3D777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charleen G.  Don</span>, <span class="hlFld-ContribAuthor ">Martin  Smieško</span>. </span><span class="cited-content_cbyCitation_article-title">Out‐compute drug side effects: Focus on cytochrome P450 2D6 modeling. </span><span class="cited-content_cbyCitation_journal-name">WIREs Computational Molecular Science</span><span> <strong>2018,</strong> <em>8 </em>
                                    (5)
                                     <a href="https://doi.org/10.1002/wcms.1366" title="DOI URL">https://doi.org/10.1002/wcms.1366</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/wcms.1366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fwcms.1366%26sid%3Dliteratum%253Aachs%26jtitle%3DWIREs%2520Computational%2520Molecular%2520Science%26atitle%3DOut%2525E2%252580%252590compute%252Bdrug%252Bside%252Beffects%25253A%252BFocus%252Bon%252Bcytochrome%252BP450%252B2D6%252Bmodeling%26aulast%3DDon%26aufirst%3DCharleen%2BG.%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Verònica  Postils</span>, <span class="hlFld-ContribAuthor ">Maud  Saint-André</span>, <span class="hlFld-ContribAuthor ">Amy  Timmins</span>, <span class="hlFld-ContribAuthor ">Xiao-Xi  Li</span>, <span class="hlFld-ContribAuthor ">Yong  Wang</span>, <span class="hlFld-ContribAuthor ">Josep  Luis</span>, <span class="hlFld-ContribAuthor ">Miquel  Solà</span>, <span class="hlFld-ContribAuthor ">Sam  de Visser</span>. </span><span class="cited-content_cbyCitation_article-title">Quantum Mechanics/Molecular Mechanics Studies on the Relative Reactivities of Compound I and II in Cytochrome P450 Enzymes. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2018,</strong> <em>19 </em>
                                    (7)
                                     , 1974. <a href="https://doi.org/10.3390/ijms19071974" title="DOI URL">https://doi.org/10.3390/ijms19071974</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms19071974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms19071974%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DQuantum%252BMechanics%25252FMolecular%252BMechanics%252BStudies%252Bon%252Bthe%252BRelative%252BReactivities%252Bof%252BCompound%252BI%252Band%252BII%252Bin%252BCytochrome%252BP450%252BEnzymes%26aulast%3DPostils%26aufirst%3DVer%25C3%25B2nica%26date%3D2018%26date%3D2018%26volume%3D19%26issue%3D7%26spage%3D1974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Judite R. M.  Coimbra</span>, <span class="hlFld-ContribAuthor ">Daniela F. F.  Marques</span>, <span class="hlFld-ContribAuthor ">Salete J.  Baptista</span>, <span class="hlFld-ContribAuthor ">Cláudia M. F.  Pereira</span>, <span class="hlFld-ContribAuthor ">Paula I.  Moreira</span>, <span class="hlFld-ContribAuthor ">Teresa C. P.  Dinis</span>, <span class="hlFld-ContribAuthor ">Armanda E.  Santos</span>, <span class="hlFld-ContribAuthor ">Jorge A. R.  Salvador</span>. </span><span class="cited-content_cbyCitation_article-title">Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2018,</strong> <em>6 </em><a href="https://doi.org/10.3389/fchem.2018.00178" title="DOI URL">https://doi.org/10.3389/fchem.2018.00178</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2018.00178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2018.00178%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DHighlights%252Bin%252BBACE1%252BInhibitors%252Bfor%252BAlzheimer%252527s%252BDisease%252BTreatment%26aulast%3DCoimbra%26aufirst%3DJudite%2BR.%2BM.%26date%3D2018%26date%3D2018%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simone  Bertini</span>, <span class="hlFld-ContribAuthor ">Elisa  Ghilardi</span>, <span class="hlFld-ContribAuthor ">Valentina  Asso</span>, <span class="hlFld-ContribAuthor ">Filippo  Minutolo</span>, <span class="hlFld-ContribAuthor ">Simona  Rapposelli</span>, <span class="hlFld-ContribAuthor ">Maria  Digiacomo</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Saccomanni</span>, <span class="hlFld-ContribAuthor ">Veronica  Salmaso</span>, <span class="hlFld-ContribAuthor ">Mattia  Sturlese</span>, <span class="hlFld-ContribAuthor ">Stefano  Moro</span>, <span class="hlFld-ContribAuthor ">Marco  Macchia</span>, <span class="hlFld-ContribAuthor ">Clementina  Manera</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfonamido-derivatives of unsubstituted carbazoles as BACE1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (21)
                                     , 4812-4816. <a href="https://doi.org/10.1016/j.bmcl.2017.09.058" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.09.058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.09.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.09.058%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSulfonamido-derivatives%252Bof%252Bunsubstituted%252Bcarbazoles%252Bas%252BBACE1%252Binhibitors%26aulast%3DBertini%26aufirst%3DSimone%26date%3D2017%26volume%3D27%26issue%3D21%26spage%3D4812%26epage%3D4816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Riccardo  Innocenti</span>, <span class="hlFld-ContribAuthor ">Elena  Lenci</span>, <span class="hlFld-ContribAuthor ">Gloria  Menchi</span>, <span class="hlFld-ContribAuthor ">Alberto  Pupi</span>, <span class="hlFld-ContribAuthor ">Andrea  Trabocchi</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of bicyclic acetals as Beta Secretase (BACE1) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (19)
                                     , 5077-5083. <a href="https://doi.org/10.1016/j.bmc.2017.03.030" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.03.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.03.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.03.030%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bbicyclic%252Bacetals%252Bas%252BBeta%252BSecretase%252B%252528BACE1%252529%252Binhibitors%26aulast%3DInnocenti%26aufirst%3DRiccardo%26date%3D2017%26volume%3D25%26issue%3D19%26spage%3D5077%26epage%3D5083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gang  Yan</span>, <span class="hlFld-ContribAuthor ">Lina  Hao</span>, <span class="hlFld-ContribAuthor ">Yan  Niu</span>, <span class="hlFld-ContribAuthor ">Wenjie  Huang</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Fengrong  Xu</span>, <span class="hlFld-ContribAuthor ">Lei  Liang</span>, <span class="hlFld-ContribAuthor ">Chao  Wang</span>, <span class="hlFld-ContribAuthor ">Hongwei  Jin</span>, <span class="hlFld-ContribAuthor ">Ping  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">2-Substituted-thio- N -(4-substituted-thiazol/1 H -imidazol-2-yl)acetamides as BACE1 inhibitors: Synthesis, biological evaluation and docking studies. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>137 </em>, 462-475. <a href="https://doi.org/10.1016/j.ejmech.2017.06.020" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.06.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.06.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.06.020%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D2-Substituted-thio-%252BN%252B-%2525284-substituted-thiazol%25252F1%252BH%252B-imidazol-2-yl%252529acetamides%252Bas%252BBACE1%252Binhibitors%25253A%252BSynthesis%25252C%252Bbiological%252Bevaluation%252Band%2525C2%2525A0docking%252Bstudies%26aulast%3DYan%26aufirst%3DGang%26date%3D2017%26volume%3D137%26spage%3D462%26epage%3D475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/medium/jm-2016-01451z_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01451&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/medium/jm-2016-01451z_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selected literature BACE1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01451&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/medium/jm-2016-01451z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Interaction between Gly230 and <b>2</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZMG">3ZMG</a>, add 61 to residue numbers to match <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZMG">3ZMG</a>’s number).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01451&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/medium/jm-2016-01451z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Strategy to mitigate challenges associated with amide pharmacophore of literature BACE inhibitors. Modeled alignment of aminomethyl design (orange) with compound <b>2</b> (yellow).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01451&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/medium/jm-2016-01451z_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0010.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01451&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeLi, Et<sub>2</sub>O, <i>n-</i>BuLi, then DMF, −78 °C, 92%; (b) amine, Na(OAc)<sub>3</sub>BH, DCE, rt, 22–97%; (c) HCl, dioxane, rt, 19–90%; (d) benzoic anhydride, TEA, THF/MeOH (2:1), rt, 86%; (e) N<sub>2</sub>H<sub>4</sub>·H<sub>2</sub>O, EtOH, rt, 31%. P = Boc or benzoyl.</p></p></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/medium/jm-2016-01451z_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Crystal structure of <b>6u</b> in BACE1 binding site. PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T1U">5T1U</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01451&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/medium/jm-2016-01451z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of trifluoromethylcyclopropyl <b>6u</b> on brain Aβx-42 following subcutaneous administration in wild-type mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01451&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/medium/jm-2016-01451z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Metabolic profile of fused THP series.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01451&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/medium/jm-2016-01451z_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0011.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01451&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeLi, Et<sub>2</sub>O, <i>n</i>-BuLi, then DMF, −78 °C, 89%; (b) amine, Na(OAc)<sub>3</sub>BH, DCE, rt, 93%; (c) HCl, dioxane, rt, 19%.</p></p></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/medium/jm-2016-01451z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0007.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Comparison of the binding of <b>6u</b> (A) and <b>12</b> (B) with the binding of <b>7</b> (C) in the active site of CYP 2D6.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01451&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/medium/jm-2016-01451z_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0012.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01451&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd<sub>2</sub>(dba)<sub>3</sub>, dppf, zinc, Zn(CN)<sub>2</sub>, DMA, 130 °C, 85%; (b) Raney Ni, H<sub>2</sub>, triethylamine, Boc<sub>2</sub>O, H<sub>2</sub>O, EtOH, rt, then HCl, MeOH, 61%; (c) 2,2,2-trifluoroethyl trifluoromethylsulfonate, trimethylamine, MeCN, 70 °C, then DBU, MeOH, 71%.</p></p></figure><figure data-id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/medium/jm-2016-01451z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0008.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Effect of fused THP analogue <b>16</b> on brain Aβx-42 following subcutaneous administration in wild-type mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01451&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/medium/jm-2016-01451z_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0009.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Co-crystal structure of <b>16</b> in BACE1. PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T1W">5T1W</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01451/20171206/images/large/jm-2016-01451z_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01451&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i82">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74835" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74835" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 36 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allsop, D.</span><span> </span><span class="NLM_article-title">Amyloid deposition as the central event in the aetiology of Alzheimer’s disease</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span><span class="refDoi"> DOI: 10.1016/0165-6147(91)90609-V</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1016%2F0165-6147%2891%2990609-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1763432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADyaK3MXmslKktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1991&pages=383-388&author=J.+Hardyauthor=D.+Allsop&title=Amyloid+deposition+as+the+central+event+in+the+aetiology+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2F0165-6147%2891%2990609-V"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid deposition as the central event in the etiology of Alzheimer's disease</span></div><div class="casAuthors">Hardy, John; Allsop, David</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">383-8</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    </div><div class="casAbstract">A review with 50 refs. of pathol. and etiol. of Alzheimer's disease; the function of β-amyloid precursor protein and the mechanism of formation of cerebrovascular amyloid peptide β/A4; and the progression of the disease from amyloid formation to neurofibrillary tangles and cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryRPqP0OKB5rVg90H21EOLACvtfcHk0lgyuAsRXS7kcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXmslKktr8%253D&md5=7756055cd27bec2821c9926267a93872</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2F0165-6147%2891%2990609-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-6147%252891%252990609-V%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DAllsop%26aufirst%3DD.%26atitle%3DAmyloid%2520deposition%2520as%2520the%2520central%2520event%2520in%2520the%2520aetiology%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1991%26volume%3D12%26spage%3D383%26epage%3D388%26doi%3D10.1016%2F0165-6147%2891%2990609-V" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertram, L.</span><span> </span><span class="NLM_article-title">Twenty years of the Alzheimer’s disease amyloid hypothesis: A genetic perspective</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">555</span><span class="refDoi"> DOI: 10.1016/j.cell.2005.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1016%2Fj.cell.2005.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=15734686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVWnu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2005&pages=545-555&author=R.+E.+Tanziauthor=L.+Bertram&title=Twenty+years+of+the+Alzheimer%E2%80%99s+disease+amyloid+hypothesis%3A+A+genetic+perspective&doi=10.1016%2Fj.cell.2005.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective</span></div><div class="casAuthors">Tanzi, Rudolph E.; Bertram, Lars</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">545-555</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  From Alois Alzheimer's description of Auguste D.'s brain in 1907 to George Glenner's biochem. dissection of β-amyloid in 1984, the "amyloid hypothesis" of Alzheimer's disease has continued to gain support over the past two decades, particularly from genetic studies.  Here we assess the amyloid hypothesis based on both known and putative Alzheimer's disease genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPVQvwUmMmXrVg90H21EOLACvtfcHk0lgyuAsRXS7kcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVWnu7k%253D&md5=3f88dc7dda6b726429789c61d5992493</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2005.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2005.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DBertram%26aufirst%3DL.%26atitle%3DTwenty%2520years%2520of%2520the%2520Alzheimer%25E2%2580%2599s%2520disease%2520amyloid%2520hypothesis%253A%2520A%2520genetic%2520perspective%26jtitle%3DCell%26date%3D2005%26volume%3D120%26spage%3D545%26epage%3D555%26doi%3D10.1016%2Fj.cell.2005.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">Proteases and proteolysis in Alzheimer Disease: a multifactorial view on the disease process</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">494</span><span class="refDoi"> DOI: 10.1152/physrev.00023.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1152%2Fphysrev.00023.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=20393191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1erurjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2010&pages=465-494&author=B.+De+Strooper&title=Proteases+and+proteolysis+in+Alzheimer+Disease%3A+a+multifactorial+view+on+the+disease+process&doi=10.1152%2Fphysrev.00023.2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process</span></div><div class="casAuthors">De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">465-494</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  Alzheimer disease is characterized by the accumulation of abnormally folded protein fragments, i.e., amyloid beta peptide (Aβ) and tau that ppt. in amyloid plaques and neuronal tangles, resp.  In this review we discuss the complicated proteolytic pathways that are responsible for the generation and clearance of these fragments, and how disturbances in these pathways interact and provide a background for a novel understanding of Alzheimer disease as a multifactorial disorder.  Recent insights evolve from the static view that the morphol. defined plaques and tangles are disease driving towards a more dynamic, biochem. view in which the intermediary sol. Aβ oligomers and sol. tau fragments are considered as the main mediators of neurotoxicity.  The relevance of proteolytic pathways, centered on the generation and clearance of toxic Aβ, on the cleavage and nucleation of tau, and on the general proteostasis of the neurons, then becomes obvious.  Blocking or stimulating these pathways provide, or have the potential to provide, interesting drug targets, which raises the hope that we will be able to provide a cure for this dreadful disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrstXCXtuTzCrVg90H21EOLACvtfcHk0lgyuAsRXS7kcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1erurjF&md5=be45257bc56a5779b6ef7e18e98b0738</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00023.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00023.2009%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DProteases%2520and%2520proteolysis%2520in%2520Alzheimer%2520Disease%253A%2520a%2520multifactorial%2520view%2520on%2520the%2520disease%2520process%26jtitle%3DPhysiol.%2520Rev.%26date%3D2010%26volume%3D90%26spage%3D465%26epage%3D494%26doi%3D10.1152%2Fphysrev.00023.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovacs, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span> </span><span class="NLM_article-title">The beta-secretase enzyme BACE in health and Alzheimer’s disease: regulation, cell biology, function, and therapeutic potential</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">12787</span><span class="NLM_x">–</span> <span class="NLM_lpage">12794</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.3657-09.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1523%2FJNEUROSCI.3657-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=19828790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSit7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=12787-12794&author=R.+Vassarauthor=D.+M.+Kovacsauthor=R.+Yanauthor=P.+C.+Wong&title=The+beta-secretase+enzyme+BACE+in+health+and+Alzheimer%E2%80%99s+disease%3A+regulation%2C+cell+biology%2C+function%2C+and+therapeutic+potential&doi=10.1523%2FJNEUROSCI.3657-09.2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The β-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential</span></div><div class="casAuthors">Vassar, Robert; Kovacs, Dora M.; Yan, Riqiang; Wong, Philip C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">12787-12794</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">A review.  The β-amyloid (Aβ) peptide is the major constituent of amyloid plaques in Alzheimer's disease (AD) brain and is likely to play a central role in the pathogenesis of this devastating neurodegenerative disorder.  The β-secretase, β-site amyloid precursor protein cleaving enzyme (BACE1; also called Asp2, memapsin 2), is the enzyme responsible for initiating Aβ generation.  Thus, BACE is a prime drug target for the therapeutic inhibition of Aβ prodn. in AD.  Since its discovery 10 years ago, much has been learned about BACE.  This review summarizes BACE properties, describes BACE translation dysregulation in AD, and discusses BACE physiol. functions in sodium current, synaptic transmission, myelination, and schizophrenia.  The therapeutic potential of BACE will also be considered.  This is a summary of topics covered at a symposium held at the 39th annual meeting of the Society for Neuroscience and is not meant to be a comprehensive review of BACE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqGn8h_x-7_bVg90H21EOLACvtfcHk0lgyuAsRXS7kcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSit7bP&md5=a462ad002cf3801570725719d71647c6</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3657-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3657-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DKovacs%26aufirst%3DD.%2BM.%26aulast%3DYan%26aufirst%3DR.%26aulast%3DWong%26aufirst%3DP.%2BC.%26atitle%3DThe%2520beta-secretase%2520enzyme%2520BACE%2520in%2520health%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520regulation%252C%2520cell%2520biology%252C%2520function%252C%2520and%2520therapeutic%2520potential%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D12787%26epage%3D12794%26doi%3D10.1523%2FJNEUROSCI.3657-09.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Marks, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, M. J.</span><span> </span><span class="NLM_article-title">BACE and gamma-secretase characterization and their sorting as therapeutic targets to reduce amyloidogenesis</span> <span class="citation_source-journal">Neurochem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span><span class="refDoi"> DOI: 10.1007/s11064-009-0054-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1007%2Fs11064-009-0054-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=19760173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFentLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=181-210&author=N.+Marksauthor=M.+J.+Berg&title=BACE+and+gamma-secretase+characterization+and+their+sorting+as+therapeutic+targets+to+reduce+amyloidogenesis&doi=10.1007%2Fs11064-009-0054-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">BACE and γ-secretase characterization and their sorting as therapeutic targets to reduce amyloidogenesis</span></div><div class="casAuthors">Marks, Neville; Berg, Martin J.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-210</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Secretases are enzymes that process amyloid precursor protein (APP), a prototypic type-1 membrane protein.  This has led directly to discovery of novel aspartic proteases (β-secretase or BACE), a tetramer complex, γ-secretase (γ-SC) contg. presenilins, nicastrin, aph-1 and pen-2, and a new role for metalloprotease(s) of the ADAM family as α-secretases.  Recent advances in defining pathways that mediate endosomal/lysosomal/autophagic/exosomal trafficking now provide targets for new drugs to attenuate abnormal prodn. of fibril-forming products characteristic of Alzheimer's disease (AD).  A key to success includes not only characterization of relevant secretases, but mechanisms for sorting and transport of key metabolites to abnormal vesicles or sites for assembly of fibrils.  New developments highlighted here include an important role for an 'early recycling endosome' coated in a retromer complex contg. lipoprotein receptor LRP-II (SorLA) for switching APP to a non-amyloidogenic pathway for α-secretase processing, or to shuttle APP to a 'late endosome compartment' to form Aβ or AICD.  LRP11 (SorLA) is of particular importance since it decreases in sporadic AD whose etiol. is otherwise unknown.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptFxOS-WJwAbVg90H21EOLACvtfcHk0lgxApK4o6mkPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFentLnJ&md5=312eb981ae39671456e316bf050166dc</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs11064-009-0054-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11064-009-0054-1%26sid%3Dliteratum%253Aachs%26aulast%3DMarks%26aufirst%3DN.%26aulast%3DBerg%26aufirst%3DM.%2BJ.%26atitle%3DBACE%2520and%2520gamma-secretase%2520characterization%2520and%2520their%2520sorting%2520as%2520therapeutic%2520targets%2520to%2520reduce%2520amyloidogenesis%26jtitle%3DNeurochem.%2520Res.%26date%3D2010%26volume%3D35%26spage%3D181%26epage%3D210%26doi%3D10.1007%2Fs11064-009-0054-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Jonsson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snaedal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulem, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudbjartsson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyte, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhangale, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huttenlocher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsdottir, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreassen, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palotie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrens, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, O. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorsteinsdottir, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, K.</span><span> </span><span class="NLM_article-title">A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">488</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span><span class="refDoi"> DOI: 10.1038/nature11283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1038%2Fnature11283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=22801501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=96-99&author=T.+Jonssonauthor=J.+K.+Atwalauthor=S.+Steinbergauthor=J.+Snaedalauthor=P.+V.+Jonssonauthor=S.+Bjornssonauthor=H.+Stefanssonauthor=P.+Sulemauthor=D.+Gudbjartssonauthor=J.+Maloneyauthor=K.+Hoyteauthor=A.+Gustafsonauthor=Y.+Liuauthor=Y.+Luauthor=T.+Bhangaleauthor=R.+R.+Grahamauthor=J.+Huttenlocherauthor=G.+Bjornsdottirauthor=O.+A.+Andreassenauthor=E.+G.+Jonssonauthor=A.+Palotieauthor=T.+W.+Behrensauthor=O.+T.+Magnussonauthor=A.+Kongauthor=U.+Thorsteinsdottirauthor=R.+J.+Wattsauthor=K.+Stefansson&title=A+mutation+in+APP+protects+against+Alzheimer%E2%80%99s+disease+and+age-related+cognitive+decline&doi=10.1038%2Fnature11283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">A mutation in APP protects against Alzheimer's disease and age-related cognitive decline</span></div><div class="casAuthors">Jonsson, Thorlakur; Atwal, Jasvinder K.; Steinberg, Stacy; Snaedal, Jon; Jonsson, Palmi V.; Bjornsson, Sigurbjorn; Stefansson, Hreinn; Sulem, Patrick; Gudbjartsson, Daniel; Maloney, Janice; Hoyte, Kwame; Gustafson, Amy; Liu, Yichin; Lu, Yanmei; Bhangale, Tushar; Graham, Robert R.; Huttenlocher, Johanna; Bjornsdottir, Gyda; Andreassen, Ole A.; Joensson, Erik G.; Palotie, Aarno; Behrens, Timothy W.; Magnusson, Olafur T.; Kong, Augustine; Thorsteinsdottir, Unnur; Watts, Ryan J.; Stefansson, Kari</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">488</span>
        (<span class="NLM_cas:issue">7409</span>),
    <span class="NLM_cas:pages">96-99</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prevalence of dementia in the Western world in people over the age of 60 has been estd. to be greater than 5%, about two-thirds of which are due to Alzheimer's disease.  The age-specific prevalence of Alzheimer's disease nearly doubles every 5 years after age 65, leading to a prevalence of greater than 25% in those over the age of 90 (ref. 3).  Here, to search for low-frequency variants in the amyloid-β precursor protein (APP) gene with a significant effect on the risk of Alzheimer's disease, we studied coding variants in APP in a set of whole-genome sequence data from 1795 Icelanders.  We found a coding mutation (A673T) in the APP gene that protects against Alzheimer's disease and cognitive decline in the elderly without Alzheimer's disease.  This substitution is adjacent to the aspartyl protease β-site in APP, and results in an approx. 40% redn. in the formation of amyloidogenic peptides in vitro.  The strong protective effect of the A673T substitution against Alzheimer's disease provides proof of principle for the hypothesis that reducing the β-cleavage of APP may protect against the disease.  Furthermore, as the A673T allele also protects against cognitive decline in the elderly without Alzheimer's disease, the two may be mediated through the same or similar mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4AFwQCLRQOLVg90H21EOLACvtfcHk0lgxApK4o6mkPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M&md5=4db9cb2e3842d5a9d4af4ce102249b70</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnature11283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11283%26sid%3Dliteratum%253Aachs%26aulast%3DJonsson%26aufirst%3DT.%26aulast%3DAtwal%26aufirst%3DJ.%2BK.%26aulast%3DSteinberg%26aufirst%3DS.%26aulast%3DSnaedal%26aufirst%3DJ.%26aulast%3DJonsson%26aufirst%3DP.%2BV.%26aulast%3DBjornsson%26aufirst%3DS.%26aulast%3DStefansson%26aufirst%3DH.%26aulast%3DSulem%26aufirst%3DP.%26aulast%3DGudbjartsson%26aufirst%3DD.%26aulast%3DMaloney%26aufirst%3DJ.%26aulast%3DHoyte%26aufirst%3DK.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DBhangale%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DR.%2BR.%26aulast%3DHuttenlocher%26aufirst%3DJ.%26aulast%3DBjornsdottir%26aufirst%3DG.%26aulast%3DAndreassen%26aufirst%3DO.%2BA.%26aulast%3DJonsson%26aufirst%3DE.%2BG.%26aulast%3DPalotie%26aufirst%3DA.%26aulast%3DBehrens%26aufirst%3DT.%2BW.%26aulast%3DMagnusson%26aufirst%3DO.%2BT.%26aulast%3DKong%26aufirst%3DA.%26aulast%3DThorsteinsdottir%26aufirst%3DU.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DStefansson%26aufirst%3DK.%26atitle%3DA%2520mutation%2520in%2520APP%2520protects%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520age-related%2520cognitive%2520decline%26jtitle%3DNature%26date%3D2012%26volume%3D488%26spage%3D96%26epage%3D99%26doi%3D10.1038%2Fnature11283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Evin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hince, C.</span><span> </span><span class="NLM_article-title">BACE1 as a therapeutic target in Alzheimer’s disease: rationale and current status</span> <span class="citation_source-journal">Drugs Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">755</span><span class="NLM_x">–</span> <span class="NLM_lpage">764</span><span class="refDoi"> DOI: 10.1007/s40266-013-0099-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1007%2Fs40266-013-0099-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=23842796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVWmt7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2013&pages=755-764&author=G.+Evinauthor=C.+Hince&title=BACE1+as+a+therapeutic+target+in+Alzheimer%E2%80%99s+disease%3A+rationale+and+current+status&doi=10.1007%2Fs40266-013-0099-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 as a Therapeutic Target in Alzheimer's Disease: Rationale and Current Status</span></div><div class="casAuthors">Evin, Genevieve; Hince, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Drugs & Aging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">755-764</span>CODEN:
                <span class="NLM_cas:coden">DRAGE6</span>;
        ISSN:<span class="NLM_cas:issn">1170-229X</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a neurodegenerative disease of the central nervous system that causes dementia in a large percentage of the aged population and for which there are only symptomatic treatments.  Disease-modifying therapies that are currently being pursued are based on the amyloid cascade theory.  This states that accumulation of amyloid β (Aβ) in the brain triggers a cascade of cellular events leading to neurodegeneration.  Aβ, which is the major constituent of amyloid plaques, is a peptidic fragment derived from proteolytic processing of the amyloid precursor protein (APP) by sequential cleavages that involve β-site APP-cleaving enzyme 1 (BACE1) and γ-secretase.  Targeting BACE1 is a rational approach as its cleavage of APP is the rate-limiting step in Aβ prodn. and this enzyme is elevated in the brain of patients with AD.  Furthermore, knocking out the BACE1 gene in mice showed little apparent consequences.  Ten years of intensive research has led to the design of efficacious BACE1 inhibitors with favorable pharmacol. properties.  Several drug candidates have shown promising results in animal models, as they reduce amyloid plaque pathol. in the brain and rescue cognitive deficits.  Phase I clin. trials indicate that these drugs are well tolerated, and the results from further trials in AD patients are now awaited eagerly.  Yet, recent novel information on BACE1 biol., and the discovery that BACE1 cleaves a selection of substrates involved in myelination, retinal homeostasis, brain circuitry, and synaptic function, alert us to potential side effects of BACE1 inhibitors that will require further evaluation to provide a safe therapy for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaEqXQKm8PabVg90H21EOLACvtfcHk0liSy-7ztVeOvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVWmt7bI&md5=356aae7bd5a2aeb1ea1c208be4b0a5f3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2Fs40266-013-0099-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40266-013-0099-3%26sid%3Dliteratum%253Aachs%26aulast%3DEvin%26aufirst%3DG.%26aulast%3DHince%26aufirst%3DC.%26atitle%3DBACE1%2520as%2520a%2520therapeutic%2520target%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520rationale%2520and%2520current%2520status%26jtitle%3DDrugs%2520Aging%26date%3D2013%26volume%3D30%26spage%3D755%26epage%3D764%26doi%3D10.1007%2Fs40266-013-0099-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tristani-Firouzi, M.</span><span> </span><span class="NLM_article-title">hERG potassium channels and cardiac arrhythmia</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">440</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span><span class="refDoi"> DOI: 10.1038/nature04710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1038%2Fnature04710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=16554806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1OlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=440&publication_year=2006&pages=463-469&author=M.+C.+Sanguinettiauthor=M.+Tristani-Firouzi&title=hERG+potassium+channels+and+cardiac+arrhythmia&doi=10.1038%2Fnature04710"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">hERG potassium channels and cardiac arrhythmia</span></div><div class="casAuthors">Sanguinetti, Michael C.; Tristani-Firouzi, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">440</span>
        (<span class="NLM_cas:issue">7083</span>),
    <span class="NLM_cas:pages">463-469</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  HERG potassium channels are essential for normal elec. activity in the heart.  Inherited mutations in the HERG gene cause long QT syndrome, a disorder that predisposes individuals to life-threatening arrhythmias.  Arrhythmia can also be induced by a blockage of hERG channels by a surprisingly diverse group of drugs.  This side effect is a common reason for drug failure in preclin. safety trials.  Insights gained from the crystal structures of other potassium channels have helped our understanding of the block of hERG channels and the mechanisms of gating.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopS3WBEpuAUrVg90H21EOLACvtfcHk0liSy-7ztVeOvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1OlsLs%253D&md5=3f355dcd51da3488d73c7c91cbe8d3b8</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1038%2Fnature04710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04710%26sid%3Dliteratum%253Aachs%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26aulast%3DTristani-Firouzi%26aufirst%3DM.%26atitle%3DhERG%2520potassium%2520channels%2520and%2520cardiac%2520arrhythmia%26jtitle%3DNature%26date%3D2006%26volume%3D440%26spage%3D463%26epage%3D469%26doi%3D10.1038%2Fnature04710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keating, M. T.</span><span> </span><span class="NLM_article-title">A mechanistic link between an inherited and an acquired cardiac arrhythmia: hERG encodes the IKr potassium channel</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span><span class="refDoi"> DOI: 10.1016/0092-8674(95)90340-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1016%2F0092-8674%2895%2990340-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=7736582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADyaK2MXlt1Kis7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1995&pages=299-307&author=M.+C.+Sanguinettiauthor=C.+Jiangauthor=M.+E.+Curranauthor=M.+T.+Keating&title=A+mechanistic+link+between+an+inherited+and+an+acquired+cardiac+arrhythmia%3A+hERG+encodes+the+IKr+potassium+channel&doi=10.1016%2F0092-8674%2895%2990340-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">A mechanistic link between an inherited and an acquired cardiac arrhythmia and HERG encodes the IKr potassium channel</span></div><div class="casAuthors">Sanguinetti, Michael C.; Jiang, Changan; Curran, Mark E.; Keating, Mark T.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">299-307</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Mutations in HERG cause an inherited cardiac arrhythmia, long QT syndrome (LQT).  To define the function of HERG, we expressed the protein in Xenopus oocytes.  The biophys. properties of expressed HERG are nearly identical to the rapidly activating delayed rectifier K+ current (IKr) in cardiac myocytes.  HERG current is K+ selective, declines with depolarizations above 0 mV, is activated by extracellular K+, and is blocked by lanthanum.  Interestingly, HERG current is not blocked by drugs that specifically block IKr, in cardiac myocytes.  These data indicate that HERG proteins form IKr, channels, but that an addnl. subunit may be required for drug sensitivity.  Since block of IKr is a known mechanism for drug-induced cardiac arrhythmias, the finding that HERG encodes IKr channels provides a mechanistic link between certain forms of inherited and acquired LQT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFu74-_mCypbVg90H21EOLACvtfcHk0liSy-7ztVeOvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlt1Kis7w%253D&md5=a417e4c5e8e9f1457a304b2651e025d0</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2895%2990340-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252895%252990340-2%26sid%3Dliteratum%253Aachs%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DCurran%26aufirst%3DM.%2BE.%26aulast%3DKeating%26aufirst%3DM.%2BT.%26atitle%3DA%2520mechanistic%2520link%2520between%2520an%2520inherited%2520and%2520an%2520acquired%2520cardiac%2520arrhythmia%253A%2520hERG%2520encodes%2520the%2520IKr%2520potassium%2520channel%26jtitle%3DCell%26date%3D1995%26volume%3D81%26spage%3D299%26epage%3D307%26doi%3D10.1016%2F0092-8674%2895%2990340-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Roden, D. M.</span><span> </span><span class="NLM_article-title">Drug-induced prolongation of the QT interval</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1022</span><span class="refDoi"> DOI: 10.1056/NEJMra032426</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1056%2FNEJMra032426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=14999113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFGjs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2004&pages=1013-1022&author=D.+M.+Roden&title=Drug-induced+prolongation+of+the+QT+interval&doi=10.1056%2FNEJMra032426"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-induced prolongation of the QT interval</span></div><div class="casAuthors">Roden, Dan M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1013-1022</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA8PoMXlMg57Vg90H21EOLACvtfcHk0liEWvHPDjwe5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFGjs7Y%253D&md5=a020a545700649d9914ed8dc61910244</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1056%2FNEJMra032426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra032426%26sid%3Dliteratum%253Aachs%26aulast%3DRoden%26aufirst%3DD.%2BM.%26atitle%3DDrug-induced%2520prolongation%2520of%2520the%2520QT%2520interval%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D350%26spage%3D1013%26epage%3D1022%26doi%3D10.1056%2FNEJMra032426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martenyi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monk, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathes, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergott, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timm, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith LaBell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhee, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ereshefsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocke, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span> </span><span class="NLM_article-title">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">16507</span><span class="NLM_x">–</span> <span class="NLM_lpage">16516</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.3647-11.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1523%2FJNEUROSCI.3647-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=22090477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=16507-16516&author=P.+C.+Mayauthor=R.+A.+Deanauthor=S.+L.+Loweauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=L.+N.+Boggsauthor=S.+A.+Monkauthor=B.+M.+Mathesauthor=D.+J.+Mergottauthor=B.+M.+Watsonauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=E.+Smith+LaBellauthor=C.+R.+Gonzalesauthor=M.+Nakanoauthor=S.+S.+Jheeauthor=M.+Yenauthor=L.+Ereshefskyauthor=T.+D.+Lindstromauthor=D.+O.+Calligaroauthor=P.+J.+Cockeauthor=D.+G.+Hallauthor=S.+Friedrichauthor=M.+Citronauthor=J.+E.+Audia&title=Robust+central+reduction+of+amyloid-%CE%B2+in+humans+with+an+orally+available%2C+non-peptidic+%CE%B2-secretase+inhibitor&doi=10.1523%2FJNEUROSCI.3647-11.2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span></div><div class="casAuthors">May, Patrick C.; Dean, Robert A.; Lowe, Stephen L.; Martenyi, Ferenc; Sheehan, Scott M.; Boggs, Leonard N.; Monk, Scott A.; Mathes, Brian M.; Mergott, Dustin J.; Watson, Brian M.; Stout, Stephanie L.; Timm, David E.; LaBell, Elizabeth Smith; Gonzales, Celedon R.; Nakano, Masako; Jhee, Stanford S.; Yen, Mark; Ereshefsky, Larry; Lindstrom, Terry D.; Calligaro, David O.; Cocke, Patrick J.; Hall, D. Greg; Friedrich, Stuart; Citron, Martin; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16507-16516</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ) is crit. for Alzheimer's disease (AD) pathogenesis.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  For more than a decade, BACE1 has been a prime target for designing drugs to prevent or treat AD.  However, development of such agents has turned out to be extremely challenging, with major hurdles in cell penetration, oral bioavailability/metabolic clearance, and brain access.  Using a fragment-based chem. strategy, we have generated LY2811376 [(S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine], the first orally available non-peptidic BACE1 inhibitor that produces profound Aβ-lowering effects in animals.  The biomarker changes obtained in preclin. animal models translate into man at doses of LY2811376 that were safe and well tolerated in healthy volunteers.  Prominent and long-lasting Aβ redns. in lumbar CSF were measured after oral dosing of 30 or 90 mg of LY2811376.  This represents the first translation of BACE1-driven biomarker changes in CNS from preclin. animal models to man.  Because of toxicol. findings identified in longer-term preclin. studies, this compd. is no longer progressing in clin. development.  However, BACE1 remains a viable target because the adverse effects reported here were recapitulated in LY2811376-treated BACE1 KO mice and thus are unrelated to BACE1 inhibition.  The magnitude and duration of central Aβ redn. obtainable with BACE1 inhibition positions this protease as a tractable small-mol. target through which to test the amyloid hypothesis in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqns_TvT2bZrVg90H21EOLACvtfcHk0liEWvHPDjwe5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F&md5=8f21f91ebd77e5fcf8b58b51c73a1a6b</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3647-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3647-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DSmith%2BLaBell%26aufirst%3DE.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DHall%26aufirst%3DD.%2BG.%26aulast%3DFriedrich%26aufirst%3DS.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DRobust%2520central%2520reduction%2520of%2520amyloid-%25CE%25B2%2520in%2520humans%2520with%2520an%2520orally%2520available%252C%2520non-peptidic%2520%25CE%25B2-secretase%2520inhibitor%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D16507%26epage%3D16516%26doi%3D10.1523%2FJNEUROSCI.3647-11.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Waring, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, C.</span><span> </span><span class="NLM_article-title">A quantitative assessment of hERG liability as a function of lipophilicity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1759</span><span class="NLM_x">–</span> <span class="NLM_lpage">1764</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2006.12.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1016%2Fj.bmcl.2006.12.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=17239590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1yrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1759-1764&author=M.+J.+Waringauthor=C.+Johnstone&title=A+quantitative+assessment+of+hERG+liability+as+a+function+of+lipophilicity&doi=10.1016%2Fj.bmcl.2006.12.061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative assessment of hERG liability as a function of lipophilicity</span></div><div class="casAuthors">Waring, Michael J.; Johnstone, Craig</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1759-1764</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The impact of lipophilicity as a factor contributing to hERG potency is assessed for a large dataset of compds. of differing ionization type.  This dataset is derived from compds. tested in the Ionworks-based in vitro electrophysiol. hERG assay at AstraZeneca.  Using logistic regression, a quantification of the risk assocd. with increasing lipophilicity is presented.  The anticipated differences between acidic, basic and neutral compds. are apparent in the data but lipophilicity is shown to be a stronger driver for hERG potency than might have been expected.  Simple rules defining target lipophilicity values for minimizing hERG liability are derived.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlCr9mVGL2-LVg90H21EOLACvtfcHk0lh2nj4c6YS5Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1yrtb8%253D&md5=3819e045d7b773f129773f1ff567b980</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.12.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.12.061%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26aulast%3DJohnstone%26aufirst%3DC.%26atitle%3DA%2520quantitative%2520assessment%2520of%2520hERG%2520liability%2520as%2520a%2520function%2520of%2520lipophilicity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1759%26epage%3D1764%26doi%3D10.1016%2Fj.bmcl.2006.12.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, G.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of hERG optimizations: highlights and hang-ups</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5029</span><span class="NLM_x">–</span> <span class="NLM_lpage">5046</span><span class="refDoi"> DOI: 10.1021/jm060379l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060379l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5029-5046&author=C.+Jamiesonauthor=E.+M.+Moirauthor=Z.+Rankovicauthor=G.+Wishart&title=Medicinal+chemistry+of+hERG+optimizations%3A+highlights+and+hang-ups&doi=10.1021%2Fjm060379l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of hERG optimizations: Highlights and hang-ups</span></div><div class="casAuthors">Jamieson, Craig; Moir, Elizabeth M.; Rankovic, Zoran; Wishart, Grant</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5029-5046</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  A brief summary of the in silico, in vitro, and in vivo approaches employed to measure blockade of hERG and QT prolongation is detailed.  The discussion aims to summarize the approaches engaged to circumvent activity at hERG, identified through an extensive literature survey.  The optimizations are recorded as pairs of compds., which have been categorized in terms of the tactics employed to diminish hERG activity. Examn. of the properties of the compds. within each category has enabled formulation os some empirical guidelines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv6eM5w53KebVg90H21EOLACvtfcHk0lh2nj4c6YS5Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D&md5=117c84a010f877c835b7dbc945996b92</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1021%2Fjm060379l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060379l%26sid%3Dliteratum%253Aachs%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DMoir%26aufirst%3DE.%2BM.%26aulast%3DRankovic%26aufirst%3DZ.%26aulast%3DWishart%26aufirst%3DG.%26atitle%3DMedicinal%2520chemistry%2520of%2520hERG%2520optimizations%253A%2520highlights%2520and%2520hang-ups%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5029%26epage%3D5046%26doi%3D10.1021%2Fjm060379l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Rochin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurbain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serneels, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fort, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raposo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Niel, G.</span><span> </span><span class="NLM_article-title">BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">10658</span><span class="NLM_x">–</span> <span class="NLM_lpage">10663</span><span class="refDoi"> DOI: 10.1073/pnas.1220748110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1073%2Fpnas.1220748110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=23754390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFejs7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=10658-10663&author=L.+Rochinauthor=I.+Hurbainauthor=L.+Serneelsauthor=C.+Fortauthor=B.+Wattauthor=P.+Leblancauthor=M.+S.+Marksauthor=B.+De+Strooperauthor=G.+Raposoauthor=G.+van+Niel&title=BACE2+processes+PMEL+to+form+the+melanosome+amyloid+matrix+in+pigment+cells&doi=10.1073%2Fpnas.1220748110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells</span></div><div class="casAuthors">Rochin, Leila; Hurbain, Ilse; Serneels, Lutgarde; Fort, Cecile; Watt, Brenda; Leblanc, Pascal; Marks, Michael S.; De Strooper, Bart; Raposo, Graca; van Niel, Guillaume</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">10658-10663,S10658/1-S10658/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Amyloids are often assocd. with pathol. processes such as in Alzheimer's disease (AD), but can also underlie physiol. processes such as pigmentation.  Formation of pathol. and functional amyloidogenic substrates can require precursor processing by proteases, as exemplified by the generation of Aβ peptide from amyloid precursor protein (APP) by beta-site APP cleaving enzyme (BACE)1 and γ-secretase.  Proteolytic processing of the pigment cell-specific Melanocyte Protein (PMEL) is also required to form functional amyloid fibrils during melanogenesis, but the enzymes involved are incompletely characterized.  Here we show that the BACE1 homolog BACE2 processes PMEL to generate functional amyloids.  BACE2 is highly expressed in pigment cells and Bace2-/- but not Bace1-/- mice display coat color defects, implying a specific role for BACE2 during melanogenesis.  By using biochem. and morphol. analyses, combined with RNA silencing, pharmacol. inhibition, and BACE2 overexpression in a human melanocytic cell line, we show that BACE2 cleaves the integral membrane form of PMEL within the juxtamembrane domain, releasing the PMEL luminal domain into endosomal precursors for the formation of amyloid fibrils and downstream melanosome morphogenesis.  These studies identify an amyloidogenic substrate of BACE2, reveal an important physiol. role for BACE2 in pigmentation, and highlight analogies in the generation of PMEL-derived functional amyloids and APP-derived pathol. amyloids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLBEney5KFyLVg90H21EOLACvtfcHk0lio_Isq-e9f3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFejs7rK&md5=3deb3f80dca6a32748aa6fe2e50c2df1</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1220748110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1220748110%26sid%3Dliteratum%253Aachs%26aulast%3DRochin%26aufirst%3DL.%26aulast%3DHurbain%26aufirst%3DI.%26aulast%3DSerneels%26aufirst%3DL.%26aulast%3DFort%26aufirst%3DC.%26aulast%3DWatt%26aufirst%3DB.%26aulast%3DLeblanc%26aufirst%3DP.%26aulast%3DMarks%26aufirst%3DM.%2BS.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DRaposo%26aufirst%3DG.%26aulast%3Dvan%2BNiel%26aufirst%3DG.%26atitle%3DBACE2%2520processes%2520PMEL%2520to%2520form%2520the%2520melanosome%2520amyloid%2520matrix%2520in%2520pigment%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D10658%26epage%3D10663%26doi%3D10.1073%2Fpnas.1220748110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Shimshek, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolly, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamurovic, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balavenkatraman, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morawiec, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreutzer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schelle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jucker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertschi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theil, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigot, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beltz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machauer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brzak, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrot, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumann, U.</span><span> </span><span class="NLM_article-title">Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">21917</span><span class="refDoi"> DOI: 10.1038/srep21917</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1038%2Fsrep21917" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=26912421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1eku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=21917&author=D.+R.+Shimshekauthor=L.+H.+Jacobsonauthor=C.+Kollyauthor=N.+Zamurovicauthor=K.+K.+Balavenkatramanauthor=L.+Morawiecauthor=R.+Kreutzerauthor=J.+Schelleauthor=M.+Juckerauthor=B.+Bertschiauthor=D.+Theilauthor=A.+Heierauthor=K.+Bigotauthor=K.+Beltzauthor=R.+Machauerauthor=I.+Brzakauthor=L.+Perrotauthor=U.+Neumann&title=Pharmacological+BACE1+and+BACE2+inhibition+induces+hair+depigmentation+by+inhibiting+PMEL17+processing+in+mice&doi=10.1038%2Fsrep21917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice</span></div><div class="casAuthors">Shimshek, Derya R.; Jacobson, Laura H.; Kolly, Carine; Zamurovic, Natasa; Balavenkatraman, Kamal Kumar; Morawiec, Laurent; Kreutzer, Robert; Schelle, Juliane; Jucker, Mathias; Bertschi, Barbara; Theil, Diethilde; Heier, Annabelle; Bigot, Karine; Beltz, Karen; Machauer, Rainer; Brzak, Irena; Perrot, Ludovic; Neumann, Ulf</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21917</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Melanocytes of the hair follicle produce melanin and are essential in detg. the differences in hair color.  Pigment cell-specific MELanocyte Protein (PMEL17) plays a crucial role in melanogenesis.  One of the crit. steps is the amyloid-like functional oligomerization of PMEL17.  Beta Site APP Cleaving Enzyme-2 (BACE2) and γ-secretase have been shown to be key players in generating the proteolytic fragments of PMEL17.  The β-secretase (BACE1) is responsible for the generation of amyloid-β (Aβ) fragments in the brain and is therefore proposed as a therapeutic target for Alzheimer's disease (AD).  Currently BACE1 inhibitors, most of which lack selectivity over BACE2, have demonstrated efficacious redn. of amyloid-β peptides in animals and the CSF of humans.  BACE2 knock-out mice have a deficiency in PMEL17 proteolytic processing leading to impaired melanin storage and hair depigmentation.  Here, we confirm BACE2-mediated inhibition of PMEL17 proteolytic processing in vitro in mouse and human melanocytes.  Furthermore, we show that wildtype as well as bace2+/- and bace2-/- mice treated with a potent dual BACE1/BACE2 inhibitor NB-360 display dose-dependent appearance of irreversibly depigmented hair.  Retinal pigmented epithelium showed no morphol. changes.  Our data demonstrates that BACE2 as well as addnl. BACE1 inhibition affects melanosome maturation and induces hair depigmentation in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtlQ-3Lxc4CLVg90H21EOLACvtfcHk0lio_Isq-e9f3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1eku7Y%253D&md5=e3641d48cc7fcf08c4502b5899a49066</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fsrep21917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep21917%26sid%3Dliteratum%253Aachs%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26aulast%3DKolly%26aufirst%3DC.%26aulast%3DZamurovic%26aufirst%3DN.%26aulast%3DBalavenkatraman%26aufirst%3DK.%2BK.%26aulast%3DMorawiec%26aufirst%3DL.%26aulast%3DKreutzer%26aufirst%3DR.%26aulast%3DSchelle%26aufirst%3DJ.%26aulast%3DJucker%26aufirst%3DM.%26aulast%3DBertschi%26aufirst%3DB.%26aulast%3DTheil%26aufirst%3DD.%26aulast%3DHeier%26aufirst%3DA.%26aulast%3DBigot%26aufirst%3DK.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DBrzak%26aufirst%3DI.%26aulast%3DPerrot%26aufirst%3DL.%26aulast%3DNeumann%26aufirst%3DU.%26atitle%3DPharmacological%2520BACE1%2520and%2520BACE2%2520inhibition%2520induces%2520hair%2520depigmentation%2520by%2520inhibiting%2520PMEL17%2520processing%2520in%2520mice%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D21917%26doi%3D10.1038%2Fsrep21917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokopcova, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H. J.</span><span> </span><span class="NLM_article-title">The evolution of amidine-based brain penetrant BACE1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2033</span><span class="NLM_x">–</span> <span class="NLM_lpage">2045</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.03.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1016%2Fj.bmcl.2014.03.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=24704031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2033-2045&author=D.+Oehlrichauthor=H.+Prokopcovaauthor=H.+J.+Gijsen&title=The+evolution+of+amidine-based+brain+penetrant+BACE1+inhibitors&doi=10.1016%2Fj.bmcl.2014.03.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of amidine-based brain penetrant BACE1 inhibitors</span></div><div class="casAuthors">Oehlrich, Daniel; Prokopcova, Hana; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2033-2045</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Beta site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors hold great potential as disease modifying anti-Alzheimer's drugs.  This digest provides an overview of the amidine contg. class of BACE1 inhibitors, of which multiple examples are now progressing through clin. trials.  The various structural modifications highlight the struggle to combine potency with the optimal properties for a brain penetrant BACE1 inhibitor, and illustrate the crowded competitive landscape.  This overview concludes with a summary of potential issues including substrate and target selectivity and a synopsis of the status of the current and past clin. assets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-4h1WxzUvbbVg90H21EOLACvtfcHk0lio_Isq-e9f3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D&md5=a929f7f1be0c7d2ff1a10fc5853de06b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.025%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%26atitle%3DThe%2520evolution%2520of%2520amidine-based%2520brain%2520penetrant%2520BACE1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2033%26epage%3D2045%26doi%3D10.1016%2Fj.bmcl.2014.03.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Woltering, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wostl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilpert, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers-Evans, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayweg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travagli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollastrini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marconi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabellieri, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guba, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narquizian, R.</span><span> </span><span class="NLM_article-title">BACE1 inhibitors: a head group scan on a series of amides</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4239</span><span class="NLM_x">–</span> <span class="NLM_lpage">4243</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1016%2Fj.bmcl.2013.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=23735744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovFaktLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4239-4243&author=T.+J.+Wolteringauthor=W.+Wostlauthor=H.+Hilpertauthor=M.+Rogers-Evansauthor=E.+Pinardauthor=A.+Maywegauthor=M.+Gobelauthor=D.+W.+Bannerauthor=J.+Benzauthor=M.+Travagliauthor=M.+Pollastriniauthor=G.+Marconiauthor=E.+Gabellieriauthor=W.+Gubaauthor=H.+Mauserauthor=M.+Andreiniauthor=H.+Jacobsenauthor=E.+Powerauthor=R.+Narquizian&title=BACE1+inhibitors%3A+a+head+group+scan+on+a+series+of+amides&doi=10.1016%2Fj.bmcl.2013.05.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 inhibitors: A head group scan on a series of amides</span></div><div class="casAuthors">Woltering, Thomas J.; Wostl, Wolfgang; Hilpert, Hans; Rogers-Evans, Mark; Pinard, Emmanuel; Mayweg, Alexander; Gobel, Martin; Banner, David W.; Benz, Jorg; Travagli, Massimiliano; Pollastrini, Martina; Marconi, Guido; Gabellieri, Emanuele; Guba, Wolfgang; Mauser, Harald; Andreini, Matteo; Jacobsen, Helmut; Power, Eoin; Narquizian, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4239-4243</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of amides bearing a variety of amidine head groups was investigated as BACE1 inhibitors with respect to inhibitory activity in a BACE1 enzyme as well as a cell-based assay.  Detn. of their basicity as well as their properties as substrates of P-glycoprotein revealed that a 2-amino-1,3-oxazine head group would be a suitable starting point for further development of brain penetrating compds. for potential Alzheimer's disease treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEF94wd3_rd7Vg90H21EOLACvtfcHk0ljTc_P_PNgBbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovFaktLk%253D&md5=3da315c76199617083b762ea111057fd</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DWoltering%26aufirst%3DT.%2BJ.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DMayweg%26aufirst%3DA.%26aulast%3DGobel%26aufirst%3DM.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DBenz%26aufirst%3DJ.%26aulast%3DTravagli%26aufirst%3DM.%26aulast%3DPollastrini%26aufirst%3DM.%26aulast%3DMarconi%26aufirst%3DG.%26aulast%3DGabellieri%26aufirst%3DE.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DMauser%26aufirst%3DH.%26aulast%3DAndreini%26aufirst%3DM.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DPower%26aufirst%3DE.%26aulast%3DNarquizian%26aufirst%3DR.%26atitle%3DBACE1%2520inhibitors%253A%2520a%2520head%2520group%2520scan%2520on%2520a%2520series%2520of%2520amides%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4239%26epage%3D4243%26doi%3D10.1016%2Fj.bmcl.2013.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hilpert, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guba, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woltering, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wostl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayweg, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers-Evans, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humm, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krummenacher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muser, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnider, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozmen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergadano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochstrasser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuglstatter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David-Pierson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narquizian, R.</span><span> </span><span class="NLM_article-title">beta-Secretase (BACE1) inhibitors with high in vivo efficacy suitable for clinical evaluation in Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3980</span><span class="NLM_x">–</span> <span class="NLM_lpage">3995</span><span class="refDoi"> DOI: 10.1021/jm400225m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400225m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtVymuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3980-3995&author=H.+Hilpertauthor=W.+Gubaauthor=T.+J.+Wolteringauthor=W.+Wostlauthor=E.+Pinardauthor=H.+Mauserauthor=A.+V.+Maywegauthor=M.+Rogers-Evansauthor=R.+Hummauthor=D.+Krummenacherauthor=T.+Muserauthor=C.+Schniderauthor=H.+Jacobsenauthor=L.+Ozmenauthor=A.+Bergadanoauthor=D.+W.+Bannerauthor=R.+Hochstrasserauthor=A.+Kuglstatterauthor=P.+David-Piersonauthor=H.+Fischerauthor=A.+Polaraauthor=R.+Narquizian&title=beta-Secretase+%28BACE1%29+inhibitors+with+high+in+vivo+efficacy+suitable+for+clinical+evaluation+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm400225m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase (BACE1) Inhibitors with High in Vivo Efficacy Suitable for Clinical Evaluation in Alzheimer's Disease</span></div><div class="casAuthors">Hilpert, Hans; Guba, Wolfgang; Woltering, Thomas J.; Wostl, Wolfgang; Pinard, Emmanuel; Mauser, Harald; Mayweg, Alexander V.; Rogers-Evans, Mark; Humm, Roland; Krummenacher, Daniela; Muser, Thorsten; Schnider, Christian; Jacobsen, Helmut; Ozmen, Laurence; Bergadano, Alessandra; Banner, David W.; Hochstrasser, Remo; Kuglstatter, Andreas; David-Pierson, Pascale; Fischer, Holger; Polara, Alessandra; Narquizian, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3980-3995</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An extensive fluorine scan of 1,3-oxazines revealed the power of fluorine(s) to lower the pKa and thereby dramatically change the pharmacol. profile of this class of BACE1 inhibitors.  The CF3 substituted oxazine 89, a potent and highly brain penetrant BACE1 inhibitor, was able to reduce significantly CSF Aβ40 and 42 in rats at oral doses as low as 1 mg/kg.  The effect was long lasting, showing a significant redn. of Aβ40 and 42 even after 24 h.  In contrast to 89, compd. 1b lacking the CF3 group was virtually inactive in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmoKRrAxxHErVg90H21EOLACvtfcHk0ljTc_P_PNgBbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtVymuro%253D&md5=e5d311d1c8fecfaed043d3a0bf16c168</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1021%2Fjm400225m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400225m%26sid%3Dliteratum%253Aachs%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DWoltering%26aufirst%3DT.%2BJ.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DMauser%26aufirst%3DH.%26aulast%3DMayweg%26aufirst%3DA.%2BV.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DHumm%26aufirst%3DR.%26aulast%3DKrummenacher%26aufirst%3DD.%26aulast%3DMuser%26aufirst%3DT.%26aulast%3DSchnider%26aufirst%3DC.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DBergadano%26aufirst%3DA.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DHochstrasser%26aufirst%3DR.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DDavid-Pierson%26aufirst%3DP.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DPolara%26aufirst%3DA.%26aulast%3DNarquizian%26aufirst%3DR.%26atitle%3Dbeta-Secretase%2520%2528BACE1%2529%2520inhibitors%2520with%2520high%2520in%2520vivo%2520efficacy%2520suitable%2520for%2520clinical%2520evaluation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3980%26epage%3D3995%26doi%3D10.1021%2Fjm400225m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rombouts, F. J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez-Lamenca, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Gool, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Molina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso de Diego, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokopcova, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borghys, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Brandt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surkyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Cleyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span> </span><span class="NLM_article-title">1,4-Oxazine β-secretase 1 (BACE1) inhibitors: from hit generation to orally bioavailable brain penetrant leads</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">8216</span><span class="NLM_x">–</span> <span class="NLM_lpage">8235</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01101</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01101" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFWktL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8216-8235&author=F.+J.+R.+Romboutsauthor=G.+Tresadernauthor=O.+Delgadoauthor=C.+Mart%C3%ADnez-Lamencaauthor=M.+Van+Goolauthor=A.+Garc%C3%ADa-Molinaauthor=S.+A.+Alonso+de+Diegoauthor=D.+Oehlrichauthor=H.+Prokopcovaauthor=J.+M.+Alonsoauthor=N.+Austinauthor=H.+Borghysauthor=S.+Van+Brandtauthor=M.+Surkynauthor=M.+De+Cleynauthor=A.+Vosauthor=R.+Alexanderauthor=G.+Macdonaldauthor=D.+Moecharsauthor=H.+Gijsenauthor=A.+A.+Trabanco&title=1%2C4-Oxazine+%CE%B2-secretase+1+%28BACE1%29+inhibitors%3A+from+hit+generation+to+orally+bioavailable+brain+penetrant+leads&doi=10.1021%2Facs.jmedchem.5b01101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14cR"><div class="casContent"><span class="casTitleNuber">14c</span><div class="casTitle"><span class="NLM_cas:atitle">1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors: From Hit Generation to Orally Bioavailable Brain Penetrant Leads</span></div><div class="casAuthors">Rombouts, Frederik J. R.; Tresadern, Gary; Delgado, Oscar; Martinez-Lamenca, Carolina; Van Gool, Michiel; Garcia-Molina, Aranzazu; Alonso de Diego, Sergio A.; Oehlrich, Daniel; Prokopcova, Hana; Alonso, Jose Manuel; Austin, Nigel; Borghys, Herman; Van Brandt, Sven; Surkyn, Michel; De Cleyn, Michel; Vos, Ann; Alexander, Richard; Macdonald, Gregor; Moechars, Dieder; Gijsen, Harrie; Trabanco, Andres A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8216-8235</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1,4-Oxazines are presented, which show good in vitro inhibition in enzymic and cellular BACE1 assays.  We describe lead optimization focused on reducing the amidine pKa while optimizing interactions in the BACE1 active site.  Our strategy permitted modulation of properties such as permeation and esp. P-glycoprotein efflux.  This led to compds. which were orally bioavailable, centrally active, and which demonstrated robust lowering of brain and CSF Aβ levels, resp., in mouse and dog models.  The amyloid lowering potential of these mols. makes them valuable leads in the search for new BACE1 inhibitors for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHVm9JF2kNa7Vg90H21EOLACvtfcHk0lhCHN_FqnFLkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFWktL3L&md5=d3563a26a17a1c86c45a4f99b18be251</span></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01101%26sid%3Dliteratum%253Aachs%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%2BR.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DMart%25C3%25ADnez-Lamenca%26aufirst%3DC.%26aulast%3DVan%2BGool%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa-Molina%26aufirst%3DA.%26aulast%3DAlonso%2Bde%2BDiego%26aufirst%3DS.%2BA.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DAustin%26aufirst%3DN.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%26aulast%3DVos%26aufirst%3DA.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3D1%252C4-Oxazine%2520%25CE%25B2-secretase%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520from%2520hit%2520generation%2520to%2520orally%2520bioavailable%2520brain%2520penetrant%2520leads%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8216%26epage%3D8235%26doi%3D10.1021%2Facs.jmedchem.5b01101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span><span class="refDoi"> DOI: 10.1021/cn100008c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties&doi=10.1021%2Fcn100008c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lhCHN_FqnFLkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449%26doi%3D10.1021%2Fcn100008c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dislich, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtenthaler, S. F.</span><span> </span><span class="NLM_article-title">The membrane-bound aspartyl protease BACE1: molecular and functional properties in Alzheimer’s disease and beyond</span> <span class="citation_source-journal">Front. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="refDoi"> DOI: 10.3389/fphys.2012.00008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.3389%2Ffphys.2012.00008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=22363289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsFyitro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=8&author=B.+Dislichauthor=S.+F.+Lichtenthaler&title=The+membrane-bound+aspartyl+protease+BACE1%3A+molecular+and+functional+properties+in+Alzheimer%E2%80%99s+disease+and+beyond&doi=10.3389%2Ffphys.2012.00008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">The membrane-bound aspartyl protease BACE1: molecular and functional properties in Alzheimer's disease and beyond</span></div><div class="casAuthors">Dislich, Bastian; Lichtenthaler, Stefan F.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Membrane Physiology and Biophysics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">Feb.</span>),
    <span class="NLM_cas:pages">8</span>CODEN:
                <span class="NLM_cas:coden">FMPBBG</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  The β-site APP cleaving enzyme 1 (BACE1) is a transmembrane aspartyl protease involved in Alzheimer's disease (AD) pathogenesis and in myelination.  BACE1 initiates the generation of the pathogenic amyloid β-peptide, which makes BACE1 a major drug target for AD.  BACE1 also cleaves and activates neuregulin 1, thereby contributing to postnatal myelination, in particular in the peripheral nervous system.  Addnl. proteins are also cleaved by BACE1, but less is known about the physiol. consequences of their cleavage.  Recently, new phenotypes were described in BACE1-deficient mice.  Although it remains unclear through which BACE1 substrates they are mediated, the phenotypes suggest a versatile role of this protease for diverse physiol. processes.  This review summarizes the enzymic and cellular properties of BACE1 as well as its regulation by lipids, by transcriptional, and by translational mechanisms.  The main focus will be on the recent progress in understanding BACE1 function and its implication for potential mechanism-based side effects upon therapeutic inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQnIcCfG4zsbVg90H21EOLACvtfcHk0lhCHN_FqnFLkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsFyitro%253D&md5=b83b7fd1542cc2bba7d73b4710c26bcd</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.3389%2Ffphys.2012.00008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphys.2012.00008%26sid%3Dliteratum%253Aachs%26aulast%3DDislich%26aufirst%3DB.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26atitle%3DThe%2520membrane-bound%2520aspartyl%2520protease%2520BACE1%253A%2520molecular%2520and%2520functional%2520properties%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520beyond%26jtitle%3DFront.%2520Physiol.%26date%3D2012%26volume%3D3%26spage%3D8%26doi%3D10.3389%2Ffphys.2012.00008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Decourt, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marwan, N.</span><span> </span><span class="NLM_article-title">BACE1 as a potential biomarker for Alzheimer’s Disease</span> <span class="citation_source-journal">J. Alzheimers Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span><span class="refDoi"> DOI: 10.3233/JAD-2011-110017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.3233%2FJAD-2011-110017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=21403391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A280%3ADC%252BC3Mvms1Gjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=53-59&issue=Suppl+2&author=B.+S.+Decourtauthor=N.+Marwan&title=BACE1+as+a+potential+biomarker+for+Alzheimer%E2%80%99s+Disease&doi=10.3233%2FJAD-2011-110017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 as a potential biomarker for Alzheimer's disease</span></div><div class="casAuthors">Decourt Boris; Sabbagh Marwan N</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24 Suppl 2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">53-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The diagnosis of Alzheimer's disease (AD) relies principally on clinical criteria for probable and possible AD as defined by the NINCDS-ADRDRA.  The field is desperately lacking of biological markers to assist with AD diagnosis and verification of treatment efficacy.  According to the Consensus Report of the Working Group on Molecular and Biochemical Markers of Alzheimer's Disease, in order to qualify as a biomarker the sample in question must adhere to certain basic requirements, including the ability to: reflect AD pathology and differentiate it from other dementia with an 80% sensitivity; be reliable and reproducible; be easy to perform and analyze; remain relatively inexpensive.  Beta secretases are crucial enzymes in the pathogenesis of AD.  Given its primary role in brain amyloidogenesis and its ubiquitous expression, one may consider measuring peripheral BACE1 levels and activity as biomarkers of AD, like performed in the brain and cerebrospinal fluid.  However, very little is known about the periphery and whether peripheral BACE1 is involved in AD pathogenesis or mirrors AD progression.  Moreover, no investigation has focused on the possibility of monitoring peripheral BACE1 to assess the efficiency of BACE1 inhibitors during the course of clinical trials.  Part of the problem may be attributed to the lack of sensitive molecular tools which are absolutely necessary to use BACE1 as a biomarker.  In this review we evaluate the progress and feasibility of developing BACE1 as a biomarker for AD in different tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS1uOMHNMCFBdLIORRPd5lbfW6udTcc2eZBcz2T9qbfw7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mvms1Gjuw%253D%253D&md5=33dfdcede9bae5dc2eaf047676576e05</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.3233%2FJAD-2011-110017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2011-110017%26sid%3Dliteratum%253Aachs%26aulast%3DDecourt%26aufirst%3DB.%2BS.%26aulast%3DMarwan%26aufirst%3DN.%26atitle%3DBACE1%2520as%2520a%2520potential%2520biomarker%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Alzheimers%2520Dis.%26date%3D2011%26volume%3D24%26issue%3DSuppl%25202%26spage%3D53%26epage%3D59%26doi%3D10.3233%2FJAD-2011-110017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Cole, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassar, R.</span><span> </span><span class="NLM_article-title">The Alzheimer’s disease β-secretase enzyme, BACE1</span> <span class="citation_source-journal">Mol. Neurodegener.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="refDoi"> DOI: 10.1186/1750-1326-2-22</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1186%2F1750-1326-2-22" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=18005427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A280%3ADC%252BD1c%252FltFChsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=22&author=S.+L.+Coleauthor=R.+Vassar&title=The+Alzheimer%E2%80%99s+disease+%CE%B2-secretase+enzyme%2C+BACE1&doi=10.1186%2F1750-1326-2-22"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16cR"><div class="casContent"><span class="casTitleNuber">16c</span><div class="casTitle"><span class="NLM_cas:atitle">The Alzheimer's disease beta-secretase enzyme, BACE1</span></div><div class="casAuthors">Cole Sarah L; Vassar Robert</div><div class="citationInfo"><span class="NLM_cas:title">Molecular neurodegeneration</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract"> The pathogenesis of Alzheimer's disease is highly complex.  While several pathologies characterize this disease, amyloid plaques, composed of the beta-amyloid peptide are hallmark neuropathological lesions in Alzheimer's disease brain.  Indeed, a wealth of evidence suggests that beta-amyloid is central to the pathophysiology of AD and is likely to play an early role in this intractable neurodegenerative disorder.  The BACE1 enzyme is essential for the generation of beta-amyloid.  BACE1 knockout mice do not produce beta-amyloid and are free from Alzheimer's associated pathologies including neuronal loss and certain memory deficits.  The fact that BACE1 initiates the formation of beta-amyloid, and the observation that BACE1 levels are elevated in this disease provide direct and compelling reasons to develop therapies directed at BACE1 inhibition thus reducing beta-amyloid and its associated toxicities.  However, new data indicates that complete abolishment of BACE1 may be associated with specific behavioral and physiological alterations.  Recently a number of non-APP BACE1 substrates have been identified.  It is plausible that failure to process certain BACE1 substrates may underlie some of the reported abnormalities in the BACE1-deficient mice.  Here we review BACE1 biology, covering aspects ranging from the initial identification and characterization of this enzyme to recent data detailing the apparent dysregulation of BACE1 in Alzheimer's disease.  We pay special attention to the putative function of BACE1 during healthy conditions and discuss in detail the relationship that exists between key risk factors for AD, such as vascular disease (and downstream cellular consequences), and the pathogenic alterations in BACE1 that are observed in the diseased state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcScU9UDiunWZtyzdcP07UmufW6udTcc2eZBcz2T9qbfw7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c%252FltFChsA%253D%253D&md5=160fdfd98cdd29db707de7a6c4c03fa0</span></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=10.1186%2F1750-1326-2-22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1326-2-22%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DS.%2BL.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DThe%2520Alzheimer%25E2%2580%2599s%2520disease%2520%25CE%25B2-secretase%2520enzyme%252C%2520BACE1%26jtitle%3DMol.%2520Neurodegener.%26date%3D2007%26volume%3D2%26spage%3D22%26doi%3D10.1186%2F1750-1326-2-22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Georgievska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustavsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundkvist, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neelissen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eketjäll, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramberg, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bueters, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agerman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juréus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lendahl, U.</span><span> </span><span class="NLM_article-title">Revisiting the peripheral sink hypothesis: inhibiting BACE1 activity in the periphery does not alter β-amyloid levels in the CNS</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">486</span><span class="refDoi"> DOI: 10.1111/jnc.12937</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1111%2Fjnc.12937" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=25156639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisFems7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2015&pages=477-486&author=B.+Georgievskaauthor=S.+Gustavssonauthor=J.+Lundkvistauthor=J.+Neelissenauthor=S.+Eketj%C3%A4llauthor=V.+Rambergauthor=T.+Buetersauthor=K.+Agermanauthor=A.+Jur%C3%A9usauthor=S.+Svenssonauthor=S.+Bergauthor=J.+F%C3%A4ltingauthor=U.+Lendahl&title=Revisiting+the+peripheral+sink+hypothesis%3A+inhibiting+BACE1+activity+in+the+periphery+does+not+alter+%CE%B2-amyloid+levels+in+the+CNS&doi=10.1111%2Fjnc.12937"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16dR"><div class="casContent"><span class="casTitleNuber">16d</span><div class="casTitle"><span class="NLM_cas:atitle">Revisiting the peripheral sink hypothesis: inhibiting BACE1 activity in the periphery does not alter β-amyloid levels in the CNS</span></div><div class="casAuthors">Georgievska, Biljana; Gustavsson, Susanne; Lundkvist, Johan; Neelissen, Jan; Eketjaell, Susanna; Ramberg, Veronica; Bueters, Tjerk; Agerman, Karin; Jureus, Anders; Svensson, Samuel; Berg, Stefan; Faelting, Johanna; Lendahl, Urban</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">477-486</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aggregation of BACE1 beta (Aβ) peptides and the subsequent neural plaque formation is a central aspect of Alzheimer's disease.  Various strategies to reduce Aβ load in the brain are therefore intensely pursued.  It has been hypothesized that reducing Aβ peptides in the periphery, that is in organs outside the brain, would be a way to diminish Aβ levels and plaque load in the brain.  In this report, we put this peripheral sink hypothesis to test by investigating how selective inhibition of Aβ prodn. in the periphery using a β-secretase (BACE)1 inhibitor or reduced BACE1 gene dosage affects Aβ load in the brain.  Selective inhibition of peripheral BACE1 activity in wild-type mice or mice over-expressing amyloid precursor protein (APPswe transgenic mice; Tg2576) reduced Aβ levels in the periphery but not in the brain, not even after chronic treatment over several months.  In contrast, a BACE1 inhibitor with improved brain disposition reduced Aβ levels in both brain and periphery already after acute dosing.  Mice heterozygous for BACE1, displayed a 62% redn. in plasma Aβ40, whereas brain Aβ40 was only lowered by 11%.  These data suggest that redn. of Aβ in the periphery is not sufficient to reduce brain Aβ levels and that BACE1 is not the rate-limiting enzyme for Aβ processing in the brain.  This provides evidence against the peripheral sink hypothesis and suggests that a decrease in Aβ via BACE1 inhibition would need to be carried out in the brain.  Aggregation of amyloid beta (Aβ) peptides in the brain is a central aspect of Alzheimer's disease.  In this study, we demonstrate that inhibition of Aβ formation by BACE1 inhibitors needs to be carried out in the brain and that redn. of Aβ in the periphery is not sufficient to reduce brain Aβ levels.  This information is useful for developing future Aβ-targeting therapies for Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqUV5DivLL-bVg90H21EOLACvtfcHk0lig6orhM_qS-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisFems7s%253D&md5=1a670fea82983689d586cd9bea83eae5</span></div><a href="/servlet/linkout?suffix=cit16d&amp;dbid=16384&amp;doi=10.1111%2Fjnc.12937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.12937%26sid%3Dliteratum%253Aachs%26aulast%3DGeorgievska%26aufirst%3DB.%26aulast%3DGustavsson%26aufirst%3DS.%26aulast%3DLundkvist%26aufirst%3DJ.%26aulast%3DNeelissen%26aufirst%3DJ.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DRamberg%26aufirst%3DV.%26aulast%3DBueters%26aufirst%3DT.%26aulast%3DAgerman%26aufirst%3DK.%26aulast%3DJur%25C3%25A9us%26aufirst%3DA.%26aulast%3DSvensson%26aufirst%3DS.%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26aulast%3DLendahl%26aufirst%3DU.%26atitle%3DRevisiting%2520the%2520peripheral%2520sink%2520hypothesis%253A%2520inhibiting%2520BACE1%2520activity%2520in%2520the%2520periphery%2520does%2520not%2520alter%2520%25CE%25B2-amyloid%2520levels%2520in%2520the%2520CNS%26jtitle%3DJ.%2520Neurochem.%26date%3D2015%26volume%3D132%26spage%3D477%26epage%3D486%26doi%3D10.1111%2Fjnc.12937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Wu, Y.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guernon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClure, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajamani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camac, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlijanian, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albright, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. A.</span><span> </span><span class="NLM_article-title">Targeting the BACE1 active site flap leads to a potent inhibitor that elicits robust brain Aβ reduction in rodents</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00432</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00432" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslensA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=271-276&author=Y.-J.+Wuauthor=J.+Guernonauthor=F.+Yangauthor=L.+Snyderauthor=J.+Shiauthor=A.+McClureauthor=R.+Rajamaniauthor=H.+Parkauthor=A.+Ngauthor=H.+Lewisauthor=C.+Y.+Changauthor=D.+Camacauthor=J.+H.+Toynauthor=M.+K.+Ahlijanianauthor=C.+F.+Albrightauthor=J.+E.+Macorauthor=L.+A.+Thompson&title=Targeting+the+BACE1+active+site+flap+leads+to+a+potent+inhibitor+that+elicits+robust+brain+A%CE%B2+reduction+in+rodents&doi=10.1021%2Facsmedchemlett.5b00432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the BACE1 Active Site Flap Leads to a Potent Inhibitor That Elicits Robust Brain Aβ Reduction in Rodents</span></div><div class="casAuthors">Wu, Yong-Jin; Guernon, Jason; Yang, Fukang; Snyder, Lawrence; Shi, Jianliang; McClure, Andrea; Rajamani, Ramkumar; Park, Hyunsoo; Ng, Alicia; Lewis, Hal; Chang, Chieh Ying; Camac, Dan; Toyn, Jeremy H.; Ahlijanian, Michael K.; Albright, Charles F.; Macor, John E.; Thompson, Lorin A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">271-276</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By targeting the flap backbone of the BACE1 active site, the authors discovered 6-dimethylisoxazole-substituted biaryl aminothiazine I with 34-fold improved BACE1 inhibitory activity over the lead compd.  The cocrystal structure of I bound to the active site indicated two hydrogen-bond interactions between the dimethylisoxazole and threonine 72 and glutamine 73 of the flap.  Incorporation of the dimethylisoxazole substitution onto the related aminothiazine carboxamide series led to pyrazine-carboxamide II as a very potent BACE1 inhibitor (IC50 < 1 nM).  This compd. demonstrated robust brain Aβ redn. in rat dose-response studies.  Thus, compd. II may be useful in testing the amyloid hypothesis of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9dTGWVgGmmrVg90H21EOLACvtfcHk0li-KIequ0utDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslensA%253D%253D&md5=b1bd7b0b6cb22ca8d2f49807b905daa9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00432%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.-J.%26aulast%3DGuernon%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DSnyder%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DMcClure%26aufirst%3DA.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DNg%26aufirst%3DA.%26aulast%3DLewis%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DC.%2BY.%26aulast%3DCamac%26aufirst%3DD.%26aulast%3DToyn%26aufirst%3DJ.%2BH.%26aulast%3DAhlijanian%26aufirst%3DM.%2BK.%26aulast%3DAlbright%26aufirst%3DC.%2BF.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26atitle%3DTargeting%2520the%2520BACE1%2520active%2520site%2520flap%2520leads%2520to%2520a%2520potent%2520inhibitor%2520that%2520elicits%2520robust%2520brain%2520A%25CE%25B2%2520reduction%2520in%2520rodents%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D271%26epage%3D276%26doi%3D10.1021%2Facsmedchemlett.5b00432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Stepan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aleo, M. D.</span><span> </span><span class="NLM_article-title">Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1345</span><span class="NLM_x">–</span> <span class="NLM_lpage">1410</span><span class="refDoi"> DOI: 10.1021/tx200168d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx200168d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC3MXos1Whtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1345-1410&author=A.+F.+Stepanauthor=D.+P.+Walkerauthor=J.+Baumanauthor=D.+A.+Priceauthor=T.+A.+Baillieauthor=A.+S.+Kalgutkarauthor=M.+D.+Aleo&title=Structural+alert%2Freactive+metabolite+concept+as+applied+in+medicinal+chemistry+to+mitigate+the+risk+of+idiosyncratic+drug+toxicity%3A+a+perspective+based+on+the+critical+examination+of+trends+in+the+top+200+drugs+marketed+in+the+United+States&doi=10.1021%2Ftx200168d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States</span></div><div class="casAuthors">Stepan, Antonia F.; Walker, Daniel P.; Bauman, Jonathan; Price, David A.; Baillie, Thomas A.; Kalgutkar, Amit S.; Aleo, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1345-1410</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Because of a preconceived notion that eliminating reactive metabolite (RM) formation with new drug candidates could mitigate the risk of idiosyncratic drug toxicity, the potential for RM formation is routinely examd. as part of lead optimization efforts in drug discovery.  Likewise, avoidance of "structural alerts" is almost a norm in drug design.  However, there is a growing concern that the perceived safety hazards assocd. with structural alerts and/or RM screening tools as standalone predictors of toxicity risks may be over exaggerated.  In addn., the multifactorial nature of idiosyncratic toxicity is now well recognized based upon observations that mechanisms other than RM formation (e.g., mitochondrial toxicity and inhibition of bile salt export pump (BSEP)) also can account for certain target organ toxicities.  Hence, fundamental questions arise such as: When is a mol. that contains a structural alert (RM pos. or neg.) a cause for concern.  Could the mol. in its parent form exert toxicity.  Can a low dose drug candidate truly mitigate metab.-dependent and -independent idiosyncratic toxicity risks.  In an effort to address these questions, we have retrospectively examd. 68 drugs (recalled or assocd. with a black box warning due to idiosyncratic toxicity) and the top 200 drugs (prescription and sales) in the United States in 2009 for trends in physiochem. characteristics, daily doses, presence of structural alerts, evidence for RM formation as well as toxicity mechanism(s) potentially mediated by parent drugs.  Collectively, our anal. revealed that a significant proportion (∼78-86%) of drugs assocd. with toxicity contained structural alerts and evidence indicating that RM formation as a causative factor for toxicity has been presented in 62-69% of these mols.  In several cases, mitochondrial toxicity and BSEP inhibition mediated by parent drugs were also noted as potential causative factors.  Most drugs were administered at daily doses exceeding several hundred milligrams.  There was no obvious link between idiosyncratic toxicity and physicochem. properties such as mol. wt., lipophilicity, etc.  Approx. half of the top 200 drugs for 2009 (prescription and sales) also contained one or more alerts in their chem. architecture, and many were found to be RM-pos.  Several instances of BSEP and mitochondrial liabilities were also noted with agents in the top 200 category.  However, with relatively few exceptions, the vast majority of these drugs are rarely assocd. with idiosyncratic toxicity, despite years of patient use.  The major differentiating factor appeared to be the daily dose; most of the drugs in the top 200 list are administered at low daily doses.  In addn., competing detoxication pathways and/or alternate nonmetabolic clearance routes provided suitable justifications for the safety records of RM-pos. drugs in the top 200 category.  Thus, while RM elimination may be a useful and pragmatic starting point in mitigating idiosyncratic toxicity risks, our anal. suggests a need for a more integrated screening paradigm for chem. hazard identification in drug discovery.  Thus, in addn. to a detailed assessment of RM formation potential (in relationship to the overall elimination mechanisms of the compd.(s)) for lead compds., effects on cellular health (e.g., cytotoxicity assays), BSEP inhibition, and mitochondrial toxicity are the recommended suite of assays to characterize compd. liabilities.  However, the prospective use of such data in compd. selection will require further validation of the cellular assays using marketed agents.  Until we gain a better understanding of the pathophysiol. mechanisms assocd. with idiosyncratic toxicities, improving pharmacokinetics and intrinsic potency as means of decreasing the dose size and the assocd. "body burden" of the parent drug and its metabolites will remain an overarching goal in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3IhczIcvVDLVg90H21EOLACvtfcHk0li-KIequ0utDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXos1Whtbo%253D&md5=632b73f755738e49eb233bc8dca1fbcc</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Ftx200168d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx200168d%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DBauman%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DAleo%26aufirst%3DM.%2BD.%26atitle%3DStructural%2520alert%252Freactive%2520metabolite%2520concept%2520as%2520applied%2520in%2520medicinal%2520chemistry%2520to%2520mitigate%2520the%2520risk%2520of%2520idiosyncratic%2520drug%2520toxicity%253A%2520a%2520perspective%2520based%2520on%2520the%2520critical%2520examination%2520of%2520trends%2520in%2520the%2520top%2520200%2520drugs%2520marketed%2520in%2520the%2520United%2520States%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26spage%3D1345%26epage%3D1410%26doi%3D10.1021%2Ftx200168d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Hilpert, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guba, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woltering, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wostl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayweg, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers-Evans, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humm, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krummenacher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muser, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnider, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozmen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergadano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochstrasser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuglstatter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David-Pierson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narquizian, R.</span><span> </span><span class="NLM_article-title">β-Secretase (BACE1) inhibitors with high in vivo efficacy suitable for clinical evaluation in Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3980</span><span class="NLM_x">–</span> <span class="NLM_lpage">3995</span><span class="refDoi"> DOI: 10.1021/jm400225m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400225m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtVymuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3980-3995&author=H.+Hilpertauthor=W.+Gubaauthor=T.+J.+Wolteringauthor=W.+Wostlauthor=E.+Pinardauthor=H.+Mauserauthor=A.+V.+Maywegauthor=M.+Rogers-Evansauthor=R.+Hummauthor=D.+Krummenacherauthor=T.+Muserauthor=C.+Schniderauthor=H.+Jacobsenauthor=L.+Ozmenauthor=A.+Bergadanoauthor=D.+W.+Bannerauthor=R.+Hochstrasserauthor=A.+Kuglstatterauthor=P.+David-Piersonauthor=H.+Fischerauthor=A.+Polaraauthor=R.+Narquizian&title=%CE%B2-Secretase+%28BACE1%29+inhibitors+with+high+in+vivo+efficacy+suitable+for+clinical+evaluation+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm400225m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase (BACE1) Inhibitors with High in Vivo Efficacy Suitable for Clinical Evaluation in Alzheimer's Disease</span></div><div class="casAuthors">Hilpert, Hans; Guba, Wolfgang; Woltering, Thomas J.; Wostl, Wolfgang; Pinard, Emmanuel; Mauser, Harald; Mayweg, Alexander V.; Rogers-Evans, Mark; Humm, Roland; Krummenacher, Daniela; Muser, Thorsten; Schnider, Christian; Jacobsen, Helmut; Ozmen, Laurence; Bergadano, Alessandra; Banner, David W.; Hochstrasser, Remo; Kuglstatter, Andreas; David-Pierson, Pascale; Fischer, Holger; Polara, Alessandra; Narquizian, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3980-3995</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An extensive fluorine scan of 1,3-oxazines revealed the power of fluorine(s) to lower the pKa and thereby dramatically change the pharmacol. profile of this class of BACE1 inhibitors.  The CF3 substituted oxazine 89, a potent and highly brain penetrant BACE1 inhibitor, was able to reduce significantly CSF Aβ40 and 42 in rats at oral doses as low as 1 mg/kg.  The effect was long lasting, showing a significant redn. of Aβ40 and 42 even after 24 h.  In contrast to 89, compd. 1b lacking the CF3 group was virtually inactive in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmoKRrAxxHErVg90H21EOLACvtfcHk0lg6Iy67V0ENRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtVymuro%253D&md5=e5d311d1c8fecfaed043d3a0bf16c168</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm400225m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400225m%26sid%3Dliteratum%253Aachs%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DWoltering%26aufirst%3DT.%2BJ.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DMauser%26aufirst%3DH.%26aulast%3DMayweg%26aufirst%3DA.%2BV.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DHumm%26aufirst%3DR.%26aulast%3DKrummenacher%26aufirst%3DD.%26aulast%3DMuser%26aufirst%3DT.%26aulast%3DSchnider%26aufirst%3DC.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DBergadano%26aufirst%3DA.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DHochstrasser%26aufirst%3DR.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DDavid-Pierson%26aufirst%3DP.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DPolara%26aufirst%3DA.%26aulast%3DNarquizian%26aufirst%3DR.%26atitle%3D%25CE%25B2-Secretase%2520%2528BACE1%2529%2520inhibitors%2520with%2520high%2520in%2520vivo%2520efficacy%2520suitable%2520for%2520clinical%2520evaluation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3980%26epage%3D3995%26doi%3D10.1021%2Fjm400225m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Audia, J. E.; Mergot, D. J.; Sheehan, S. M.; Watson, B. M.</span><span> </span><span class="NLM_article-title">Aminodihydrothiazine derivatives as BACE inhibitors for the treatment of Alzheimer’s disease</span>. WO2009134617,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=J.+E.+Audia&author=D.+J.+Mergot&author=S.+M.+Sheehan&author=B.+M.+Watson&title=Aminodihydrothiazine+derivatives+as+BACE+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DAminodihydrothiazine%2520derivatives%2520as%2520BACE%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Butler, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreiro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vajdos, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parris, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varghese, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helal, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lira, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzon, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutra, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Alsina, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogilvie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atchison, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robshaw, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. T.</span><span> </span><span class="NLM_article-title">Discovery of a series of efficient, centrally efficacious BACE1 inhibitors through structure-based drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2678</span><span class="NLM_x">–</span> <span class="NLM_lpage">2702</span><span class="refDoi"> DOI: 10.1021/jm501833t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501833t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtVSjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2678-2702&author=C.+R.+Butlerauthor=M.+A.+Brodneyauthor=E.+M.+Beckauthor=G.+Barreiroauthor=C.+E.+Nolanauthor=F.+Panauthor=F.+Vajdosauthor=K.+Parrisauthor=A.+H.+Vargheseauthor=C.+J.+Helalauthor=R.+Liraauthor=S.+D.+Doranauthor=D.+R.+Riddellauthor=L.+M.+Buzonauthor=J.+K.+Dutraauthor=L.+A.+Martinez-Alsinaauthor=K.+Ogilvieauthor=J.+C.+Murrayauthor=J.+M.+Youngauthor=K.+Atchisonauthor=A.+Robshawauthor=C.+Gonzalesauthor=J.+Wangauthor=Y.+Zhangauthor=B.+T.+O%E2%80%99Neill&title=Discovery+of+a+series+of+efficient%2C+centrally+efficacious+BACE1+inhibitors+through+structure-based+drug+design&doi=10.1021%2Fjm501833t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Series of Efficient, Centrally Efficacious BACE1 Inhibitors through Structure-Based Drug Design</span></div><div class="casAuthors">Butler, Christopher R.; Brodney, Michael A.; Beck, Elizabeth M.; Barreiro, Gabriela; Nolan, Charles E.; Pan, Feng; Vajdos, Felix; Parris, Kevin; Varghese, Alison H.; Helal, Christopher J.; Lira, Ricardo; Doran, Shawn D.; Riddell, David R.; Buzon, Leanne M.; Dutra, Jason K.; Martinez-Alsina, Luis A.; Ogilvie, Kevin; Murray, John C.; Young, Joseph M.; Atchison, Kevin; Robshaw, Ashley; Gonzales, Cathleen; Wang, Jinlong; Zhang, Yong; O'Neill, Brian T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2678-2702</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of centrally efficacious β-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease (AD) has historically been thwarted by an inability to maintain alignment of potency, brain availability, and desired absorption, distribution, metab., and excretion (ADME) properties.  In this paper, the authors describe a series of truncated, fused thioamidines that are efficiently selective in garnering BACE1 activity without simultaneously inhibiting the closely related cathepsin D or neg. impacting brain penetration and ADME alignment, as exemplified by I.  Upon oral administration, these inhibitors exhibit robust brain availability and are efficacious in lowering central Amyloid β (Aβ) levels in mouse and dog.  In addn., chronic treatment in aged PS1/APP mice effects a decrease in the no. and size of Aβ-derived plaques.  Most importantly, evaluation of I in a 2-wk exploratory toxicol. study revealed no accumulation of autofluorescent material in retinal pigment epithelium or histol. findings in the eye, issues obsd. with earlier BACE1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiNT62AGyml7Vg90H21EOLACvtfcHk0lg6Iy67V0ENRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtVSjtro%253D&md5=ac2a6fd661f7e9fd8b925deffd5e1010</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm501833t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501833t%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DC.%2BR.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DPan%26aufirst%3DF.%26aulast%3DVajdos%26aufirst%3DF.%26aulast%3DParris%26aufirst%3DK.%26aulast%3DVarghese%26aufirst%3DA.%2BH.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DRiddell%26aufirst%3DD.%2BR.%26aulast%3DBuzon%26aufirst%3DL.%2BM.%26aulast%3DDutra%26aufirst%3DJ.%2BK.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%2BA.%26aulast%3DOgilvie%26aufirst%3DK.%26aulast%3DMurray%26aufirst%3DJ.%2BC.%26aulast%3DYoung%26aufirst%3DJ.%2BM.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DRobshaw%26aufirst%3DA.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DDiscovery%2520of%2520a%2520series%2520of%2520efficient%252C%2520centrally%2520efficacious%2520BACE1%2520inhibitors%2520through%2520structure-based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2678%26epage%3D2702%26doi%3D10.1021%2Fjm501833t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Shalaeva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenseth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastin, A.</span><span> </span><span class="NLM_article-title">Measurement of dissociation constants (p<i>K</i><sub>a</sub> values) of organic compounds by multiplexed capillary electrophoresis using aqueous and cosolvent buffers</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">2581</span><span class="NLM_x">–</span> <span class="NLM_lpage">2606</span><span class="refDoi"> DOI: 10.1002/jps.21287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1002%2Fjps.21287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=18228610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotF2mu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2008&pages=2581-2606&author=M.+Shalaevaauthor=J.+Kensethauthor=F.+Lombardoauthor=A.+Bastin&title=Measurement+of+dissociation+constants+%28pKa+values%29+of+organic+compounds+by+multiplexed+capillary+electrophoresis+using+aqueous+and+cosolvent+buffers&doi=10.1002%2Fjps.21287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Measurement of dissociation constants (pKa values) of organic compounds by multiplexed capillary electrophoresis using aqueous and cosolvent buffers</span></div><div class="casAuthors">Shalaeva, Marina; Kenseth, Jeremy; Lombardo, Franco; Bastin, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2581-2606</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Evaluation of a multiplexed capillary electrophoresis (CE) method for pKa measurements of org. compds., including low soly. compds., is presented.  The method is validated on a set of 105 diverse compds., mostly drugs, and results are compared to literature values obtained from multiple refs.  Two versions of the instrument in two different labs were used to collect data over a period of 3 years and inter-lab. and inter-instrument variations are discussed.  Twenty-four point aq. and mixed cosolvent buffer systems were employed to improve the accuracy of pKa measurements.  It has been demonstrated that the method allows direct pKa measurements in aq. buffers for many compds. of low soly., often unattainable by other methods.  The pKa measurements of compds. with extremely low soly. using multiplexed CE with methanol/water cosolvent buffers are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIyedITaWF77Vg90H21EOLACvtfcHk0lg6Iy67V0ENRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotF2mu78%253D&md5=0945460c6ace92ced07cfc4209995c7d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fjps.21287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21287%26sid%3Dliteratum%253Aachs%26aulast%3DShalaeva%26aufirst%3DM.%26aulast%3DKenseth%26aufirst%3DJ.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DBastin%26aufirst%3DA.%26atitle%3DMeasurement%2520of%2520dissociation%2520constants%2520%2528pKa%2520values%2529%2520of%2520organic%2520compounds%2520by%2520multiplexed%2520capillary%2520electrophoresis%2520using%2520aqueous%2520and%2520cosolvent%2520buffers%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2008%26volume%3D97%26spage%3D2581%26epage%3D2606%26doi%3D10.1002%2Fjps.21287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos-Korcsok, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robshaw, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barricklow, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, M.</span><span> </span><span class="NLM_article-title">Cerebrospinal fluid amyloid-β (Aβ) as an effect biomarker for brain Aβ lowering verified by quantitative preclinical analyses</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">342</span><span class="NLM_x">, </span> <span class="NLM_fpage">366</span><span class="NLM_x">–</span> <span class="NLM_lpage">375</span><span class="refDoi"> DOI: 10.1124/jpet.112.192625</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1124%2Fjpet.112.192625" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=22562771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOru7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2012&pages=366-375&author=Y.+Luauthor=D.+Riddellauthor=E.+Hajos-Korcsokauthor=K.+Balesauthor=K.+M.+Woodauthor=C.+E.+Nolanauthor=A.+E.+Robshawauthor=L.+Zhangauthor=L.+Leungauthor=S.+L.+Beckerauthor=E.+Tsengauthor=J.+Barricklowauthor=E.+H.+Millerauthor=S.+Osgoodauthor=B.+T.+O%E2%80%99Neillauthor=M.+A.+Brodneyauthor=D.+S.+Johnsonauthor=M.+Pettersson&title=Cerebrospinal+fluid+amyloid-%CE%B2+%28A%CE%B2%29+as+an+effect+biomarker+for+brain+A%CE%B2+lowering+verified+by+quantitative+preclinical+analyses&doi=10.1124%2Fjpet.112.192625"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Cerebrospinal fluid amyloid-β (Aβ) as an effect biomarker for brain Aβ lowering verified by quantitative preclinical analyses</span></div><div class="casAuthors">Lu, Yasong; Riddell, David; Hajos-Korcsok, Eva; Bales, Kelly; Wood, Kathleen M.; Nolan, Charles E.; Robshaw, Ashley E.; Zhang, Liming; Leung, Louis; Becker, Stacey L.; Tseng, Elaine; Barricklow, Jason; Miller, Emily H.; Osgood, Sarah; O'Neill, Brian T.; Brodney, Michael A.; Johnson, Douglas S.; Pettersson, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">342</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">366-375</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Reducing the generation of amyloid-β (Aβ) in the brain via inhibition of β-secretase or inhibition/modulation of γ-secretase has been pursued as a potential disease-modifying treatment for Alzheimer's disease.  For the discovery and development of β-secretase inhibitors (BACEi), γ-secretase inhibitors (GSI), and γ-secretase modulators (GSM), Aβ in cerebrospinal fluid (CSF) has been presumed to be an effect biomarker for Aβ lowering in the brain.  However, this presumption is challenged by the lack of quant. understanding of the relationship between brain and CSF Aβ lowering.  In this study, we strived to elucidate how the intrinsic pharmacokinetic (PK)/pharmacodynamic (PD) relationship for CSF Aβ lowering is related to that for brain Aβ through quant. modeling of preclin. data for numerous BACEi, GSI, and GSM across multiple species.  Our results indicate that the intrinsic PK/PD relationship in CSF is predictive of that in brain, at least in the postulated pharmacol. relevant range, with excellent consistency across mechanisms and species.  As such, the validity of CSF Aβ as an effect biomarker for brain Aβ lowering is confirmed preclinically.  Meanwhile, we have been able to reproduce the dose-dependent sepn. between brain and CSF effect profiles using simulations.  We further discuss the implications of our findings to drug discovery and development with regard to preclin. PK/PD characterization and clin. prediction of Aβ lowering in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0fekVpcL50rVg90H21EOLACvtfcHk0liVT328j_FyLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOru7vN&md5=65443990fd05b2244ce611e91629341e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.192625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.192625%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DY.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DHajos-Korcsok%26aufirst%3DE.%26aulast%3DBales%26aufirst%3DK.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DRobshaw%26aufirst%3DA.%2BE.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLeung%26aufirst%3DL.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DBarricklow%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DE.%2BH.%26aulast%3DOsgood%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DPettersson%26aufirst%3DM.%26atitle%3DCerebrospinal%2520fluid%2520amyloid-%25CE%25B2%2520%2528A%25CE%25B2%2529%2520as%2520an%2520effect%2520biomarker%2520for%2520brain%2520A%25CE%25B2%2520lowering%2520verified%2520by%2520quantitative%2520preclinical%2520analyses%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D342%26spage%3D366%26epage%3D375%26doi%3D10.1124%2Fjpet.112.192625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rendic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlo, F. J. D.</span><span> </span><span class="NLM_article-title">Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors</span> <span class="citation_source-journal">Drug Metab. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">580</span><span class="refDoi"> DOI: 10.3109/03602539709037591</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.3109%2F03602539709037591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=9187528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADyaK2sXkt1Onur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1997&pages=413-580&author=S.+Rendicauthor=F.+J.+D.+Carlo&title=Human+cytochrome+P450+enzymes%3A+a+status+report+summarizing+their+reactions%2C+substrates%2C+inducers%2C+and+inhibitors&doi=10.3109%2F03602539709037591"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors</span></div><div class="casAuthors">Rendic, Slobodan; Di Carlo, Frederick J.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1 & 2</span>),
    <span class="NLM_cas:pages">413-580</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Dekker</span>)
        </div><div class="casAbstract">A review with 295 refs.  Topics discussed include: cytochrome P 450 enzymes; superfamily of CYP enzymes and metab. of xenobiotics and physiol. compds.; an extensive compilation of information on human cytochrome P 450 enzymes (catalytic activity, substrate specificity, inducers, inhibitors).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKNrQWd5tzi7Vg90H21EOLACvtfcHk0liVT328j_FyLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkt1Onur8%253D&md5=f9261b74fbf47c6eeb965c6a3eb35635</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.3109%2F03602539709037591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F03602539709037591%26sid%3Dliteratum%253Aachs%26aulast%3DRendic%26aufirst%3DS.%26aulast%3DCarlo%26aufirst%3DF.%2BJ.%2BD.%26atitle%3DHuman%2520cytochrome%2520P450%2520enzymes%253A%2520a%2520status%2520report%2520summarizing%2520their%2520reactions%252C%2520substrates%252C%2520inducers%252C%2520and%2520inhibitors%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D1997%26volume%3D29%26spage%3D413%26epage%3D580%26doi%3D10.3109%2F03602539709037591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Teh, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertilsson, L.</span><span> </span><span class="NLM_article-title">Pharmacogenomics of CYP 2D6: molecular genetics, interethnic differences and clinical importance</span> <span class="citation_source-journal">Drug Metab. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span><span class="refDoi"> DOI: 10.2133/dmpk.DMPK-11-RV-121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.2133%2Fdmpk.DMPK-11-RV-121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=22185816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1Ggtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2012&pages=55-67&author=L.+K.+Tehauthor=L.+Bertilsson&title=Pharmacogenomics+of+CYP+2D6%3A+molecular+genetics%2C+interethnic+differences+and+clinical+importance&doi=10.2133%2Fdmpk.DMPK-11-RV-121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacogenomics of CYP2D6: molecular genetics, interethnic differences and clinical importance</span></div><div class="casAuthors">Teh, Lay Kek; Bertilsson, Leif</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-67</span>CODEN:
                <span class="NLM_cas:coden">DMPRB8</span>;
        ISSN:<span class="NLM_cas:issn">1347-4367</span>.
    
            (<span class="NLM_cas:orgname">Japanese Society for the Study of Xenobiotics</span>)
        </div><div class="casAbstract">A review.  CYP2D6 has received intense attention since the beginning of the pharmacogenetic era in the 1970s.  This is because of its involvement in the metab. of more than 25% of the marketed drugs, the large geog. and inter-ethnic differences in the genetic polymorphism and possible drug-induced toxicity.  Many interesting reviews have been published on CYP2D6 and this review aims to reinstate the importance of the genetic polymorphism of CYP2D6 in different populations as well as some clin. implications and important drug interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvyrqscYrvpLVg90H21EOLACvtfcHk0liVT328j_FyLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1Ggtrw%253D&md5=3e5ec4e479ebd0d03f6e4d4b7415e6ef</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.2133%2Fdmpk.DMPK-11-RV-121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2133%252Fdmpk.DMPK-11-RV-121%26sid%3Dliteratum%253Aachs%26aulast%3DTeh%26aufirst%3DL.%2BK.%26aulast%3DBertilsson%26aufirst%3DL.%26atitle%3DPharmacogenomics%2520of%2520CYP%25202D6%253A%2520molecular%2520genetics%252C%2520interethnic%2520differences%2520and%2520clinical%2520importance%26jtitle%3DDrug%2520Metab.%2520Pharmacokinet.%26date%3D2012%26volume%3D27%26spage%3D55%26epage%3D67%26doi%3D10.2133%2Fdmpk.DMPK-11-RV-121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bertilsson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahl, M.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalén, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Shurbaji, A.</span><span> </span><span class="NLM_article-title">Molecular genetics of CYP 2D6: Clinical relevance with focus on psychotropic drugs</span> <span class="citation_source-journal">br J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span><span class="refDoi"> DOI: 10.1046/j.0306-5251.2001.01548.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1046%2Fj.0306-5251.2001.01548.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2002&pages=111-122&author=L.+Bertilssonauthor=M.-L.+Dahlauthor=P.+Dal%C3%A9nauthor=A.+Al-Shurbaji&title=Molecular+genetics+of+CYP+2D6%3A+Clinical+relevance+with+focus+on+psychotropic+drugs&doi=10.1046%2Fj.0306-5251.2001.01548.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24c&amp;dbid=16384&amp;doi=10.1046%2Fj.0306-5251.2001.01548.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.0306-5251.2001.01548.x%26sid%3Dliteratum%253Aachs%26aulast%3DBertilsson%26aufirst%3DL.%26aulast%3DDahl%26aufirst%3DM.-L.%26aulast%3DDal%25C3%25A9n%26aufirst%3DP.%26aulast%3DAl-Shurbaji%26aufirst%3DA.%26atitle%3DMolecular%2520genetics%2520of%2520CYP%25202D6%253A%2520Clinical%2520relevance%2520with%2520focus%2520on%2520psychotropic%2520drugs%26jtitle%3Dbr%2520J.%2520Clin.%2520Pharmacol.%26date%3D2002%26volume%3D53%26spage%3D111%26epage%3D122%26doi%3D10.1046%2Fj.0306-5251.2001.01548.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Brodney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreiro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parris, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atchison, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robshaw, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundesmann, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutra, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henegar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaChapelle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lira, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Alsina, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikochik, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogilvie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakya, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. T.</span><span> </span><span class="NLM_article-title">Utilizing structures of CYP 2D6 and BACE1 complexes to reduce risk of drug–drug interactions with a novel series of centrally efficacious BACE1 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3223</span><span class="NLM_x">–</span> <span class="NLM_lpage">3252</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00191</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00191" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3223-3252&author=M.+A.+Brodneyauthor=E.+M.+Beckauthor=C.+R.+Butlerauthor=G.+Barreiroauthor=E.+F.+Johnsonauthor=D.+Riddellauthor=K.+Parrisauthor=C.+E.+Nolanauthor=Y.+Fanauthor=K.+Atchisonauthor=C.+Gonzalesauthor=A.+E.+Robshawauthor=S.+D.+Doranauthor=M.+W.+Bundesmannauthor=L.+Buzonauthor=J.+Dutraauthor=K.+Henegarauthor=E.+LaChapelleauthor=X.+Houauthor=B.+N.+Rogersauthor=J.+Panditauthor=R.+Liraauthor=L.+Martinez-Alsinaauthor=P.+Mikochikauthor=J.+C.+Murrayauthor=K.+Ogilvieauthor=L.+Priceauthor=S.+M.+Sakyaauthor=A.+Yuauthor=Y.+Zhangauthor=B.+T.+O%E2%80%99Neill&title=Utilizing+structures+of+CYP+2D6+and+BACE1+complexes+to+reduce+risk+of+drug%E2%80%93drug+interactions+with+a+novel+series+of+centrally+efficacious+BACE1+inhibitors&doi=10.1021%2Facs.jmedchem.5b00191"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00191%26sid%3Dliteratum%253Aachs%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DButler%26aufirst%3DC.%2BR.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DParris%26aufirst%3DK.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DRobshaw%26aufirst%3DA.%2BE.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DBundesmann%26aufirst%3DM.%2BW.%26aulast%3DBuzon%26aufirst%3DL.%26aulast%3DDutra%26aufirst%3DJ.%26aulast%3DHenegar%26aufirst%3DK.%26aulast%3DLaChapelle%26aufirst%3DE.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%26aulast%3DMikochik%26aufirst%3DP.%26aulast%3DMurray%26aufirst%3DJ.%2BC.%26aulast%3DOgilvie%26aufirst%3DK.%26aulast%3DPrice%26aufirst%3DL.%26aulast%3DSakya%26aufirst%3DS.%2BM.%26aulast%3DYu%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DUtilizing%2520structures%2520of%2520CYP%25202D6%2520and%2520BACE1%2520complexes%2520to%2520reduce%2520risk%2520of%2520drug%25E2%2580%2593drug%2520interactions%2520with%2520a%2520novel%2520series%2520of%2520centrally%2520efficacious%2520BACE1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3223%26epage%3D3252%26doi%3D10.1021%2Facs.jmedchem.5b00191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="note"><p class="first last">Compound <b>13</b> was prepared in analogous fashion to ref <a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">21</a>. Preparation and characterization information is included in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01451/suppl_file/jm6b01451_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Kalvass, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, T. S.</span><span> </span><span class="NLM_article-title">Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery</span> <span class="citation_source-journal">Biopharm. Drug Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span><span class="refDoi"> DOI: 10.1002/bdd.325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1002%2Fbdd.325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=12415573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVansbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=327-338&author=J.+C.+Kalvassauthor=T.+S.+Maurer&title=Influence+of+nonspecific+brain+and+plasma+binding+on+CNS+exposure%3A+implications+for+rational+drug+discovery&doi=10.1002%2Fbdd.325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery</span></div><div class="casAuthors">Kalvass, J. Cory; Maurer, Tristan S.</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">327-338</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Relative plasma, brain and cerebrospinal fluid (CSF) exposures and unbound fractions in plasma and brain were examd. for 18 proprietary compds. in rats.  The relation between in vivo brain-to-plasma ratio and in vitro plasma-to-brain unbound fraction (fu) was examd.  In addn., plasma fu and brain fu were examd. for their relation to in vivo CSF-to-plasma and CSF-to-brain ratios, resp.  Findings were delineated based on the presence or absence of active efflux.  Finally, the same comparisons were examd. in FVB vs. MDR 1a/1b knockout mice for a selected P-glycoprotein (Pgp) substrate.  For the nine compds. without indications of active efflux, predictive correlations were obsd. between ratios of brain-to-plasma exposure and plasma-to-brain fu (r2 = 0.98), CSF-to-brain exposure vs. brain fu (r2 = 0.72), and CSF-to-plasma exposure vs. plasma fu (r2 = 0.82).  For the nine compds. with indications of active efflux, nonspecific binding data tended to over predict the brain-to-plasma and CSF-to-plasma exposure ratios.  Interestingly, CSF-to-brain exposure ratio was consistently under predicted by brain fu for this set.  Using a select Pgp substrate, it was demonstrated that the brain-to-plasma exposure ratio was identical to that predicted by plasma-to-brain fu ratio in MDR 1a/1b knockout mice.  In FVB mice, plasma-to-brain fu over predicted brain-to-plasma exposure ratio to the same degree as the difference in brain-to-plasma exposure ratio between MDR 1a/1b and FVB mice.  Consistent results were obtained in rats, suggesting a similar kinetic behavior between species.  These data illustrate how an understanding of relative tissue binding (plasma, brain) can allow for a quant. examn. of active processes that det. CNS exposure.  The general applicability of this approach offers advantages over species- and mechanism-specific approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfFvLLvDQohLVg90H21EOLACvtfcHk0lgxgIpjqBaWtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsVansbk%253D&md5=96b80d1a745b254f74b9c19e8e8af627</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fbdd.325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.325%26sid%3Dliteratum%253Aachs%26aulast%3DKalvass%26aufirst%3DJ.%2BC.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26atitle%3DInfluence%2520of%2520nonspecific%2520brain%2520and%2520plasma%2520binding%2520on%2520CNS%2520exposure%253A%2520implications%2520for%2520rational%2520drug%2520discovery%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2002%26volume%3D23%26spage%3D327%26epage%3D338%26doi%3D10.1002%2Fbdd.325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Kutchinsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asmild, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taboryski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vestergaard, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krzywkowski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroder, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ljungstrom, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helix, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorensen, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bech, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willumsen, N. J.</span><span> </span><span class="NLM_article-title">Characterization of potassium channel modulators with QPatch automated patch-clamp technology: system characteristics and performance</span> <span class="citation_source-journal">Assay Drug Dev. Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">693</span><span class="refDoi"> DOI: 10.1089/154065803770381048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1089%2F154065803770381048" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=685-693&author=J.+Kutchinskyauthor=S.+Friisauthor=M.+Asmildauthor=R.+Taboryskiauthor=S.+Pedersenauthor=R.+K.+Vestergaardauthor=R.+B.+Jacobsenauthor=K.+Krzywkowskiauthor=R.+L.+Schroderauthor=T.+Ljungstromauthor=N.+Helixauthor=C.+B.+Sorensenauthor=M.+Bechauthor=N.+J.+Willumsen&title=Characterization+of+potassium+channel+modulators+with+QPatch+automated+patch-clamp+technology%3A+system+characteristics+and+performance&doi=10.1089%2F154065803770381048"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1089%2F154065803770381048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252F154065803770381048%26sid%3Dliteratum%253Aachs%26aulast%3DKutchinsky%26aufirst%3DJ.%26aulast%3DFriis%26aufirst%3DS.%26aulast%3DAsmild%26aufirst%3DM.%26aulast%3DTaboryski%26aufirst%3DR.%26aulast%3DPedersen%26aufirst%3DS.%26aulast%3DVestergaard%26aufirst%3DR.%2BK.%26aulast%3DJacobsen%26aufirst%3DR.%2BB.%26aulast%3DKrzywkowski%26aufirst%3DK.%26aulast%3DSchroder%26aufirst%3DR.%2BL.%26aulast%3DLjungstrom%26aufirst%3DT.%26aulast%3DHelix%26aufirst%3DN.%26aulast%3DSorensen%26aufirst%3DC.%2BB.%26aulast%3DBech%26aufirst%3DM.%26aulast%3DWillumsen%26aufirst%3DN.%2BJ.%26atitle%3DCharacterization%2520of%2520potassium%2520channel%2520modulators%2520with%2520QPatch%2520automated%2520patch-clamp%2520technology%253A%2520system%2520characteristics%2520and%2520performance%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2003%26volume%3D1%26spage%3D685%26epage%3D693%26doi%3D10.1089%2F154065803770381048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Bridges, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svenson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowling, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovering, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akopian, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiBlasio-Smith, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annis-Freeman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marvell, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaVallie, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zollner, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somers, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kriz, R. W.</span><span> </span><span class="NLM_article-title">A novel approach to identifying β-secretase inhibitors: Bis-statine peptide mimetics discovered using structure and spot synthesis</span> <span class="citation_source-journal">Peptides (N. Y., NY, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1877</span><span class="NLM_x">–</span> <span class="NLM_lpage">1885</span><span class="refDoi"> DOI: 10.1016/j.peptides.2006.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1016%2Fj.peptides.2006.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=16574278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsFCis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=1877-1885&author=K.+G.+Bridgesauthor=R.+Chopraauthor=L.+Linauthor=K.+Svensonauthor=A.+Tamauthor=G.+Jinauthor=R.+Cowlingauthor=F.+Loveringauthor=T.+N.+Akopianauthor=E.+DiBlasio-Smithauthor=B.+Annis-Freemanauthor=T.+H.+Marvellauthor=E.+R.+LaVallieauthor=R.+S.+Zollnerauthor=J.+Bardauthor=W.+S.+Somersauthor=M.+L.+Stahlauthor=R.+W.+Kriz&title=A+novel+approach+to+identifying+%CE%B2-secretase+inhibitors%3A+Bis-statine+peptide+mimetics+discovered+using+structure+and+spot+synthesis&doi=10.1016%2Fj.peptides.2006.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">A novel approach to identifying β-secretase inhibitors: Bis-statine peptide mimetics discovered using structure and spot synthesis</span></div><div class="casAuthors">Bridges, Kristie Grove; Chopra, Rajiv; Lin, Laura; Svenson, Kristine; Tam, Amy; Jin, Guixian; Cowling, Rebecca; Lovering, Frank; Akopian, Tatos N.; DiBlasio-Smith, Elizabeth; Annis-Freeman, Bethany; Marvell, Tod H.; LaVallie, Edward R.; Zollner, Richard S.; Bard, Jonathan; Somers, William S.; Stahl, Mark L.; Kriz, Ronald W.</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1877-1885</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">β-Secretase 1 (BACE1) is an aspartic protease believed to play a crit. role in Alzheimer's disease.  Inhibitors of this enzyme have been designed by incorporating the noncleavable hydroxyethylene and statine isosteres into peptides corresponding to BACE1 substrate sequences.  The authors sought to develop new methods to quickly characterize and optimize inhibitors based on the statine core.  Minimal sequence requirements for binding were first established using both crystallog. and peptide spot synthesis.  These shortened peptide inhibitors were then optimized by using spot synthesis to perform iterative cycles of substitution and deletion.  The present study resulted in the identification of novel "bis-statine" inhibitors shown by crystallog. to have a unique binding mode.  Our results demonstrate the application of peptide spot synthesis as an effective method for enhancing peptidomimetic drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkQbYX8NmEhLVg90H21EOLACvtfcHk0ljX3WDVU9KgnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsFCis7c%253D&md5=bb58fc3d1bc2d6233295a6847a0b54fc</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.peptides.2006.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.peptides.2006.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DK.%2BG.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DSvenson%26aufirst%3DK.%26aulast%3DTam%26aufirst%3DA.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DCowling%26aufirst%3DR.%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DAkopian%26aufirst%3DT.%2BN.%26aulast%3DDiBlasio-Smith%26aufirst%3DE.%26aulast%3DAnnis-Freeman%26aufirst%3DB.%26aulast%3DMarvell%26aufirst%3DT.%2BH.%26aulast%3DLaVallie%26aufirst%3DE.%2BR.%26aulast%3DZollner%26aufirst%3DR.%2BS.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DSomers%26aufirst%3DW.%2BS.%26aulast%3DStahl%26aufirst%3DM.%2BL.%26aulast%3DKriz%26aufirst%3DR.%2BW.%26atitle%3DA%2520novel%2520approach%2520to%2520identifying%2520%25CE%25B2-secretase%2520inhibitors%253A%2520Bis-statine%2520peptide%2520mimetics%2520discovered%2520using%2520structure%2520and%2520spot%2520synthesis%26jtitle%3DPeptides%2520%2528N.%2520Y.%252C%2520NY%252C%2520U.%2520S.%2529%26date%3D2006%26volume%3D27%26spage%3D1877%26epage%3D1885%26doi%3D10.1016%2Fj.peptides.2006.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Vonrhein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flensburg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smart, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paciorek, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Womack, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bricogne, G.</span><span> </span><span class="NLM_article-title">Data processing and analysis with the <i>autoPROC</i> toolbox</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span><span class="refDoi"> DOI: 10.1107/S0907444911007773</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1107%2FS0907444911007773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=21460447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=293-302&author=C.+Vonrheinauthor=C.+Flensburgauthor=P.+Kellerauthor=A.+Sharffauthor=O.+Smartauthor=W.+Paciorekauthor=T.+Womackauthor=G.+Bricogne&title=Data+processing+and+analysis+with+the+autoPROC+toolbox&doi=10.1107%2FS0907444911007773"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Data processing and analysis with the autoPROC toolbox</span></div><div class="casAuthors">Vonrhein, Clemens; Flensburg, Claus; Keller, Peter; Sharff, Andrew; Smart, Oliver; Paciorek, Wlodek; Womack, Thomas; Bricogne, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">293-302</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A typical diffraction expt. will generate many images and data sets from different crystals in a very short time.  This creates a challenge for the high-throughput operation of modern synchrotron beamlines as well as for the subsequent data processing.  Novice users in particular may feel overwhelmed by the tables, plots and nos. that the different data-processing programs and software packages present to them.  Here, some of the more common problems that a user has to deal with when processing a set of images that will finally make up a processed data set are shown, concg. on difficulties that may often show up during the first steps along the path of turning the expt. (i.e. data collection) into a model (i.e. interpreted electron d.).  Difficulties such as unexpected crystal forms, issues in crystal handling and suboptimal choices of data-collection strategies can often be dealt with, or at least diagnosed, by analyzing specific data characteristics during processing.  In the end, one wants to distinguish problems over which one has no immediate control once the expt. is finished from problems that can be remedied a posteriori.  A new software package, autoPROC, is also presented that combines third-party processing programs with new tools and an automated workflow script that is intended to provide users with both guidance and insight into the offline processing of data affected by the difficulties mentioned above, with particular emphasis on the automated treatment of multi-sweep data sets collected on multi-axis goniostats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmah7iUrMLXLVg90H21EOLACvtfcHk0ljX3WDVU9KgnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLs%253D&md5=a0a3579f6b371b6312819883864aa80d</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1107%2FS0907444911007773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911007773%26sid%3Dliteratum%253Aachs%26aulast%3DVonrhein%26aufirst%3DC.%26aulast%3DFlensburg%26aufirst%3DC.%26aulast%3DKeller%26aufirst%3DP.%26aulast%3DSharff%26aufirst%3DA.%26aulast%3DSmart%26aufirst%3DO.%26aulast%3DPaciorek%26aufirst%3DW.%26aulast%3DWomack%26aufirst%3DT.%26aulast%3DBricogne%26aufirst%3DG.%26atitle%3DData%2520processing%2520and%2520analysis%2520with%2520the%2520autoPROC%2520toolbox%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D293%26epage%3D302%26doi%3D10.1107%2FS0907444911007773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Kabsch, W.</span><span> </span><span class="NLM_article-title">XDS</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=XDS&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0ljX3WDVU9KgnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">French, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K.</span><span> </span><span class="NLM_article-title">On the treatment of negative intensity observations</span> <span class="citation_source-journal">Acta Crystallogr., Sect. A: Cryst. Phys., Diffr., Theor. Gen. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">A34</span><span class="NLM_x">, </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">525</span><span class="refDoi"> DOI: 10.1107/S0567739478001114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1107%2FS0567739478001114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADyaE1cXkvVehu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=A34&publication_year=1978&pages=517-525&author=S.+Frenchauthor=K.+Wilson&title=On+the+treatment+of+negative+intensity+observations&doi=10.1107%2FS0567739478001114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32aR"><div class="casContent"><span class="casTitleNuber">32a</span><div class="casTitle"><span class="NLM_cas:atitle">On the treatment of negative intensity observations</span></div><div class="casAuthors">French, Simon; Wilson, Keith</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section A:  Crystal Physics, Diffraction, Theoretical and General Crystallography</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">A34</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">517-25</span>CODEN:
                <span class="NLM_cas:coden">ACACBN</span>;
        ISSN:<span class="NLM_cas:issn">0567-7394</span>.
    </div><div class="casAbstract">A method is described which produces sensible ests. of the structure factor moduli from intensity observations, whether the latter are pos. or neg.  Preliminary applications of the method to data from the protein phosphorylase b are summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyzMPfrZ9OTbVg90H21EOLACvtfcHk0ljf69n46JNsow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXkvVehu7o%253D&md5=7506d033509f63ebc9c5a06bcdd3e388</span></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.1107%2FS0567739478001114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0567739478001114%26sid%3Dliteratum%253Aachs%26aulast%3DFrench%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DK.%26atitle%3DOn%2520the%2520treatment%2520of%2520negative%2520intensity%2520observations%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520A%253A%2520Cryst.%2520Phys.%252C%2520Diffr.%252C%2520Theor.%2520Gen.%2520Crystallogr.%26date%3D1978%26volume%3DA34%26spage%3D517%26epage%3D525%26doi%3D10.1107%2FS0567739478001114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Collaborative computational project, number 4</span><span> </span><span class="NLM_article-title">The <i>CCP4</i> suite: programs for protein crystallography</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">760</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span><span class="refDoi"> DOI: 10.1107/S0907444994003112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1107%2FS0907444994003112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=15299374" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1994&pages=760-763&author=Collaborative+computational+project%2C+number+4&title=The+CCP4+suite%3A+programs+for+protein+crystallography&doi=10.1107%2FS0907444994003112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=10.1107%2FS0907444994003112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444994003112%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DThe%2520CCP4%2520suite%253A%2520programs%2520for%2520protein%2520crystallography%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1994%26volume%3D50%26spage%3D760%26epage%3D763%26doi%3D10.1107%2FS0907444994003112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span> </span><span class="NLM_article-title">Refinement of macromolecular structures by the maximum-likelihood method</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">D53</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span><span class="refDoi"> DOI: 10.1107/S0907444996012255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D53&publication_year=1997&pages=240-255&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+macromolecular+structures+by+the+maximum-likelihood+method&doi=10.1107%2FS0907444996012255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. σA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial α-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0ljf69n46JNsow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520macromolecular%2520structures%2520by%2520the%2520maximum-likelihood%2520method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3DD53%26spage%3D240%26epage%3D255%26doi%3D10.1107%2FS0907444996012255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Bricogne, G.; Blanc, E.; Brandl, M.; Flensburg, C.; Keller, P.; Paciorek, W.; Roversi, P.; Smart, O. S.; Vonrhein, C.; Womack, T. O.</span>BUSTER; <span class="NLM_publisher-name">Global Phasing Ltd</span>: <span class="NLM_publisher-loc">Cambridge, UK</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=P.+Roversi&author=O.+S.+Smart&author=C.+Vonrhein&author=T.+O.+Womack&title=BUSTER"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26jtitle%3DBUSTER%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title"><i>Coot</i>: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">D60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span><span class="refDoi"> DOI: 10.1107/S0907444904019158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics&doi=10.1107%2FS0907444904019158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0ljf69n46JNsow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3DD60%26spage%3D2126%26epage%3D2132%26doi%3D10.1107%2FS0907444904019158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afonine, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunkoczi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Echols, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headd, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, L.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapral, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriarty, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oeffner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terwilliger, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwart, P. H.</span><span> </span><span class="NLM_article-title">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span><span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunkocziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.-W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+a+comprehensive+Python-based+system+for+macromolecular+structure+solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0lhMHJeKSBWxrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunkoczi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.-W.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520a%2520comprehensive%2520Python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZMG" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZMG','PDB','3ZMG'); return false;">PDB: 3ZMG</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T1U" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T1U','PDB','5T1U'); return false;">PDB: 5T1U</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XRY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XRY','PDB','4XRY'); return false;">PDB: 4XRY</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T1W" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T1W','PDB','5T1W'); return false;">PDB: 5T1W</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TFT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TFT','PDB','5TFT'); return false;">PDB: 5TFT</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TFU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TFU','PDB','5TFU'); return false;">PDB: 5TFU</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i77"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01451">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_82323"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01451">10.1021/acs.jmedchem.6b01451</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Data collection and refinement statistics for crystal structures of BACE1 with <b>6u</b> and <b>16</b>, and CYP 2D6 with <b>6u</b> and <b>12</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01451/suppl_file/jm6b01451_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01451/suppl_file/jm6b01451_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01451/suppl_file/jm6b01451_si_001.pdf">jm6b01451_si_001.pdf (218.21 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01451/suppl_file/jm6b01451_si_002.csv">jm6b01451_si_002.csv (1.76 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Atomic coordinates and structure factors for the following BACE1 cocrystal structures have been deposited with the RCSB: compound <b>6u</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T1U">5T1U</a>), compound <b>16</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T1W">5T1W</a>). Atomic coordinates and structure factors have been desposited with the RCSB for crystal structures of CYP 2D6 complexed with compound <b>6u</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TFT">5TFT</a>), and with compound <b>12</b> (PDB:<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TFU">5TFU</a>).</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01451&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-1%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01451" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01451" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67994bdb994dd18b","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
